CRISPRimmunity

Please click to download your results

Overview of predicted results

Overview of the results

Contig_ID	Contig_def	CRISPR array number	Contig Signature genes	Self targeting spacer number	Target MGE spacer number	Prophage number	Anti-CRISPR protein number
NZ_CP033459	Alloprevotella sp. E39 chromosome, complete genome	9 crisprs	DEDDh,PD-DExK,WYL,cas9,cas1,cas2,RT	1	9	0	0

Results visualization

Click the left colored region to show detailed information

CRISPR-Cas detection and classification

Crispr_ID: NZ_CP033459_1

CRISPR_ID

CRISPR_location

CRISPR_type

Repeat_type

Spacer_info

Cas_protein_info

CRISPR-Cas_info

NZ_CP033459_1

879170-879286

Orphan

Consensus_repeat	Method
ACGATACTTTAGACCAACAAATAACAGAAAGGAG	CRISPRCasFinder

1 spacers

WYL,PD-DExK

The CRISPR arrays of NZ_CP033459_1

>merge|NZ_CP033459|1|879170-879286|CRISPRCasFinder
ACGATACTTTAGACCAACAAATAACAGAAAGGAGTTAAAGAATTTCGAAGTTAACGAAGTTAGCGAAGTTAATGAAGTTAACAACGATACTTTAGACCGACAAATAACAGAAAGGAG

>NZ_CP033459|1|1|879170-879286|CRISPRCasFinder
ACGATACTTTAGACCAACAAATAACAGAAAGGAG	TTAAAGAATTTCGAAGTTAACGAAGTTAGCGAAGTTAATGAAGTTAACA
ACGATACTTTAGACCGACAAATAACAGAAAGGAG

Protein	Signature genes	Signature genes Name	Protein_function
NZ_CP033459.1\|WP_111899271.1\|879598_880972_+\|sodium-dependent-transporter	unknown	unknown	gnl\|CDD\|271367
NZ_CP033459.1\|WP_146739494.1\|886493_886796_-\|hypothetical-protein	unknown	unknown	gnl\|CDD\|366337
NZ_CP033459.1\|WP_111899262.1\|868426_870046_-\|N-6-DNA-methylase	unknown	unknown	gnl\|CDD\|280533
NZ_CP033459.1\|WP_111899297.1\|885937_886510_-\|N-acetylmuramoyl-L-alanine-amidase	unknown	unknown	gnl\|CDD\|119407
NZ_CP033459.1\|WP_111899261.1\|867275_868424_-\|DUF1016-family-protein	PD-DExK	COG4804_PD-DExK_CAS-I:CAS-III	gnl\|CDD\|377634
NZ_CP033459.1\|WP_146739493.1\|884264_884723_-\|hypothetical-protein	unknown	unknown	unknown
NZ_CP033459.1\|WP_146739495.1\|887471_889466_-\|hypothetical-protein	unknown	unknown	unknown
NZ_CP033459.1\|WP_146739491.1\|877747_878041_+\|hypothetical-protein	unknown	unknown	gnl\|CDD\|275085
NZ_CP033459.1\|WP_111899273.1\|881674_881941_-\|hypothetical-protein	unknown	unknown	unknown
NZ_CP033459.1\|WP_111899276.1\|884884_885556_-\|hypothetical-protein	unknown	unknown	gnl\|CDD\|377878
NZ_CP033459.1\|WP_111899277.1\|885634_885847_-\|hypothetical-protein	unknown	unknown	unknown
NZ_CP033459.1\|WP_111899270.1\|878159_879095_+\|class-I-SAM-dependent-methyltransferase	unknown	unknown	gnl\|CDD\|372616
NZ_CP033459.1\|WP_146739492.1\|883488_884178_+\|hypothetical-protein	unknown	unknown	unknown
NZ_CP033459.1\|WP_111899266.1\|874742_874949_-\|helix-turn-helix-transcriptional-regulator	unknown	unknown	gnl\|CDD\|238045
NZ_CP033459.1\|WP_111899268.1\|877288_877582_+\|four-helix-bundle-protein	unknown	unknown	gnl\|CDD\|319869
NZ_CP033459.1\|WP_111899267.1\|875237_876989_+\|hypothetical-protein	unknown	unknown	unknown
NZ_CP033459.1\|WP_146739490.1\|871164_873672_-\|N-6-DNA-methylase	unknown	unknown	gnl\|CDD\|280533
NZ_CP033459.1\|WP_111899265.1\|873747_874743_-\|WYL-domain-containing-protein	WYL	pfam13280_WYL_CAS-I:CAS-III	gnl\|CDD\|379100
NZ_CP033459.1\|WP_111899272.1\|880983_881688_+\|SAM-dependent-methyltransferase	unknown	unknown	gnl\|CDD\|381176
NZ_CP033459.1\|WP_111899263.1\|870050_871172_-\|hypothetical-protein	unknown	unknown	unknown

Protein	Function_ID	Function_description	E-value
NZ_CP033459.1\|WP_111899271.1\|879598_880972_+\|sodium-dependent-transporter	gnl\|CDD\|271367	cd10336, SLC6sbd_Tyt1-Like, solute carrier 6 subfamily, Fusobacterium nucleatum Tyt1-like; solute-binding domain. SLC6 proteins (also called the sodium- and chloride-dependent neurotransmitter transporter family or Na+/Cl--dependent transporter family) include neurotransmitter transporters (NTTs): these are sodium- and chloride-dependent plasma membrane transporters for the monoamine neurotransmitters serotonin (5-hydroxytryptamine), dopamine, and norepinephrine, and the amino acid neurotransmitters GABA and glycine. These NTTs are widely expressed in the mammalian brain, involved in regulating neurotransmitter signaling and homeostasis, and the target of a range of therapeutic drugs for the treatment of psychiatric diseases. Bacterial members of the SLC6 family include the LeuT amino acid transporter. An arrangement of 12 transmembrane (TM) helices appears to be as a common topological motif for eukaryotic and some prokaryotic and archaeal NTTs. However, this subfamily which contains the majority of bacterial members and some archaeal members, appears to contain only 11 TMs; for example the functional Fusobacterium nucleatum tyrosine transporter Tyt1.	5.37209e-174
NZ_CP033459.1\|WP_146739494.1\|886493_886796_-\|hypothetical-protein	gnl\|CDD\|366337	pfam00854, PTR2, POT family. The POT (proton-dependent oligopeptide transport) family all appear to be proton dependent transporters.	0.00016495
NZ_CP033459.1\|WP_111899262.1\|868426_870046_-\|N-6-DNA-methylase	gnl\|CDD\|280533	pfam02384, N6_Mtase, N-6 DNA Methylase. Restriction-modification (R-M) systems protect a bacterial cell against invasion of foreign DNA by endonucleolytic cleavage of DNA that lacks a site specific modification. The R-M system is a complex containing three polypeptides: M (this family), S (pfam01420), and R. This family consists of N-6 adenine-specific DNA methylase EC:2.1.1.72 from Type I and Type IC restriction systems. These methylases have the same sequence specificity as their corresponding restriction enzymes.	8.80595e-94
NZ_CP033459.1\|WP_111899297.1\|885937_886510_-\|N-acetylmuramoyl-L-alanine-amidase	gnl\|CDD\|119407	cd02696, MurNAc-LAA, N-acetylmuramoyl-L-alanine amidase or MurNAc-LAA (also known as peptidoglycan aminohydrolase, NAMLA amidase, NAMLAA, Amidase 3, and peptidoglycan amidase; EC 3.5.1.28) is an autolysin that hydrolyzes the amide bond between N-acetylmuramoyl and L-amino acids in certain cell wall glycopeptides. These proteins are Zn-dependent peptidases with highly conserved residues involved in cation co-ordination. MurNAc-LAA in this family is one of several peptidoglycan hydrolases (PGHs) found in bacterial and bacteriophage or prophage genomes that are involved in the degradation of the peptidoglycan. In Escherichia coli, there are five MurNAc-LAAs present: AmiA, AmiB, AmiC and AmiD that are periplasmic, and AmpD that is cytoplasmic. Three of these (AmiA, AmiB and AmiC) belong to this family, the other two (AmiD and AmpD) do not. E. coli AmiA, AmiB and AmiC play an important role in cleaving the septum to release daughter cells after cell division. In general, bacterial MurNAc-LAAs are members of the bacterial autolytic system and carry a signal peptide in their N-termini that allows their transport across the cytoplasmic membrane. However, the bacteriophage MurNAc-LAAs are endolysins since these phage-encoded enzymes break down bacterial peptidoglycan at the terminal stage of the phage reproduction cycle. As opposed to autolysins, almost all endolysins have no signal peptides and their translocation through the cytoplasmic membrane is thought to proceed with the help of phage-encoded holin proteins. The amidase catalytic module is fused to another functional module (cell wall binding module or CWBM) either at the N- or C-terminus, which is responsible for high affinity binding of the protein to the cell wall.	3.14462e-42
NZ_CP033459.1\|WP_111899261.1\|867275_868424_-\|DUF1016-family-protein	gnl\|CDD\|377634	pfam06250, DUF1016, Protein of unknown function (DUF1016). Family of uncharacterized proteins found in viruses, archaea and bacteria.	3.17663e-67
NZ_CP033459.1\|WP_146739491.1\|877747_878041_+\|hypothetical-protein	gnl\|CDD\|275085	TIGR04258, hypothetical_protein, four helix bundle suffix domain. This domain occurs as a suffix domain to some members of the much broader protein family TIGR02436, a few of whose other members are encoded within intervening sequences of bacterial 23S ribosomal RNA. Some proteins with this domain, in turn, are followed by a predicted DNA topoisomerase type C4 zinc finger.	2.22708e-07
NZ_CP033459.1\|WP_111899266.1\|874742_874949_-\|helix-turn-helix-transcriptional-regulator	gnl\|CDD\|238045	cd00093, HTH_XRE, Helix-turn-helix XRE-family like proteins. Prokaryotic DNA binding proteins belonging to the xenobiotic response element family of transcriptional regulators.	8.08982e-09
NZ_CP033459.1\|WP_111899270.1\|878159_879095_+\|class-I-SAM-dependent-methyltransferase	gnl\|CDD\|372616	pfam13489, Methyltransf_23, Methyltransferase domain. This family appears to be a methyltransferase domain.	1.74169e-22
NZ_CP033459.1\|WP_111899276.1\|884884_885556_-\|hypothetical-protein	gnl\|CDD\|377878	pfam07603, DUF1566, Protein of unknown function (DUF1566). These proteins of unknown function are found in Leptospira interrogans and in several gamma proteobacteria.	0.00192169
NZ_CP033459.1\|WP_111899268.1\|877288_877582_+\|four-helix-bundle-protein	gnl\|CDD\|319869	cd16377, 23S_rRNA_IVP_like, 23S rRNA-intervening sequence protein and similar proteins. A family of functionally uncharacterized bacterial proteins, some of which are encoded by an atypically large intervening sequence present within some 23S rRNA genes. The distantly related bAvd protein, which also forms a homopentamer of four-helix bundles, has been suggested to interact with nucleic acids and a reverse transcriptase.	2.52976e-07
NZ_CP033459.1\|WP_146739490.1\|871164_873672_-\|N-6-DNA-methylase	gnl\|CDD\|280533	pfam02384, N6_Mtase, N-6 DNA Methylase. Restriction-modification (R-M) systems protect a bacterial cell against invasion of foreign DNA by endonucleolytic cleavage of DNA that lacks a site specific modification. The R-M system is a complex containing three polypeptides: M (this family), S (pfam01420), and R. This family consists of N-6 adenine-specific DNA methylase EC:2.1.1.72 from Type I and Type IC restriction systems. These methylases have the same sequence specificity as their corresponding restriction enzymes.	9.06444e-35
NZ_CP033459.1\|WP_111899265.1\|873747_874743_-\|WYL-domain-containing-protein	gnl\|CDD\|379100	pfam13280, WYL, WYL domain. WYL is a Sm-like SH3 beta-barrel fold containing domain. It is a member of the WYL-like superfamily, named for three conserved amino acids found in a subset of the superfamily. However, these residues are not strongly conserved throughout the family. Rather, the conservation pattern includes four basic residues and a position often occupied by a cysteine, which are predicted to line a ligand-binding groove typical of the Sm-like SH3 beta-barrels. A WYL domain protein (sll7009) is a negative regulator of the I-D CRISPR-Cas system in Synechocystis sp. It is predicted to be a ligand-sensing domain that could bind negatively charged ligands, such as nucleotides or nucleic acid fragments, to regulate CRISPR-Cas and other defense systems such as the abortive infection AbiG system.	3.24776e-31
NZ_CP033459.1\|WP_111899272.1\|880983_881688_+\|SAM-dependent-methyltransferase	gnl\|CDD\|381176	cd11649, RsmI_like, uncharacterized subfamily of the tetrapyrrole methylase family similar to Ribosomal RNA small subunit methyltransferase I (RsmI). RsmI, also known as rRNA (cytidine-2'-O-)-methyltransferase, is an S-AdoMet (S-adenosyl-L-methionine or SAM)-dependent methyltransferase responsible for the 2'-O-methylation of cytidine 1402 (C1402) at the P site of bacterial 16S rRNA. Another S-AdoMet-dependent methyltransferase, RsmH (not included in this family), is responsible for N4-methylation at C1402. These methylation reactions may occur at a late step during 30S assembly in the cell. The dimethyl modification is believed to be conserved in bacteria, may play a role in fine-tuning the shape and functions of the P-site to increase the translation fidelity, and has been shown for Staphylococcus aureus, to contribute to virulence in host animals by conferring resistance to oxidative stress.	1.31616e-138

>NZ_CP033459.1|WP_111899270.1|878159_879095_+|class-I-SAM-dependent-methyltransferase
MTQETQNKQTNTDGQPKFHLDTCPLCGSTEFAKERTCTDFYASGEQFDVCRCSKCGFIFTQDAPDESVVGPYYETKDYISLSDTNEGVMNKVYHAVRNHMLKRKSRLVQQAAGMEKGTILDIGTGTGYFLHTMQQAGWKVEGIEKSAEGRKFSKEHFGLDIHDNDYLSQTDTASKDVITLWHVMEHLQQLNESWQHIARTLKPGGTLVVAVPNCGSADADHYQDYWAAYDTPRHLWHFQPDTMKAFGEKHGFELQKIHPMPFDAFYVSMLSEKYRGKSATFLRGAWQGLICYFKALGKPQRSSSVIYVFRK
>NZ_CP033459.1|WP_146739491.1|877747_878041_+|hypothetical-protein
MANCLLVLTGRLVMMISRQIERQLEDFKAEGGFTEGLTAERLEYRKQQSAHADAPPCPQCGKPMIRRVAKKRRQRRQRILELQRLSQVHGNNVDITI
>NZ_CP033459.1|WP_111899268.1|877288_877582_+|four-helix-bundle-protein
MAMQITRFGYYWLDTWVLANVIQLATQDFCSRFLNNSNDPGGRQYDQMTQAARSAPANIAEGNSRHATSKETEMKLTDVARATLSELANDYLNWLLR
>NZ_CP033459.1|WP_111899267.1|875237_876989_+|hypothetical-protein
MELIVQKILEFHDLFPKEKELDVRTILKKYSREYIVRCCHVLCNNYSNAAFIPDNNNTFFSEASKKHIPSLNERISNYLNSTGQDRVCYCTVKTALELMRVAFSIPVQEYKNKGQKEDFEYDMFRSILMLNEHLMAYTHADNLDLASLLFANNYVQNDIINQNQSDTFVRQVTHYKKLVGFIENYPKCANAHELFLQKMGINSMDEYSKTWGALVTLSMDYLKSGVKACPVFDYNQLKDEHHLISKPVLDNLCIDITATIPYDAEDAESRDNNVDYRNFRSHPLVRVDDGKYLIYSLHLLLERLYSSLFFDIKDGVKNAFGFYNKEFVERRLFQPAVLAALSKYTSFYLPSKHDVEELNSPAEKDGQPDFYIREDYNIILFECKAIRIKGEIKDKSDISELLDLLKQKLYQSTHNTDKTRKEKKKPEDLGVKQLVNLMTRIDEDTFEFDDNIPDEVAYYPVLVLEDTHLVIPGISSIINSWYKELIHKELPNQMCHPVVVMSINTLIWHKQAFARFGFHTIFNNYYSKAAKYEEDGILWSFNPLADFDTFMNEHYRISKSERQKMFNESLSALGLKKETTSVN
>NZ_CP033459.1|WP_111899266.1|874742_874949_-|helix-turn-helix-transcriptional-regulator
MDSKHLNRIKVALAEKEKTNKWLAEQLGKDQATISKWVTNTTQPNLEMLLQIAKVLEVNVNELVRPLE
>NZ_CP033459.1|WP_111899265.1|873747_874743_-|WYL-domain-containing-protein
MANVKNGSFRESIIDRCLQSRRGYSTQEIFDRCNDALERRGELPISALNTIRNDILSIENRWHIVVEQIRSGREIRYRYEDPHFSIFNTPLNEEEIAQLTQSVSMLRRFEGMPGFEWVEEMSAHLQETVSARPEPVIGFDENKELKGMSFFTPLFKAVSEKKAIKIKYYTYRSNKIIEGVIHPYYLKEYNQRWFLFALNDEYKNISIYALDRVEAMGKTSAKFIPNTEIDFSHYFDNIVGVSVKSDEVPQTVKIWVDKEQLPYTLSKPLHKSQTVIEEKEDGGAIVAIKVIPNFELEQLLLSFGERFEVLAPSSLRDKIADRIKKNMEKYQ
>NZ_CP033459.1|WP_146739490.1|871164_873672_-|N-6-DNA-methylase
MVKMQETNKMEVANNMNIENKLKRILNLFFGMNPRNKFWLLEVLLLAKRGELVICNNEIEADDFILCVVDTSILAVTGGTEKTLQDWKEKGVKAQYAVGRTTAEIKKLFSEIDNAFSERGQSQNKFFAIKQMEPLDLMEIIHILCTLPDDWFQSGVGIFTEEVLSFIARNEGKAGGMFFQPIQVTRLMTRLLGATEGSVYNPYAGLASYGMFLNDKIDYHAQEMSQMYLIARLNLLLHGKDDSHCVQGDSVSEWLGQSFDYIVATPPFHARISDAKHDTMEADFFTKAYNQAKKKVAAIVSGWFCAATGGLSFSIRKTLIEKDLVESVIRLPNNLFFGTNIATYVVILNREKEHKGKVRFVDASECFIRQGINNLLDEKMVISLLQSEDSNHSTIVDKSIFFSNGCSFIPERYIARMLLEAKDGERTIALEHILQPCSRKEIELKEGQHPIVIFPFPELQLSIKSSDIPPKDVNTHVPAYQIDEDCIIVDTRRQPRSVYVKLDGSPAYYMPYYRAFKVDTSIVLPEYLVIQLRQPYMAKQIVDGTGTIVSRGVSVLFMTAKMLLPSLDEQKAAVIRYKEQLLQEMGVHLNELNEKRLKDFEITQRERKHAVGHVLGDIYPAILDVSDFIQLNDSVSKDSIVTRQGDSLEEYVLKIVANVEKVTKMVQHFTDVEKFHSPTPLNVEKSINAYIQKKIAKNYEVVLEYLDEGELIINISEEDLHQVFDNLINNAEKYGFIDKKRYDYKVKITVSSSEDGLKAIIHIRNNGIPASKHFDVNKIFAWGEGHGDGIGCNQVKNIIEHFGGTVNYTEMGNEADGFVCDFEIVLPLTNDINND
>NZ_CP033459.1|WP_111899263.1|870050_871172_-|hypothetical-protein
MIKNILWIDDNPSNSLINRAYNKKKMNVVAKEYVDAGIEELLNPSVSYDAIILDANCVKHKPGSEEEKKANTTVNALSYALMRITEKHINLPWFVYSAGDFEGESSIAVIVNGYERSYDDKPYYSKPAEMEIMLDKIEEVIANSDLYKMKSKYPQICDFYSQNDIIELMVDYENISKFSGDVNIPHKVRNMLEMASGHLYKAGIIFFDVKGSDINKCSQFIGKNGGLVPSYIQRAFHSLVDYANPGSHYETIIRAAIQNGTAPFLNTQAFNELLTVLHWCASLDMSEDAVAKRFLDSRECAKNNKFKVYYFEGEVEKDDIGTIHCGPYVLDTKNIPTAESLIGKRIGVASKDENQDERTKRMYKFIVKKYVIV
>NZ_CP033459.1|WP_111899262.1|868426_870046_-|N-6-DNA-methylase
MAKKVSKKEETLNLDNILFKCRDILRQAKNSGSFFEKRDMMLTLVFLRFMGEKYEDGVASLRQRLIEEGLDPDDEEIIKAFFDDATFADGTFDLPVEARWSTIINTAAPQLNVALDTALRSIGETNPTLKGCFVEGTFTQRNLGANDMKKIVDEVNKISHKTFGEEKDLIGRVYEYFLKEFAVNATKEEGEFYTPHDVVQLIATVIEPFDGTLYDPCCGSGGMFIQSTDLVKAKQGDISRINVYGQEKEAATYRLAKMNLALRGISHNLGPESDSTFTKDLHKGLYFDYIMANPPFNLKGWYNDNLKNDSRWTDYATPPESNANYAWILHMLSHLKPLSGVAGFLLANGALGDTDALEIRKELIKNDKVEAIIILPRELFITTDISVTFWILNQNKKGGKYHGRQLRNREHEILFMDLRQWNENPVKGEQKKKVRLIAEQIQYVADIYHQWQSEGTDGNNFAVPELYRSVGIDEIEQSNWTLVPSKYIEFVDHDLEIDYPKEMARIQQEMKQLMQREKESQKMLEEAFGGIGYSIKEGE
>NZ_CP033459.1|WP_111899261.1|867275_868424_-|DUF1016-family-protein
MASTIQYNNKSEEKSFISDLRTIVSAARDTSYRMANMMQVVQNWLIGRRIVLQEQQGKARADYGKHVIELASQSLTEEFGRGFSETQVRNYRKFYLAFSNLLIQQTTPAEFRSKLASIQQTMPAESVSNGIVLPVQLSWSHYERLIRVADPEARMWYMQEAATQQWDYRTLKRNIDSQYYYRLTQTPEIKRQEVVDEMHRLTADYEKEKSTFVKNPMLVEFLGLSHREAFTESKLEQAILDHLEHFLMEMGKGYALVNRQMHIHTEDDDYYIDLVFYNYLLKCFVLVDLKTTKVSYEDVGQMDMYLKLFDTYKRTEGDNPTIGIILCSETNADVARFSTLASNKQMYASKYLTYMPSKEVLAREIEQQKEIFRLQNNGEEEK
>NZ_CP033459.1|WP_111899271.1|879598_880972_+|sodium-dependent-transporter
MSRSNFSGKLGLILASAGSAVGLGNLWRFPTETGENGGSAFLIIYLACVIVFGLPVMISEFMIGRSSRVSVGRSYSVLAPGSLWKWLGPLQVLTPFLILCYYNVVAGWTLWYAGEAAVNGFSTMAQSSESAAVFSDFFAEFVGSWWKQILCLIVFMGITHYVIVQGVTKGIERSSKVLMPGLFILLLLLVGCALTMPGAKEGLNFLFKPDFSKITTSTVLSAMGQAFFSLSLGMGILTTYASYFKDDANLGKSALSIGAIDTFVAILAGVFIFPAVFTAGIEPSKGPSLLFEALPNVFQSAFGGLPWLSYIVSLAFYLLLILATLTSAISIHEAVTSYLAEALHWSRRKAATLVSLSTAAIGVLCALSLGALKGELTFFDMALFDIFDYVTAKWLLPIGGMLITIFAGWRLSKRVWWKQMTNSGTKRFPIFPIFVFMIRFVCPIGILLIFLNELKVF
>NZ_CP033459.1|WP_111899272.1|880983_881688_+|SAM-dependent-methyltransferase
MTPALYLIPCPIGATPTEQVLPAYNKEVILSIRHFIVEEIRTARRFLKSVDRSIDIDALTFHAMGKHADQALFASYLEPLRRGESVGIISEAGCPAVADPGADIVAIAQREGMRVIPLVGPSSILMALMASGLNGQSFAFNGYLPIDPTQRTRRIKQLEARAQTEHQPQIFIETPYRNHKMLSDIIAACRPGTRLCIAAAISTEQEYIRTQTIADWKKHPAPNLAKLPTIFIVG
>NZ_CP033459.1|WP_111899273.1|881674_881941_-|hypothetical-protein
MGCYRHTQLPSHAPENDGIRHLLDLLCYRRRPRQLFGPCAPQERKRLFLPRFALEKTEVLEYSECSEYSEYSEYSEYSEYSQPSAILL
>NZ_CP033459.1|WP_146739492.1|883488_884178_+|hypothetical-protein
MDLQLTLIQLILFAIGASLVVCFLTFVVANICYGRQPLWRFSKLMLRTIVFGLLIAGVLIYVGYKHLPRNIEIYDGGETVTRYGINIQSYQHRNRVLLTNKTAQEELFYIQTGEGQNGKEATFEVISKDIPLEVYGVPKAYLVKAADAKAQNLMPIVVTEAEAKTYFGGAADWRTVRNIYYRTEMQEKEIEDIIRQKTEEAKRKDTIAAKLKTSIHPEVVVDSALKMKP
>NZ_CP033459.1|WP_146739493.1|884264_884723_-|hypothetical-protein
MQIRISKSSVFAEVQKLAAYVAAKQADGSADGSAYPRIAIQDEDREVLESAWQDVLTDVARILAPYITDAELPPLPHGIDLAADFVLNVAVPETLPSAHAAALPTAIVRYAVRRLLATWTAIAMPEQADRFAAYAETARKTLRSLLLSQVRR
>NZ_CP033459.1|WP_111899276.1|884884_885556_-|hypothetical-protein
MKRFVIILMALAVGLPISAQQTCPDSNHPHAIDLGLPSGTKWACCNVGASRPTAYGDYYAWGEIATKTNYDWSTYKWGEIIELTKYCDNPDFGENWHTDNKTVLDPEDDVAHVKWGGQWRMPTKEQMEELCNNTKEKWIENYKGTGVNGSLLTATNGKSIFLPAGGERDDTQLYCAYAGFFWSSSLVSGCPGSAYGLSIGSGEVFVDDFNSRTTGRTVRPVRP
>NZ_CP033459.1|WP_111899277.1|885634_885847_-|hypothetical-protein
MLIAQVNAPGEDNQRQWRAVSAKAADIQIIWLLPLQGETTKHQFTQGVALGYGLDGLSARFPDTPKQIER
>NZ_CP033459.1|WP_111899297.1|885937_886510_-|N-acetylmuramoyl-L-alanine-amidase
MKVLIDNGHGSDTAGKRSPDGRLREYAYVREIAERVEKELHRRGVDAERIVKEMWDVSLAERCRRVNRHPAGSTILVSIHCNAAGHGQWMNARGWSGWVYRQCSERAKRLAGCLYDATKAQGLQVRTPSRSQKYWTAGFYILKHTVCPAVLTENFFQDNREDVAFLLSEAGKAAVVRLHVEGIMKYIESL
>NZ_CP033459.1|WP_146739494.1|886493_886796_-|hypothetical-protein
MKNTQTITAVGMLVAGLAFAVAGFITPPPGEISDSVLWLFSQCLIYAGSIFGVGIYVDRRFSAFTKEFRRSGLNPENNTNEQPENERENEQDYEKTESTD
>NZ_CP033459.1|WP_146739495.1|887471_889466_-|hypothetical-protein
MNYQRLNNLGDFPSMDALWARYPEGGREGDYATVGGEDVFWDRYKVRWSTGDEESHGRQLTTVNGDCLVSGDLTVGGTLRYSGLRTAFKGFYDGLAALVAACASPEPGDWAYVTEDGTTYVYRCATAGAWTQGEAVDMSDVTGLTARVDALEQSHRRRIYRYFADDVFTETGLMRADGSVSTSSAYLHTAPLAVEGVERFLLYNKLVSETATTFFPIVVWLGAGGGVVGHVDCTAGEGSYELTPPAGAEAAVFNALRTFVVQTDKTLCHADIVSAKPFARRIYLSPQGSDLNDGLSADSPVLSLRRANTLLAPDGELVMLSGDYLNLPIDLSNYGRLTGAGRVRCISCYRVTAAETAAGYTRVLCATIDKPPTRGTYLWQHDVADAATAILPSEVHPAQEGTTHRLPSTRIYPASSIAEIEASTDVLKWYVSGTTLYFSKAEGTDLATHPVVIPRRTISGTVGGTTAVRNVAFLYAPLLLTGMHGLLENVSVGMVNAAGAIRYDGTTDFLMCRCEAYGCSNDGFNGHGTADSPSDIVLENCWGHDNCDDGESCHEHCTVTSRGGLYEYNGSGCTPASGGRAAYYGTMARKNLPTHAWTGSSREGTGFSAQGAAPSGAETAMLCHACYATANSIGIRTTLATGTHAIGCISTGNGTDYAGNVERV

You can click texts colored in the table to view more detailed information

Click the colored protein region to show detailed information

Crispr_ID: NZ_CP033459_2

CRISPR_ID

CRISPR_location

CRISPR_type

Repeat_type

Spacer_info

Cas_protein_info

CRISPR-Cas_info

NZ_CP033459_2

980334-980426

Orphan

Consensus_repeat	Method
AGTTAGCGCTTCGCTCGAAGTTAACGAC	CRISPRCasFinder

1 spacers

PD-DExK

The CRISPR arrays of NZ_CP033459_2

>merge|NZ_CP033459|2|980334-980426|CRISPRCasFinder
AGTTAGCGCTTCGCTCGAAGTTAACGACATTACCTCTTTCTCTTTGAAGTTATCGAAGTTAACGGAGTTAGCGCTTCGCTCGAAGTTAACGAC

>NZ_CP033459|2|2|980334-980426|CRISPRCasFinder
AGTTAGCGCTTCGCTCGAAGTTAACGAC	ATTACCTCTTTCTCTTTGAAGTTATCGAAGTTAACGG
AGTTAGCGCTTCGCTCGAAGTTAACGAC

Protein	Signature genes	Signature genes Name	Protein_function
NZ_CP033459.1\|WP_111898450.1\|984269_984968_+\|sel1-repeat-family-protein	unknown	unknown	gnl\|CDD\|276807
NZ_CP033459.1\|WP_111898441.1\|965269_967525_+\|sodium:proton-antiporter	unknown	unknown	gnl\|CDD\|223551
NZ_CP033459.1\|WP_111898449.1\|983531_984170_+\|HD-domain-containing-protein	unknown	unknown	gnl\|CDD\|182251
NZ_CP033459.1\|WP_111898447.1\|980639_981635_-\|biotin/lipoyl-binding-protein	unknown	unknown	gnl\|CDD\|235136
NZ_CP033459.1\|WP_111898444.1\|974352_975561_+\|aminotransferase-class-V-fold-PLP-dependent-enzyme	unknown	unknown	gnl\|CDD\|235068
NZ_CP033459.1\|WP_111898515.1\|969478_973222_+\|T9SS-type-A-sorting-domain-containing-protein	unknown	unknown	gnl\|CDD\|227068
NZ_CP033459.1\|WP_111898516.1\|976419_977307_-\|OmpA-family-protein	unknown	unknown	gnl\|CDD\|181618
NZ_CP033459.1\|WP_111898514.1\|967528_968650_-\|ATP-binding-protein	unknown	unknown	gnl\|CDD\|224292
NZ_CP033459.1\|WP_111898454.1\|988203_990816_+\|hypothetical-protein	unknown	unknown	gnl\|CDD\|378045
NZ_CP033459.1\|WP_111898446.1\|979061_980249_-\|ABC-transporter-permease	unknown	unknown	gnl\|CDD\|378925
NZ_CP033459.1\|WP_111898445.1\|975657_976323_+\|hypothetical-protein	unknown	unknown	gnl\|CDD\|377531
NZ_CP033459.1\|WP_111898517.1\|977777_978944_-\|ABC-transporter-permease	unknown	unknown	gnl\|CDD\|378925
NZ_CP033459.1\|WP_111898448.1\|981891_983385_-\|TolC-family-protein	unknown	unknown	gnl\|CDD\|224455
NZ_CP033459.1\|WP_111898451.1\|984992_986048_+\|DUF1016-domain-containing-protein	PD-DExK	COG4804_PD-DExK_CAS-I:CAS-III	gnl\|CDD\|377634
NZ_CP033459.1\|WP_111898452.1\|986215_986767_+\|hypothetical-protein	unknown	unknown	unknown
NZ_CP033459.1\|WP_111898519.1\|992109_994002_+\|1-deoxy-D-xylulose-5-phosphate-synthase	unknown	unknown	gnl\|CDD\|235470
NZ_CP033459.1\|WP_111898439.1\|963491_964757_+\|peptidase-M64	unknown	unknown	gnl\|CDD\|370517
NZ_CP033459.1\|WP_146739417.1\|973628_974273_+\|hypothetical-protein	unknown	unknown	unknown
NZ_CP033459.1\|WP_111898518.1\|990892_991918_+\|hypothetical-protein	unknown	unknown	gnl\|CDD\|223704
NZ_CP033459.1\|WP_111898453.1\|986794_987961_+\|hypothetical-protein	unknown	unknown	gnl\|CDD\|379135

Protein	Function_ID	Function_description	E-value
NZ_CP033459.1\|WP_111898450.1\|984269_984968_+\|sel1-repeat-family-protein	gnl\|CDD\|276807	sd00010, SLR, Sel1-like repeat. Sel1-like repeats (SLRs) share similar alpha-helical conformations with Tetratricopeptide repeats (TPRs), but with different consensus sequence lengths and superhelical topologies. SLRs contain 36 to 44 amino acids and are present in bacteria and eukaryotes but not in archaea. SLR proteins are involved in a variety of functions, and many serve as adaptor proteins for the assembly of macromolecular complexes. The SLR family was named after the Caenorhabditis elegans Sel1 protein which is predicted to fold into 11 SLRs, a transmembrane domain, and an N-terminal signal sequence. The human Sel1L protein contains an additional fibronectin type-II domain and an N-terminal PEST sequence. Its downregulation is associated with the development of breast and pancreatic carcinomas.	1.95062e-38
NZ_CP033459.1\|WP_111898441.1\|965269_967525_+\|sodium:proton-antiporter	gnl\|CDD\|223551	COG0475, KefB, Kef-type K+ transport systems, membrane components [Inorganic ion transport and metabolism].	3.48363e-66
NZ_CP033459.1\|WP_111898449.1\|983531_984170_+\|HD-domain-containing-protein	gnl\|CDD\|182251	PRK10119, PRK10119, putative hydrolase; Provisional.	2.45554e-05
NZ_CP033459.1\|WP_111898447.1\|980639_981635_-\|biotin/lipoyl-binding-protein	gnl\|CDD\|235136	PRK03598, PRK03598, putative efflux pump membrane fusion protein; Provisional.	6.70619e-30
NZ_CP033459.1\|WP_111898444.1\|974352_975561_+\|aminotransferase-class-V-fold-PLP-dependent-enzyme	gnl\|CDD\|235068	PRK02769, PRK02769, histidine decarboxylase; Provisional.	1.54412e-69
NZ_CP033459.1\|WP_111898515.1\|969478_973222_+\|T9SS-type-A-sorting-domain-containing-protein	gnl\|CDD\|227068	COG4724, COG4724, Endo-beta-N-acetylglucosaminidase D [Carbohydrate transport and metabolism].	1.87905e-43
NZ_CP033459.1\|WP_111898516.1\|976419_977307_-\|OmpA-family-protein	gnl\|CDD\|181618	PRK09038, PRK09038, flagellar motor protein MotD; Reviewed.	1.1593e-33
NZ_CP033459.1\|WP_111898514.1\|967528_968650_-\|ATP-binding-protein	gnl\|CDD\|224292	COG1373, COG1373, Predicted ATPase (AAA+ superfamily) [General function prediction only].	6.91647e-45
NZ_CP033459.1\|WP_111898454.1\|988203_990816_+\|hypothetical-protein	gnl\|CDD\|378045	pfam08757, CotH, CotH kinase protein. Members of this family include the spore coat protein H (cotH). This protein is an atypical protein kinase that phosphorylates CotB and CotG.	1.49891e-40
NZ_CP033459.1\|WP_111898446.1\|979061_980249_-\|ABC-transporter-permease	gnl\|CDD\|378925	pfam12698, ABC2_membrane_3, ABC-2 family transporter protein. This family is related to the ABC-2 membrane transporter family pfam01061.	1.70162e-28
NZ_CP033459.1\|WP_111898445.1\|975657_976323_+\|hypothetical-protein	gnl\|CDD\|377531	pfam05598, DUF772, Transposase domain (DUF772). This presumed domain is found at the N-terminus of many proteins found in transposons.	1.63416e-07
NZ_CP033459.1\|WP_111898517.1\|977777_978944_-\|ABC-transporter-permease	gnl\|CDD\|378925	pfam12698, ABC2_membrane_3, ABC-2 family transporter protein. This family is related to the ABC-2 membrane transporter family pfam01061.	7.86046e-39
NZ_CP033459.1\|WP_111898448.1\|981891_983385_-\|TolC-family-protein	gnl\|CDD\|224455	COG1538, TolC, Outer membrane protein [Cell envelope biogenesis, outer membrane / Intracellular trafficking and secretion].	4.91069e-33
NZ_CP033459.1\|WP_111898451.1\|984992_986048_+\|DUF1016-domain-containing-protein	gnl\|CDD\|377634	pfam06250, DUF1016, Protein of unknown function (DUF1016). Family of uncharacterized proteins found in viruses, archaea and bacteria.	1.93207e-60
NZ_CP033459.1\|WP_111898453.1\|986794_987961_+\|hypothetical-protein	gnl\|CDD\|379135	pfam13350, Y_phosphatase3, Tyrosine phosphatase family. This family is closely related to the pfam00102 and pfam00782 families.	1.36221e-20
NZ_CP033459.1\|WP_111898519.1\|992109_994002_+\|1-deoxy-D-xylulose-5-phosphate-synthase	gnl\|CDD\|235470	PRK05444, PRK05444, 1-deoxy-D-xylulose-5-phosphate synthase; Provisional.	0
NZ_CP033459.1\|WP_111898439.1\|963491_964757_+\|peptidase-M64	gnl\|CDD\|370517	pfam09471, Peptidase_M64, IgA Peptidase M64. This is a family of highly selective metallo-endopeptidases. The primary structure of the Clostridium ramosum IgA proteinase shows no significant overall similarity to any other known metallo-endopeptidase.	1.42143e-85
NZ_CP033459.1\|WP_111898518.1\|990892_991918_+\|hypothetical-protein	gnl\|CDD\|223704	COG0631, PTC1, Serine/threonine protein phosphatase [Signal transduction mechanisms].	0.00505917

>NZ_CP033459.1|WP_111898446.1|979061_980249_-|ABC-transporter-permease
MSEKKKSSAIMSYLRLFVREFKRMASRPVYWFVMVFAPLFTFFFFLTLMGEGLPEDLPVGLVDLDNTTTSRSIVRNLDAFQQTKITAKYANVTDARRAMQRGEIYAFFYIPQGTTHKANRQEQPTISLYVNYSYLIAGSLTYRDMRMMSELASGAAARKVLLAKGATESQAMAFLQPIVVDTHAINNPWLNYNVYLCNTLLPGILILCVSLLTAYGIGTEIKDGTAREWLSTANDSIKRAVFVKFVPQFIVFALVGAILILLLYGYLRFPCHCGIPTMLLAMLLLVLAGQGLGLFFFAIFPSLRMSMSMAALWGVLSFSVCGMSFPVMGMHPAIQGLTWLFPLRHYFLIYVNSALNGYPIQYAWTNVICLLAFAMLPMLLMPRLKHNVLTYDYAP
>NZ_CP033459.1|WP_111898517.1|977777_978944_-|ABC-transporter-permease
MGMVFKDEGVMLFFLVVPIFYPIVYSMIYTSETIREVPAVVVDDSRSALSREYIRKVDATAELHIISYCANMQEAREIMRQREAYGIIYIPRNFVKDIAQGKQTHVNIFCDMSGLLYYKAMLMANTNVSLNINADIKKQLAQNTTNRQDEVTIKPIASEDINLYNPQAGIASFLLPGVLVLIIQQTLLLGIAMMAGTSRERNRLHELIPVGRHNHGLLRIVLAKTSVYLTIYVVQSVFCFGVVPRIFSLPQIGNPVTLVFFFLPFLLAVIFFGMTVSAVVRERENGVLIFVFTSVILIFISGLSWPSAAIPGYWKLFSYIFPSTFAINGYVHINNMGASLLDVRKEWDALWLQAAFYFFTCCLSYRYKILAARIRTYKDYRVRRKVES
>NZ_CP033459.1|WP_111898516.1|976419_977307_-|OmpA-family-protein
MKRNLFTFAIAAVLMLMSTSCVTKKQYVGLQNNYDSLRTRYGTLRGDYNSLQSDYNDAKVALAEARTQNKSLEERLADEQARNKELKEQYAALMGSYDTNLKQGSVNIEKLVNEINASNQYIRKLVDAKTKSDSLNQALTNKLTRSLTREEMLDVNVQVLKGVVYISLADNMLYKSGSYEIGERAGETLMKIAKIITDYKDYEVLVEGNTDNVPISRENIRNNWDLSALRASSVVQELQNKYGVDPKRLSAAGRGEYNPIATNDTENGKQRNRRTQIIITPKLDQFMDLIEQAPE
>NZ_CP033459.1|WP_111898445.1|975657_976323_+|hypothetical-protein
MNMTELQEMQPVSGVLSQTVNFEGLLDRDNKARVIDVMVDKFADAPDVEALYTKGGNHRGRPATPLAALLKIWVYGWINGIETSRALAIEVKRNVELMFMLRSVNPAQHSISDFRRDEHAVIHAFFEYVRSFSEEAWLIIAAEDSALGERARRVEFSTVVEVINALKALDENALLGAEDRDTSSQIANLWDMEIERLNEKVEKLKRQKARLNERLKKLTQK
>NZ_CP033459.1|WP_111898444.1|974352_975561_+|aminotransferase-class-V-fold-PLP-dependent-enzyme
MKKRFFFLATLFSVSLALLAQSSGFKELDEWAKQTKEEQKTFFGYPANEQSPLQGFYEWYVSSGMCEVNMNNAGDPMTDHPNSMSSQRFEREVIEFFAPLYDFKKDNVWGIVTHSGTDGNNHGIYFGAKYLYNTTGLKPIVYVSDEAHYSNLRLCDLQNLDVRIVKSDDMGRMIPEELENVLDPSRPALMIYAMGSTFKGAIDDQEALNAVLDKYPQMKVYRHIDAALFGGYLPFTKYRDMVSCKKMRYQSIAISGHKFFGIDSPSGLFLCTRETYDNQNNFNVTYLNGNMRMINCSRDAVQPIKFWWLIKTIGRDNWSKQATQMLDCADYLKAQLDKMNYPCWKNTYSNTVFFRRPSPEIVKHFNLAHGYDERFGGELAHIVVMQHVTKEKIDLFIEALKK
>NZ_CP033459.1|WP_146739417.1|973628_974273_+|hypothetical-protein
MKTIKLFFALLVVGAFCTLNVSAKKVKLTIDGTVSPSQTTLYLIVNEDKENAMLVPIQDAKFSVTLKVESNAFIRLSDNKNWPERSVFVLIPDSKHITINWRTGSIEGSPMSNKLQMAMKEIREAFPEGFHIDVFSDNPDDWKIAREREASMRAQMQMRQHEAIMRIIVENSDNNIPAWIYYCYKPTIAMKAENIGPKDSKWLNHAIVRGLEDK
>NZ_CP033459.1|WP_111898515.1|969478_973222_+|T9SS-type-A-sorting-domain-containing-protein
MNFKKLLLCGFALMAVSASAQELKDGYISWGPGSSDFPSTLNTWTPGSQVTEDDNFFISRVKPRERFRNQKTQVNTSLTAANDKKLLAWLPVNSSSKNGLPDGVFDSEVFTMWPYVTHWGNWTAPVGRIPGAFLDVAHKNGVAVSGVASIPWGNINTQPNWMNFLNTLPNYTEKAAQFFKYYGIDGIGYNSEFTGGYSYMSKIRNFHANLVKEMRKVNPLFENLWYDGTNDNGTIQFDNGLYTHNDDNFGNGDNVRTSLFFNYNWNSDALLSSSATYARTINRDPLDLYAGVNMQGGQPGSDSWPVLKNYPISIGLWGAHSTNMFWESRGELGSAPEQNQRAYMLRTESWFTGGTRNPANCPEVISSMKYTAYNTNFHGMSTFMSARSSLKWDLNEEPFISYFNIGNGKFFNWKGKQENDREWYNVGVQDYLPTWRWWFSNGLLTTSVPSSGLDAEFVWDDAYVGGSTARIYGSAADEYLHLFKTDFALQTGDVITFRYKVMKGSADINLVLTTVNSERVAVDESAMSLLTTSQDTDEDVWVEKTFTVGSSLSGKELALVALHFQNASDLNLYLGEFSIVRGTAATPAKPVVTKTQVLSYTRKGYDGKIIFEMPNDKATGEPCYNLDVKTSFFKLWAQQEGCEPVFMGITTSWAGMYYSAPLNLKAASHNIRFGVSATSLDHKSDSEIAWGDYLNPGTYVFNDDVQIDKTTIKPNEEFTMSFVDPAHEDASWVLLDAAGNTVFSATGHTVTCPGLPEIGSYNLRVRGPHYNSAGTSRLNTSRTFASFVQITSEGVGALPQIYTLTGNGEEADITVEAGDEVAMAYTGRKADGAGSQGVNMNEQRFGASCANLGIANKQPFTVAFWLKLNKVQDGTQFFSVANKNDGWPLTDWGWVWSTIGGSGNLGWITFRNSIQAENPPSVVYKYDNTKLPVGNWVHLALAVDFNSSGQMHFELYINGEKETPSGGRVNGTDTSGDPGYQNFTYVIDEYDVLAIGGTAHGRVGIDGVIDNFQVWKKAITADEAKLSMGDLNPSSLPSGLTYFWDLETAAEGTKFMSKGSGASIPCGVHTYTASGGEGQGIITWQTPEYTSGCPFISGTAFPVETKPEWKAKKATIVESEGTDQAGSAKLTYAKGGDYSVTLTLANSLGSDSKTFSVIKVDATDAIGSVAETEMKAYTVGEDVFVDFAETGNYGVALYTIDGRCIVQKSVTVGGKEKVRIHAPQQGVYILRVEKDGKTVRSAKLLRK
>NZ_CP033459.1|WP_111898514.1|967528_968650_-|ATP-binding-protein
MIERLLQQRLTNAYRRKKVIVVLGPRQVGKSTLLDALSAGKQNVRNLNCDNEDERLLLQGRTSTELRQLVSPYDFFLIDEAQRVKNIGLTLKMIGDLKLQTQVIVTGSSSFDLADEINEPATGRLLNYNLFPFSLPELAAATSRLDEQRLLERRMIYGLYPEVVNEPEVARETLINLTNNYLYKDLLTFRGIRKPEIIINLVRALALQIGSEVSYNELSSLIGIDKITVENYINLLEKCFIVFRLNSFSRNVRNEIKKGKKVYFYDNGIRNAVLSNFAPLEMRSDTGALWENLMISERIKRNAYCGSYAQLFFWRTHDQKEIDLIEESDGRLTAFEFKWNNRKKTKVPKTFAEMYPNHSFNTVGRDTFWDFLS
>NZ_CP033459.1|WP_111898441.1|965269_967525_+|sodium:proton-antiporter
MPSLITDLALILIVAGIVTILFKRLKQPLVLGYIVAGFLVGPNMTYMPTITDAATVKVWSDIGVIFLMFSLGLEFSFKKILKMGSAPIIAATSVMLCMFGVGNAVGRLFGWAEMDAMFLGGMLAMSSTTIIYKALDDLGMRSKKFAGEVLSVLILEDILGILLMVLLSAMAVSREFQGGELVASMLKLAFFLILWFIVGIFIVPLVLKRAQKWITNEMLLIVSIGLCFLMVVLADQAGYSEAFGAFMMGSILAETIEAEKIEKVVTPLKDLFGAIFFVSVGMMVEPAVLVEYWLPILCLVIAVVVGQAIFGTTSFLISGQSLKISMQCGFSLAQIGEFAFIIASLGVSLGVTGKFLYPVVVAVSIITTFFTPYMIKAAEPAYGFLERVLPDKVISRFSERDSRKTGGQAGDGTEGNVRSHWRAHLINVAVQVAIYAVLCFAAIGIGLNALLPICRNTFTHWPGNAICGLTIFFVVAPFLRAIVMRSTKTPHTRFIHRQKGIHPWLLLLLFIARSALAVYFIYYIINYLSPYASWLHVLIAIALLVGIVISRRVKLMSIRLERTFINNLRMRDFKSAQARPAYARRLYAHDVYTVVMEVPQNSKWAGKTLRDLNFSRVDGVMIAAIVRGNTKQNVPDADAMIFPGDRLTVISDDSGIQRFKERLEAEVTEQDTIFSNEQMIYGRLNIKDHPEFIGKTVGESGIRENYQCLIVGFLTPNGSLDIPFAGRVMQPTDTIWLVGEPKDLKALGAKR
>NZ_CP033459.1|WP_111898439.1|963491_964757_+|peptidase-M64
MKIRLILAALLLPLTAFATVDFDYWFADATLRLDYIFAGSNTKQEISLSEMSTTEGWAGRRVNMDALLLEGNGQITVTDHQTDKVLYRNSFSTLFQEWQHTEEAVKVRRAFENTLLVPMPIKPVDITITLVDNHRKITAQMTHLVNPKDKNIRKGKVRYPDYVRQIFSNGEPSEKIDIVFVAEGYTKEQMGQFFKDVETARRSLFSHAPFDQYENRFNAIAVAIPSEKTDVSVPQDGQWHDTPCKSHFNTLYSARYLMTERVFQLHDLLEGLPYEHIIILANTHTYGGGGIYNMYMLTTARHYEFRPVVVHEFGHSFAGLADEYFYDDMYETYYPADTEPWEPNLTTLVNFDAKWRNMVKDVSKRDTGDVGIYEGGGYQSKGVYRGSYDCRMKTNSYPVFCPVCQDAIKRVIEYNTVEQTQ
>NZ_CP033459.1|WP_111898447.1|980639_981635_-|biotin/lipoyl-binding-protein
MAKKKNIENRPNIFLPLIIFAGIIGLVAAGSYFAFREQTETIQGQADVTEYRVSSKVPSRVMELRVKAGDIVHAGDVLAVMEAPEVEAKQAQAEAAVEAAQAVENKADNGAREEQIRGAKELWEKSKVGVDIAQKSFQRMDNLFNEGVVTEQKRDEVKAKLDAAIADERAAKSQYDMAVNGARQEDKAAAHAQVKRARGAVQEVQSYKRETILRATQDGEVTDVFPSVGELVGTGAPIMNVALMNDIWVTFNVREDHLSKFSINKIVEATVPALGEKAYKFKVFYMKDLGSYAAWKATKTTGQYDMKTFEVKAKPIEKIEGLRPGMSVLLK
>NZ_CP033459.1|WP_111898448.1|981891_983385_-|TolC-family-protein
MNKKLLLLMVFLAGVAVQAQTVYSLSECREMALRNNKTLAISREEVNKATYEREAAETNKLPKVSGSVSYVRLGREISLLSNDQKNALSNLGTNVYNAMSANMGNFSQAVQPIIEKYPEFTNLLTQFSGQGLAGADALNAAGQRVVDAFDSDNRNMGGAMLILKQPLYMGGKIMAYERITKYLEQLSGEKLRLEEQEILLDVDKAYWQVVSLVSKKQLADDYLGMLQHLEHDVDLMLKNGVATKANLLTVNVKVNEAEMMQTKVEDGLSLSRMLLCQLIGLPLNAPIVLEDENLDNIPIENAETQVNIETAFANRPEIQQLELATNIYKEKVNIQRSDYLPHVALIGGAGLTTPSLYNGFESKLRGNWALGITCTMPIWNWGEGRSKIKAAKAEAKIQEYRLDEAKEKIELQVNQSTFRLNEANKRLKLSKKNMEKAAENLRIANLGHREGVIATSDVLAAHTAWMQAKSDIIDAQIEVRLAHAVLDKSLGLTNMDY
>NZ_CP033459.1|WP_111898449.1|983531_984170_+|HD-domain-containing-protein
MDYPELKKHIEANILPQYAHFDAAHRLDHADAVIAASLRYARSCGADEQMAYVIAAYHDVGLSEGREMHHLASARILLSDEVLRRWFSEEQLRVMAEAVEDHRASATHPPRSIYGRIVAEADRQIDADTVIRRTVQYGLTHYPDMSREEHFERMCAHLREKYGDGGYLKLWISDSDNVAKLEELRKIIRNEDILHRKFEEIMAESTGLLQPL
>NZ_CP033459.1|WP_111898450.1|984269_984968_+|sel1-repeat-family-protein
MKKIILLLLLAVALPTMLLAQIKPTEAQFAALKYKAQQGDPEAQYNLGYCYEKGWFVGQHYAEALEWYMKSAKQGYAVAQWNVGYYYAEGISVEQNYIEAVKWYKLAADQGDHRAMHNLAVCYEWGRGVGGPNVEKAVELYKKAAALGDIQAIYNMGVCYETGTNVPQDYYKAVEYYEKGAKLGHGASQYNLACCYYDGTGVAKDKKKAKELFKLAKKNGIEEAKAALKKIK
>NZ_CP033459.1|WP_111898451.1|984992_986048_+|DUF1016-domain-containing-protein
MNKNSIENFGKVLSRTLILDLRQIIEQARNHIAATANYELTMMYWHIGERINRDILDKKRAEYGKQIIESLSQQLQVEYGKKGFETRNIRRMMQFATLFPEEQIVSQVATQLTWSHFIEVLHIKNDIQREFYITLAASERWGRNRLRKEIDSMLFERTAISDKPEEYIKKELSNLRDNNKISPDLIFKSPYFLEFTGLTGMYSEKDLEESLVAHLEQFIIELGNGFSFIARQKRMIIDGEDFYLDLLFYHRRLHRLIAIDLKLGRFKAQYKGQMELYLRWLEKNEMEKGEETPLGLLLCTEGGEEQIELLQLDKSGIKVAQYMTELPPREILMRQIRESLKATKARLENYE
>NZ_CP033459.1|WP_111898452.1|986215_986767_+|hypothetical-protein
MASRKEHYTRCTKKALVLVALLLCSIFPSAVSINYSANGINISGKDIPRAAVNKIVRMTGYQGNIVISSVARTPEQQARCMLNNIKSNGMDEQRKTYKYEGQQVLNAYNPNLSDEENICRMTQKIKEVGPHRVSRHCVASGNLCVFDVEKSSLSNVATFKQSIRTIAELVLDENNCVHVEMRL
>NZ_CP033459.1|WP_111898453.1|986794_987961_+|hypothetical-protein
MKKTFLFAFALIATTAFAQTDIDDIEVINIENKAVQDYMADKTYETNSNYAQTVINKYNKTAIYGKKLYWPNGKEVRWEPSTSAANIAEIRITVSENVNFTDSVTHNPDSKDVSSFVIRNTIPNRIYYYKVEEILNSGEVRYRTDGVFRTIGQVRMIQVRNCGNVRDLGGWPTQYGKPVKYGYLYRSASLDRITPEGRHDFAGNLNVGAELDLRSESRLKQSRLGSDKGLLVLPHNAGLAGLRDKKYVYVKDLRFLSEYLKKGVAVNWHCAIGCDRCGAVSFLIEGLLGMSEIDLCRDFELSTLSLSEKNLRPRSHISSMMKYIKNFGEPDNLAQCFYNYWLSLGVDKEELNWFIRTILDVDDEQIAATLQLYEPKDAEEEADYDEVR
>NZ_CP033459.1|WP_111898454.1|988203_990816_+|hypothetical-protein
MSFFSLRHTAISLSTLTLLAALLLSSCDEAGTIDLTRSDDFDKEIVINEVMASNRTGLLAADGNLYDWVEVKNVSDKAISLADYALATVKYPKDKSAKKKKKGEKGEEAADSVSNENTEKHHMTDAKGKKDKKDKKDKKDKANAPVVDSLGGVLLTWDFPKMELAPGECMLVFASKLPENSTDKELHASFKLGSKNGVVQLIKKGKYIMSEAKFGDLNGDQCLRRLTDGSYEKSYMQTPGTDNDAKGYEAYNVTIEKQRKSPLRIWELQAKGKKHETWIELQNTSNTPINLQEYCLTTKPTKADRWQFPNRTLQPGERYVVDCGKANFKIKGSCCVLLLKGEQFMDGLCSHHAPYGVTMGRVEGKQGFFYFTSPTRNEVNTSKAYRFIADKPLFSELPGVYAEKKSLQLKINTHGYTVHYTLDGSEPTKDSPIYKDAIRIDSSCVVRAFCEGDSTSMSSHIATATYLIGQEHDLAVMCISVNHNDLYDYRSGIYVSGPGGGGPYPHEGANYWKQWWKKAHVEFFDGKEGFQADCGLAIFGGFSRTLEKKSFKIKFNDKFGPSKVTYDFFGDGQPLEFKNLVLRSGSQDMGGVMVRDEFFTSLMQPECPTLLTQKYRPVALYINGSYFGLYYIREKIDKHFVARKLNTTNDSISIIMSKGYCEEGTKTKFTELMNFARNNDLSKKENYDRICQMIDINSVIDQKIGEIYSSNVDVGNIRYVRSDDANSDKKWYIVYYDLDLTWSSSGTKPASFYLRPGDSESGIHNVLVGNLLKNSDFRQLFLQRLSHHLHKTISANNATKVFDGITGTIKQEMKLNCKRWPKLLVYEKWEKNLADFKEKINKRDKEVLDDLRKELAITPEENKKYFGDLE
>NZ_CP033459.1|WP_111898518.1|990892_991918_+|hypothetical-protein
MNWEEFEKHKPFAGEKKSSMLRRRVGHDYESRRIYLITMTTEGRRPLLGKLVGNADAPKGSIDAPKIVLTPLGEEVRSCWLSIEKHYPDIRVLATTIMPDHLHGILFVTRKMEQHLGMVIKGFKAGCNKAYRRLQNPLSPMLQHCCSKENRGDSRSHGLLWSRNYNDHILEGRGELNRWFQYLHDNPRRLALRRAHPDFFRVVFDINIAGQTYAAIGNRFLLSYPEKQQVQCSRSLTDEQIEDTVKQMLAKARRGAVLVSPAISKGEQAVMRAALEAHLPLIFLTPWGFNTFSRPDHQYYAACAEGHFLILAPWPHENRRIPLSREMCLTLNAMTAIICQQ
>NZ_CP033459.1|WP_111898519.1|992109_994002_+|1-deoxy-D-xylulose-5-phosphate-synthase
MELKILPNINTPEDLRQLPEEQLSALCEELRSDIVSELSVNPGHLASSLGVIELTVALHYVFSTPYDRIVWDVGHQAYAHKILTGRRDLFKTNRKFGGLRPFPSPDESEYDTFACGHASNSISAALGMSVAAMQKKEEDRHIVAVIGDGAMSGGLAFEGLNNASDKPNNMLIILNDNNMSIDQSVGGMKQYLLNLHTSSTYNRLRFRAARTLQKWGIIDENRRRTILRFNNAMKSLITRQKNIFEGMDIRYFGPMDGHDIKQLVRVLKEIKDMKGPKLLHIKTTKGKGYQPAEEEATIWHAPGKFDAETGERKVDETPKPPKFQDVFGETILELARRNPRIVGITPAMPTGCSLSLMMKEMPERTYDVGIAEGHAATFAGGLAKEGMQPFCNIYSAFSQRAYDNIIHDVALLDLPVVFCLDRAGLVGEDGPTHHGAFDLAALRPIPNVTIASPYDEHELRRLMYTAQLPGKGTFVIRYPRGRGELLDWQCPLEEVPVGKGRTIKEGTDLAVISLGPIGKDATRAIAEAERTLGCSIAHYDLRFLKPIDEEMLSEIGSKFSKVITIEDGVKAGGMGSAVLEYFSDKGTVPHLVRLGLPDSFVPHGSVAEERRLVGLDNDSIVQTISSLLKA

You can click texts colored in the table to view more detailed information

Click the colored protein region to show detailed information

Crispr_ID: NZ_CP033459_3

CRISPR_ID

CRISPR_location

CRISPR_type

Repeat_type

Spacer_info

Cas_protein_info

CRISPR-Cas_info

NZ_CP033459_3

1209625-1209695

Orphan

Consensus_repeat	Method
CACGACCACGGCGAAGGATGCGG	CRISPRCasFinder

1 spacers

The CRISPR arrays of NZ_CP033459_3

>merge|NZ_CP033459|3|1209625-1209695|CRISPRCasFinder
CACGACCACGGCGAAGGATGCGGCTGCGGTCACCACCATGGCCATGACCACGATCACGGCGAAGGATGCGG

>NZ_CP033459|3|3|1209625-1209695|CRISPRCasFinder
CACGACCACGGCGAAGGATGCGG	CTGCGGTCACCACCATGGCCATGAC
CACGATCACGGCGAAGGATGCGG

Protein	Signature genes	Signature genes Name	Protein_function
NZ_CP033459.1\|WP_111897286.1\|1214312_1215665_-\|DUF4339-domain-containing-protein	unknown	unknown	gnl\|CDD\|259806
NZ_CP033459.1\|WP_111897280.1\|1210946_1212197_-\|hypothetical-protein	unknown	unknown	gnl\|CDD\|378181
NZ_CP033459.1\|WP_111897277.1\|1207310_1209089_+\|DNA-polymerase-III-subunit-gamma/tau	unknown	unknown	gnl\|CDD\|237874
NZ_CP033459.1\|WP_111897276.1\|1206651_1207014_-\|NADH-quinone-oxidoreductase-subunit-A	unknown	unknown	gnl\|CDD\|376344
NZ_CP033459.1\|WP_111897281.1\|1212364_1212673_+\|addiction-module-killer-protein	unknown	unknown	gnl\|CDD\|226079
NZ_CP033459.1\|WP_111897274.1\|1204428_1205994_-\|NADH-quinone-oxidoreductase-subunit-D	unknown	unknown	gnl\|CDD\|180385
NZ_CP033459.1\|WP_111897284.1\|1213477_1213864_-\|DUF4339-domain-containing-protein	unknown	unknown	gnl\|CDD\|379517
NZ_CP033459.1\|WP_111897270.1\|1201525_1201831_-\|NADH-quinone-oxidoreductase-subunit-NuoK	unknown	unknown	gnl\|CDD\|180218
NZ_CP033459.1\|WP_111897288.1\|1217029_1217803_-\|hypothetical-protein	unknown	unknown	unknown
NZ_CP033459.1\|WP_111897283.1\|1213107_1213464_-\|hypothetical-protein	unknown	unknown	unknown
NZ_CP033459.1\|WP_111897279.1\|1209738_1210806_+\|chorismate-synthase	unknown	unknown	gnl\|CDD\|376510
NZ_CP033459.1\|WP_111897268.1\|1197889_1199389_-\|NADH-quinone-oxidoreductase-subunit-M	unknown	unknown	gnl\|CDD\|235622
NZ_CP033459.1\|WP_111897272.1\|1202421_1203147_-\|4Fe-4S-dicluster-domain-containing-protein	unknown	unknown	gnl\|CDD\|235637
NZ_CP033459.1\|WP_111897282.1\|1212682_1212994_+\|HigA-family-addiction-module-antidote-protein	unknown	unknown	gnl\|CDD\|274228
NZ_CP033459.1\|WP_111897287.1\|1215878_1216949_-\|hypothetical-protein	unknown	unknown	gnl\|CDD\|313734
NZ_CP033459.1\|WP_111897273.1\|1203237_1204323_-\|NADH-quinone-oxidoreductase-subunit-NuoH	unknown	unknown	gnl\|CDD\|376297
NZ_CP033459.1\|WP_111897269.1\|1199445_1201464_-\|NADH-quinone-oxidoreductase-subunit-L	unknown	unknown	gnl\|CDD\|235836
NZ_CP033459.1\|WP_111897271.1\|1201867_1202383_-\|NADH-quinone-oxidoreductase-subunit-J	unknown	unknown	gnl\|CDD\|376343
NZ_CP033459.1\|WP_111897275.1\|1206019_1206661_-\|NADH-quinone-oxidoreductase-subunit-B	unknown	unknown	gnl\|CDD\|173277
NZ_CP033459.1\|WP_111897285.1\|1213901_1214234_-\|hypothetical-protein	unknown	unknown	unknown

Protein	Function_ID	Function_description	E-value
NZ_CP033459.1\|WP_111897286.1\|1214312_1215665_-\|DUF4339-domain-containing-protein	gnl\|CDD\|259806	cd03408, SPFH_like_u1, Uncharacterized family; SPFH (stomatin, prohibitin, flotillin, and HflK/C) superfamily. This model summarizes an uncharacterized family of proteins similar to stomatin, prohibitin, flotillin, HflK/C (SPFH) and podocin. The conserved domain common to the SPFH superfamily has also been referred to as the Band 7 domain. Many superfamily members are associated with lipid rafts. Individual proteins of the SPFH superfamily may cluster to form membrane microdomains which may in turn recruit multiprotein complexes. Microdomains formed from flotillin proteins may in addition be dynamic units with their own regulatory functions. Flotillins have been implicated in signal transduction, vesicle trafficking, cytoskeleton rearrangement and are known to interact with a variety of proteins. Stomatin interacts with and regulates members of the degenerin/epithelia Na+ channel family in mechanosensory cells of Caenorhabditis elegans and vertebrate neurons and participates in trafficking of Glut1 glucose transporters. Prohibitin may act as a chaperone for the stabilization of mitochondrial proteins. Prokaryotic HflK/C plays a role in the decision between lysogenic and lytic cycle growth during lambda phage infection. Flotillins have been implicated in the progression of prion disease, in the pathogenesis of neurodegenerative diseases such as Parkinson's and Alzheimer's disease and, in cancer invasion and metastasis. Mutations in the podocin gene give rise to autosomal recessive steroid resistant nephritic syndrome.	1.60251e-20
NZ_CP033459.1\|WP_111897280.1\|1210946_1212197_-\|hypothetical-protein	gnl\|CDD\|378181	pfam09411, PagL, Lipid A 3-O-deacylase (PagL). PagL is an outer membrane protein with lipid A 3-O-deacylase activity. It forms an 8 stranded beta barrel structure.	1.26229e-05
NZ_CP033459.1\|WP_111897277.1\|1207310_1209089_+\|DNA-polymerase-III-subunit-gamma/tau	gnl\|CDD\|237874	PRK14971, PRK14971, DNA polymerase III subunit gamma/tau.	0
NZ_CP033459.1\|WP_111897276.1\|1206651_1207014_-\|NADH-quinone-oxidoreductase-subunit-A	gnl\|CDD\|376344	pfam00507, Oxidored_q4, NADH-ubiquinone/plastoquinone oxidoreductase, chain 3.	2.01628e-37
NZ_CP033459.1\|WP_111897281.1\|1212364_1212673_+\|addiction-module-killer-protein	gnl\|CDD\|226079	COG3549, HigB, Plasmid maintenance system killer protein [General function prediction only].	4.88801e-14
NZ_CP033459.1\|WP_111897274.1\|1204428_1205994_-\|NADH-quinone-oxidoreductase-subunit-D	gnl\|CDD\|180385	PRK06075, PRK06075, NADH-quinone oxidoreductase subunit D.	8.76422e-152
NZ_CP033459.1\|WP_111897284.1\|1213477_1213864_-\|DUF4339-domain-containing-protein	gnl\|CDD\|379517	pfam14237, DUF4339, Domain of unknown function (DUF4339). This domain is found in bacteria, archaea and eukaryotes, and is approximately 50 amino acids in length. There are two completely conserved residues (G and W) that may be functionally important.	5.50917e-14
NZ_CP033459.1\|WP_111897270.1\|1201525_1201831_-\|NADH-quinone-oxidoreductase-subunit-NuoK	gnl\|CDD\|180218	PRK05715, PRK05715, NADH-quinone oxidoreductase subunit NuoK.	8.51705e-23
NZ_CP033459.1\|WP_111897279.1\|1209738_1210806_+\|chorismate-synthase	gnl\|CDD\|376510	pfam01264, Chorismate_synt, Chorismate synthase.	0
NZ_CP033459.1\|WP_111897268.1\|1197889_1199389_-\|NADH-quinone-oxidoreductase-subunit-M	gnl\|CDD\|235622	PRK05846, PRK05846, NADH:ubiquinone oxidoreductase subunit M; Reviewed.	4.59297e-116
NZ_CP033459.1\|WP_111897272.1\|1202421_1203147_-\|4Fe-4S-dicluster-domain-containing-protein	gnl\|CDD\|235637	PRK05888, PRK05888, NADH-quinone oxidoreductase subunit NuoI.	3.92891e-34
NZ_CP033459.1\|WP_111897282.1\|1212682_1212994_+\|HigA-family-addiction-module-antidote-protein	gnl\|CDD\|274228	TIGR02607, Virulence-associated_protein_I, addiction module antidote protein, HigA family. Members of this family form a distinct clade within the larger family HTH_3 of helix-turn-helix proteins, described by pfam01381. Members of this clade are strictly bacterial and nearly always shorter than 110 amino acids. This family includes the characterized member HigA, without which the killer protein HigB cannot be cloned. The hig (host inhibition of growth) system is noted to be unusual in that killer protein is uncoded by the upstream member of the gene pair. [Regulatory functions, DNA interactions, Regulatory functions, Protein interactions, Mobile and extrachromosomal element functions, Other].	1.69237e-20
NZ_CP033459.1\|WP_111897287.1\|1215878_1216949_-\|hypothetical-protein	gnl\|CDD\|313734	pfam10571, UPF0547, Uncharacterized protein family UPF0547. This domain contains a zinc-ribbon motif.	0.000311328
NZ_CP033459.1\|WP_111897273.1\|1203237_1204323_-\|NADH-quinone-oxidoreductase-subunit-NuoH	gnl\|CDD\|376297	pfam00146, NADHdh, NADH dehydrogenase.	9.09165e-129
NZ_CP033459.1\|WP_111897269.1\|1199445_1201464_-\|NADH-quinone-oxidoreductase-subunit-L	gnl\|CDD\|235836	PRK06590, PRK06590, NADH:ubiquinone oxidoreductase subunit L; Reviewed.	0
NZ_CP033459.1\|WP_111897271.1\|1201867_1202383_-\|NADH-quinone-oxidoreductase-subunit-J	gnl\|CDD\|376343	pfam00499, Oxidored_q3, NADH-ubiquinone/plastoquinone oxidoreductase chain 6.	5.0894e-23
NZ_CP033459.1\|WP_111897275.1\|1206019_1206661_-\|NADH-quinone-oxidoreductase-subunit-B	gnl\|CDD\|173277	PRK14816, PRK14816, NADH-quinone oxidoreductase subunit B.	1.38598e-121

>NZ_CP033459.1|WP_111897277.1|1207310_1209089_+|DNA-polymerase-III-subunit-gamma/tau
MEKYIVSARKYRPRNFDSVVGQNALTTTLKNAIASGKLAHAYLFCGPRGVGKTTCARIFAKAINCLNPGQNGEPCDECESCRAFNENRSYNIHELDAASNNSVDDMRSLIEQTQIPPQVGKYKTFIIDEVHMLSTGAFNAFLKTLEEPPAHDIFILATTEKHKLLPTILSRCQIYDFKRMEIPDIVNHLKYVAKDMGVSYEDEALNVIAQKADGGMRDALSIFDQVASFSEGNITYHKVIEDLNVLDYEYYFRLTDCLLKCDIPESLLILNEVLSKGFDAQHFIGGLATHLRDLLVSKEPRTTKLLDVADSVRQRYTEQSQRCKPAILYKALRLCNDCDINYRTASNKRLLVELTLIQVAQLSSDEEPSAGRSPAKNIKPIFSSAPANNPAQERKPAATTAATTTTPATTPAADPKQAVQSTPIKAPAAATTTAPQPKGPRILSISGLANEKNQKSAAQEKPLDELTANLGEKPFTDSDLRVHWQRYASQLPIEKRAMSERMKNMQPALKEGAQVEVVVDNRQVLEYMEEMRYDITLHLRRELDNRHINLNMRIREMTERRPAYSQKEIFEQLLETHPEFRQLKEDLKLELN
>NZ_CP033459.1|WP_111897276.1|1206651_1207014_-|NADH-quinone-oxidoreductase-subunit-A
MNFTLFLTALLTGVGFVAVVTVLAKLLAPRSFNAQKEEPYESGIPTRGRSWMQFRVGYYLFAILFLMFDVETMFLFPWAVTLQSTVDKYGPVALVSVLFFLIILVLGLVYAWRKGALKWH
>NZ_CP033459.1|WP_111897275.1|1206019_1206661_-|NADH-quinone-oxidoreductase-subunit-B
MALKLKRPKIKSIPYDEFNDNETFEQLVQKLNENGVNIVVKKLDDLFDWGRSNSLWPLTFATSCCGIEFMAVCAARYDIARFGFEVTRNSPRHADVILVNGTITTKMAPVLKRLYDQMADPKYVVAIGGCAVSGGPFRKSYHVVQGVDQIIPVDVYVPGCPPRPEAFLYGMMQLQRIVKVENFFGTTNRKEKDPFKKEYKTLNSELIDTQEQA
>NZ_CP033459.1|WP_111897274.1|1204428_1205994_-|NADH-quinone-oxidoreductase-subunit-D
MNLEYTIVAPEDLHKEMFRLREEKNMDFLVHLTGVDWGEEGLGVVYQLESTKSGEQVNIKSVSPNREQPVLPTVSDIWEVANIYEREVYDFLGIIFTDHPDMRRIFLREDWVGYPLRKDDNPLEENPLRMENEPLSDSTVSYELHEDGTLSTHNNVIFEEDDYVVNFGPQHPSTHGVLHFRIALEGERIKRIDPHLGYIHRGIEKMNESMTYPQMLALTDRMDYLGAMQSRHALCKVIEDAMGVEVSDRVQVIRTIMDELQRIDSHILFYSCLAQDFGATTGFLYGFRDREKILDVLEETCGGRLIINYNTIGGVQADIHPNFVKRVKELIPVIRKGVDEFNDLFTGNVIAHNRMEGVGVLTKEQVISMGCTGGTGRAAGWHNDLRKHRPYAAYDRVDFDEITFEEGDCFARYMVRINEIEQSLRIIEQLIDNIPEGPFQEKMKPIIKVPEGVYYTAVEGSRGQFGVYLESKGDKSPYRVHYRSTGLPLVAAMDAACRGNLIADFVAIGGTLDYIVPDVDR
>NZ_CP033459.1|WP_111897273.1|1203237_1204323_-|NADH-quinone-oxidoreductase-subunit-NuoH
MFDFSTVTKWIDNLLRVDAGFPSWAATLTECILVALVIITLYAVFAIVLIYMERKICAFFQCRLGPNRVGKWGLLQVFADVFKMLQKEIMKMRQTDRFLHDLAPFFVVTASMITFSCLPWGKGASIIDFNIGIFFILAVSSVGVVGILLAGWGSNSKYPLIGAMRSGAQIISYEISIGITMLTMICLTGTMSVSGIVEQQYEEGWNIFRGHLPALIAFVVYLIAGNAECNRGPFDLPEAESELTAGYHTEYSGMHFGYFYLAEYLNLFIVAGIATTMFLGGWAPLHIVGLEGFNNVMDMIPSSLWFIGKTLFVVFLLMWERWTLPRLRIDNILSLEWKYLMPISLINLLLMALVVAFGIHF
>NZ_CP033459.1|WP_111897272.1|1202421_1203147_-|4Fe-4S-dicluster-domain-containing-protein
MYKDKGYFDGLFSGLKSIGIGLKTTMREFFTKKITEQYPENRKELEMFDRFRGSLTMPHNENNQHKCVACGLCQMACPNDSINVISEMKEVDGKKKKVLVTYEYNLGSCMFCMLCVNACPHGAITFDQSFENAVFDRSKLIKVLNQPGSSVIERPKPAPRSAVAKPTAPVAEKPAPAAERPAPQVAEEAKPATPAAEKPLVQPAVDEKPSTPVVEKPMEKPSPADKGINAEESKSADAPSE
>NZ_CP033459.1|WP_111897271.1|1201867_1202383_-|NADH-quinone-oxidoreductase-subunit-J
MDSYNIMFIVLAVVIVISSIVTVTARSIMRSTTALFFTLLGTAGIYFMLGYTFLGAVQIMVYAGGIIVLYVFAILLTRGSKDQLSENSKTKIALSAILSIVGFGLVVFLIFTSHLRGALLEPVQGPHGMTMQYIGENLLSSGEKGYLLPFEAVSLLLLACIVAGLMVARKR
>NZ_CP033459.1|WP_111897270.1|1201525_1201831_-|NADH-quinone-oxidoreductase-subunit-NuoK
MIRIEYILIISAVMMFAGIFGFLTRRGTLAILLSIELMLNATDINFAVFNRMLGTGHDGYFFTLFSIAISAAESAIAIAIMINIYRQLKDVSVDKLSKLKW
>NZ_CP033459.1|WP_111897269.1|1199445_1201464_-|NADH-quinone-oxidoreductase-subunit-L
MEYQHTLLILLLPLLSFLILGICGKWLSHKTAGLIGTSLMAIVTVLAYYTAYVYFTSDRVDGVFQTIVPFNFEWLPFYIPGLANLHFDMGIMLDPISVMMLIVITTVSLMVHIYSFGYMHGEVGFQRYYAFLGLFSMSMLGLVVATNIFQMYMFWELVGVCSYLLIGFYYTEKPAIAASKKAFIVTRFADLGFLVGILIYGYYTGSFSFDFTGTAVYAEGALHGAGPDAARALAAGGFILPTALFLMFLGGAGKSAMFPLHIWLPDAMEGPTPVSALIHAATMVVAGVFQIARLFPMWIQHAPETLHYVAWIGAFTAFYAAAVACAQSDIKRVLAFSTISQIAFMMVALGVCVPGHGQENVIDNHGSLGYMASMYHLFTHAMFKATLFLCAGCIIHAVHSNEMSAMGGMRKYMPVTHITFLIATLAISGIPPFSGFFSKDEILAASFNYSGVLGWIMTIIAAMTAFYMFRLYYGIFWGTENKELHDELKAHGHFGEAPAVMTVPLVILTIYTVFVGWALPATDGSFSLQGTFGTYVSASGEAYHIHLDPSIAVTSVVIAVISIVLATVIYIRPTQPVAEKMKSAMPRLHQWAYRRFYIDEIYQFVTHRIIFAYISRPIAWIDRHIVDGVLNGLANGTNVVGENIRPLQSGKIQQYAYVFFLGIVVLFFLMLI
>NZ_CP033459.1|WP_111897268.1|1197889_1199389_-|NADH-quinone-oxidoreductase-subunit-M
MNALSIFVLIPLIMLLGLWLVKDQRGIRTVMVIGSTALLASAVVLTVVFLQDRAAGNTAEMLYTASFDWFTPLHIKYAVGVDGISVAMLLLSGIIVFTGTFVSWDMCKEYFLWFTLLSLGVFGFFITVDMFTMFMFYEVALIPMYLLIGVWGSGKKEYSAMKLTLMLMGGSAFLMCGIFGIFYGAGGNTMNLVEIANHTNGATPIALNSQLIWFPMTFVGFGVLGALFPFHTWSPDGHAAAPTAVSMLHAGVLMKLGGYGCFRIAMYLMPEAANELAWIFIILTGISVVYGAFSACVQTDMKYINAYSSVSHCGLVLFALLMMNQTACTGAVIQMLSHGLMTALFFALIGMIYGRTHTRDIRELNGLMKIMPFLSVCYVIVGLGNLGLPGLSGFVAEMTIFVGSFEHTDTFHRIFTILACSSIVTTAVYILRMVGKILYGKCTNEHHLQLTDATLVERFPVIVLICCIAGIGLAPFFVSHLVSGGVEPIVNHLMQVAAQ
>NZ_CP033459.1|WP_111897279.1|1209738_1210806_+|chorismate-synthase
MNTIGNIFRLTSFGESHGAAIGGIIDGMPPGIDIDMAFIQSELDRRKPGQSDLTTGRKEGDRVEILSGVFEGKSTGTPIGFIVRNENQHSADYDNLRDIFRPSHADYTYFCKYGIRDHRGGGRTSARETISRVVAGAFAKLVLRQKGICIRAYTSQVGNISLSGTYQDYDLALAETNPVRCPDPETAERMAELIREVKAEGDTIGGVITGVITGCPAGLGEPVFDKLHAALGSAMLSINAAKGFEYGEGFAGVTQRGSEQNDIFTTDGKGGITTQTNHSGGIQGGISNGNDICFRVAFKPVATLLREQPTVGTDGNTTTVQARGRHDPCVLPRAVPIVEAMAAIVTLDKCLQAKC
>NZ_CP033459.1|WP_111897280.1|1210946_1212197_-|hypothetical-protein
MKWFLTVLLTFFSFNVWAEDVDSVQCADTARNEMASDTGKDFWGVSVAGNVSYLIHAGEYNKELLHSYGTNHYDLRLRWQPRGRHETAYDRAMGHPTILAGLIYEDFGRVKIYRNDPSHRARIGYLLSLYGGVQFNIVRKGRWAIGLDLMQGIAYCPHPFDENSNRDNEVIGSTFSIFFGAGVSAKYRFAPRWHASIGLDFKHYSNGTLDRPNLGANTIGPTLALHYDLGNQEGNMKGKGSKNTAPEDKNYRKGFYVDAVAGMGLKSLIDHFTIHQSKDNPLYGFFTTMVAPMYRYHLLHASGIGLDYTYADYIYKVRDYDRLQGRTGYRYSPHILGVSARHEVFYRHLSVNVGVGVYLLNRTGHVAKTEESRIYQNVGLRYAFPFTHDRVFIGYNIKAHRFQKVNCVQLLLGCRI
>NZ_CP033459.1|WP_111897281.1|1212364_1212673_+|addiction-module-killer-protein
MEISFEKDYLRELFYEGKTSDRHHRYQPEIVKRYIRVINILESVEKPVDLFRFRSLHYEKLIGDKVGLESVRVNKQYRVEFKSQPSGEITICRIIDLSNHYK
>NZ_CP033459.1|WP_111897282.1|1212682_1212994_+|HigA-family-addiction-module-antidote-protein
MGSLGYGAYPTHPGEVLKDELAERGISQRKLAESMGLTYSVVNEILNGHRPLTAKTALMFEAALDVPADSLMYLQTKYNMQTARKDTTLLSNIKKIKKIAAVF
>NZ_CP033459.1|WP_111897283.1|1213107_1213464_-|hypothetical-protein
MKLKLFPTLLSLIITAAFAYLAYYIANSKGDESDWLLATGTEVCLLSAILPLIALRLDNDRQNVNMKVWSTIVLFLMLAVNLCFAIFGVAVPLYIVSVVLILCVHFLVLWKLVEIKDV
>NZ_CP033459.1|WP_111897284.1|1213477_1213864_-|DUF4339-domain-containing-protein
MNDQSFFSVDRLVEFGLSMAVAQQMVNMMNQTMRTMYIPGSIQSMPAPNPAAAPGMCPPPLPATCYVALEGKQVGPLSESELCSLITQGKVTKDSLCWFPGLTSWQPVENTPQVLRLVALAPPPMPNQ
>NZ_CP033459.1|WP_111897285.1|1213901_1214234_-|hypothetical-protein
MAHYENIKIPRSEGWKFSRTQGTNGDDYYAKVLINDKGEIDESSYSESYQRRMNPPQVTEKVIHIKETTKKEGCIKKIIKAPFRLLWWIIKQVLIIVSVGMLADWLNDNK
>NZ_CP033459.1|WP_111897286.1|1214312_1215665_-|DUF4339-domain-containing-protein
MALFGKGKGGGLMNVIRCDEEDYMVWKWRPLGQDVNSTSRENSIRYGSSLRVKDGEVAVFVYKSKDGPLQDFIEGPFDQTIKTANFPVLASIVGMAFGGESPFQAEIYFINLAGNNQLRFAVPFFDVFDPRLPDHGIPMAVRGTITFNITDYKNFIKLNRLINFDHERFRGQIKDALSKYVKGVVMNIPQELGMPVVQMERQILTINERVEAYLKPRIENDFGVNLKGFDIAALDIDKDSPYYEELRELTAGNTAKTINAQTDLGIRNMQDTQRINLANMEESLRIQREEMQRAQRLQTESNFMGAHSLDQQTEVLKTGAQSLGQMGAMNMSGDGNSMNPAGMMTGMMMGGAVGQQMAGMMQNMGQQMQGAMNTPPPMPSVQYLVSINGAQSGPFNLQELKMMAQSGQITRQTYVWKQGMANWDFAGNVAELASIFAPPAPGTPPPPPMP
>NZ_CP033459.1|WP_111897287.1|1215878_1216949_-|hypothetical-protein
MFSQELQKLIEASLVDGRITDEERAVIRNRAVSEGINPAEVDMILDAEVQKIRQRQQAAMNKVKKCPNCGEIMPALSGVCPSCGHTVGVNRNDDNELLALIENMENALVALKSGKNDKMQKALVEKYRRMARTLYAEDKKVQYLLSEIDSELLIHNKSKRTKNIIIGCIVFIVLIFTLFIYKSCKGDGPKEIISKVTILVNEGNLDEATALVEEFRSKKKNSEGDIMSAYETICNARIEKGEYDKAINIFGSGHPGSLYRLKANVIKKSIDKCINEGKYDEAIQFYNTSSLNLGITFENIIYKCIDHMKTKGEETSIKSFIDRVSPASSEWRKKHLKQLYNYAGLDSSNISFDDND
>NZ_CP033459.1|WP_111897288.1|1217029_1217803_-|hypothetical-protein
MAEKSMVLLIIIVEICKKQFMAKKINNLSPFGVHSCLCAFNPWTKITWNNTIADCDKNTITTFTQNNPNILDTSDLPEPYSGSFINSDVICLNLNPGGTVNATDFKQSQYLQLRQETLLHKTDDFMWFKDIKDINGNLHAGCIWWRERTKELCTELNTQNLNIFVLEYFPYHSKQSFNYPELPSDAYRDYLLFQALIQGKLLVIMRGKRYWEKVLLRTILRLCSYRYKIIEMNSPQSAFFSKNNFGSNWRDLIKTLS

You can click texts colored in the table to view more detailed information

Click the colored protein region to show detailed information

Crispr_ID: NZ_CP033459_4

CRISPR_ID

CRISPR_location

CRISPR_type

Repeat_type

Spacer_info

Cas_protein_info

CRISPR-Cas_info

NZ_CP033459_4

1339117-1339214

Orphan

Consensus_repeat	Method
GGAGCTCATACGTTATTTCCACTCTCAACTATC	CRISPRCasFinder

1 spacers

The CRISPR arrays of NZ_CP033459_4

>merge|NZ_CP033459|4|1339117-1339214|CRISPRCasFinder
GGAGCTCATACGTTATTTCCACTCTCAACTATCCTCGACACACTCCACTACAGCATCAGTAAGCCGGAGCTCATACATTATTTCCACTCTCAACTATC

>NZ_CP033459|4|4|1339117-1339214|CRISPRCasFinder
GGAGCTCATACGTTATTTCCACTCTCAACTATC	CTCGACACACTCCACTACAGCATCAGTAAGCC
GGAGCTCATACATTATTTCCACTCTCAACTATC

Protein	Signature genes	Signature genes Name	Protein_function
NZ_CP033459.1\|WP_111897381.1\|1351684_1352953_-\|nucleotide-sugar-dehydrogenase	unknown	unknown	gnl\|CDD\|185104
NZ_CP033459.1\|WP_111897446.1\|1351045_1351498_+\|thioredoxin-dependent-thiol-peroxidase	unknown	unknown	gnl\|CDD\|239315
NZ_CP033459.1\|WP_146739317.1\|1328677_1329517_+\|hypothetical-protein	unknown	unknown	unknown
NZ_CP033459.1\|WP_111897379.1\|1346322_1350225_+\|hypothetical-protein	unknown	unknown	unknown
NZ_CP033459.1\|WP_111897445.1\|1341584_1342133_-\|NUDIX-hydrolase	unknown	unknown	gnl\|CDD\|239516
NZ_CP033459.1\|WP_111897370.1\|1333414_1334290_+\|rod-shape-determining-protein-MreC	unknown	unknown	gnl\|CDD\|237560
NZ_CP033459.1\|WP_146739319.1\|1345434_1345761_-\|hypothetical-protein	unknown	unknown	gnl\|CDD\|271215
NZ_CP033459.1\|WP_111897376.1\|1341322_1341529_-\|heavy-metal-associated-domain-containing-protein	unknown	unknown	gnl\|CDD\|238219
NZ_CP033459.1\|WP_111897373.1\|1336792_1338268_+\|rod-shape-determining-protein-RodA	unknown	unknown	gnl\|CDD\|274033
NZ_CP033459.1\|WP_111897367.1\|1329519_1330287_+\|hypothetical-protein	unknown	unknown	unknown
NZ_CP033459.1\|WP_111897372.1\|1334851_1336765_+\|penicillin-binding-protein-2	unknown	unknown	gnl\|CDD\|274573
NZ_CP033459.1\|WP_111897377.1\|1342203_1345419_-\|hypothetical-protein	unknown	unknown	gnl\|CDD\|366737
NZ_CP033459.1\|WP_146739321.1\|1350560_1350854_-\|hypothetical-protein	unknown	unknown	unknown
NZ_CP033459.1\|WP_111897374.1\|1338298_1338811_+\|hypothetical-protein	unknown	unknown	unknown
NZ_CP033459.1\|WP_111897368.1\|1331519_1332116_+\|IMP-cyclohydrolase	unknown	unknown	gnl\|CDD\|234854
NZ_CP033459.1\|WP_111897365.1\|1326690_1328691_+\|hypothetical-protein	unknown	unknown	unknown
NZ_CP033459.1\|WP_111897369.1\|1332162_1333251_+\|rod-shape-determining-protein	unknown	unknown	gnl\|CDD\|237562
NZ_CP033459.1\|WP_146739318.1\|1334311_1334839_+\|rod-shape-determining-protein-MreD	unknown	unknown	unknown
NZ_CP033459.1\|WP_111897375.1\|1339227_1341132_-\|heavy-metal-translocating-P-type-ATPase	unknown	unknown	gnl\|CDD\|319783
NZ_CP033459.1\|WP_146739320.1\|1350307_1350490_+\|hypothetical-protein	unknown	unknown	unknown

Protein	Function_ID	Function_description	E-value
NZ_CP033459.1\|WP_111897446.1\|1351045_1351498_+\|thioredoxin-dependent-thiol-peroxidase	gnl\|CDD\|239315	cd03017, PRX_BCP, Peroxiredoxin (PRX) family, Bacterioferritin comigratory protein (BCP) subfamily; composed of thioredoxin-dependent thiol peroxidases, widely expressed in pathogenic bacteria, that protect cells against toxicity from reactive oxygen species by reducing and detoxifying hydroperoxides. The protein was named BCP based on its electrophoretic mobility before its function was known. BCP shows substrate selectivity toward fatty acid hydroperoxides rather than hydrogen peroxide or alkyl hydroperoxides. BCP contains the peroxidatic cysteine but appears not to possess a resolving cysteine (some sequences, not all, contain a second cysteine but its role is still unknown). Unlike other PRXs, BCP exists as a monomer. The plant homolog of BCP is PRX Q, which is expressed only in leaves and is cellularly localized in the chloroplasts and the guard cells of stomata. Also included in this subfamily is the fungal nuclear protein, Dot5p (for disrupter of telomere silencing protein 5), which functions as an alkyl-hydroperoxide reductase during post-diauxic growth.	2.47625e-67
NZ_CP033459.1\|WP_111897377.1\|1342203_1345419_-\|hypothetical-protein	gnl\|CDD\|366737	pfam01640, Peptidase_C10, Peptidase C10 family. This family represents just the active peptide part of these proteins. Residues 1-120 are not part of the model as they form the pro-peptide, which before cleavage blocks the active site from the substrate. The catalytic residues of histidine and cysteine are brought close together at the active site by the folding of the active peptide.	6.69821e-72
NZ_CP033459.1\|WP_111897445.1\|1341584_1342133_-\|NUDIX-hydrolase	gnl\|CDD\|239516	cd03424, ADPRase_NUDT5, ADP-ribose pyrophosphatase (ADPRase) catalyzes the hydrolysis of ADP-ribose and a variety of additional ADP-sugar conjugates to AMP and ribose-5-phosphate. Like other members of the Nudix hydrolase superfamily, it requires a divalent cation, such as Mg2+, for its activity. It also contains a highly conserved 23-residue Nudix motif (GX5EX7REUXEEXGU, where U = I, L or V) which functions as a metal binding site/catalytic site. In addition to the Nudix motif, there are additional conserved amino acid residues, distal from the signature sequence, that correlate with substrate specificity. In humans, there are four distinct ADPRase activities, three putative cytosolic enzymes (ADPRase-I, -II, and -Mn) and a single mitochondrial enzyme (ADPRase-m). Human ADPRase-II is also referred to as NUDT5. It lacks the N-terminal target sequence unique to mitochondrial ADPRase. The different cytosolic types are distinguished by their specificities for substrate and specific requirement for metal ions. NUDT5 forms a homodimer.	8.21699e-48
NZ_CP033459.1\|WP_146739319.1\|1345434_1345761_-\|hypothetical-protein	gnl\|CDD\|271215	cd14256, Dockerin_I, Type I dockerin repeat domain. Bacterial cohesin domains bind to a complementary protein domain named dockerin, and this interaction is required for the formation of the cellulosome, a cellulose-degrading complex. The cellulosome consists of scaffoldin, a noncatalytic scaffolding polypeptide, that comprises repeating cohesion modules and a single carbohydrate-binding module (CBM). Specific calcium-dependent interactions between cohesins and dockerins appear to be essential for cellulosome assembly. This subfamily represents type I dockerins, which are responsible for anchoring a variety of enzymatic domains to the complex.	5.85238e-10
NZ_CP033459.1\|WP_111897376.1\|1341322_1341529_-\|heavy-metal-associated-domain-containing-protein	gnl\|CDD\|238219	cd00371, HMA, Heavy-metal-associated domain (HMA) is a conserved domain of approximately 30 amino acid residues found in a number of proteins that transport or detoxify heavy metals, for example, the CPx-type heavy metal ATPases and copper chaperones. HMA domain contains two cysteine residues that are important in binding and transfer of metal ions, such as copper, cadmium, cobalt and zinc. In the case of copper, stoichiometry of binding is one Cu+ ion per binding domain. Repeats of the HMA domain in copper chaperone has been associated with Menkes/Wilson disease due to binding of multiple copper ions.	3.81218e-10
NZ_CP033459.1\|WP_111897373.1\|1336792_1338268_+\|rod-shape-determining-protein-RodA	gnl\|CDD\|274033	TIGR02210, Rod_shape-determining_protein_RodA, rod shape-determining protein RodA. This protein is a member of the FtsW/RodA/SpoVE family (pfam01098). It is found only in species with rod (or spiral) shapes. In many species, mutation of rodA has been shown to correlate with loss of the normal rod shape. Note that RodA homologs are found, scoring below the cutoffs for this model, in a number of both rod-shaped and coccoid bacteria, including four proteins in Bacillus anthracis, for example. [Cell envelope, Biosynthesis and degradation of murein sacculus and peptidoglycan, Cellular processes, Cell division].	6.0004e-63
NZ_CP033459.1\|WP_111897370.1\|1333414_1334290_+\|rod-shape-determining-protein-MreC	gnl\|CDD\|237560	PRK13922, PRK13922, rod shape-determining protein MreC; Provisional.	3.57128e-50
NZ_CP033459.1\|WP_111897372.1\|1334851_1336765_+\|penicillin-binding-protein-2	gnl\|CDD\|274573	TIGR03423, pbp2_mrdA, penicillin-binding protein 2. Members of this protein family are penicillin-binding protein 2 (PBP-2), a protein whose gene (designated pbpA or mrdA) generally is found next to the gene for RodA, a protein required for rod (bacillus) shape in many bacteria. PBP-2 acts as a transpeptidase for cell elongation (hence, rod-shape). [Cell envelope, Biosynthesis and degradation of murein sacculus and peptidoglycan].	9.30357e-169
NZ_CP033459.1\|WP_111897368.1\|1331519_1332116_+\|IMP-cyclohydrolase	gnl\|CDD\|234854	PRK00881, purH, bifunctional phosphoribosylaminoimidazolecarboxamide formyltransferase/IMP cyclohydrolase; Provisional.	5.11295e-101
NZ_CP033459.1\|WP_111897369.1\|1332162_1333251_+\|rod-shape-determining-protein	gnl\|CDD\|237562	PRK13927, PRK13927, rod shape-determining protein MreB; Provisional.	2.6479e-180
NZ_CP033459.1\|WP_111897375.1\|1339227_1341132_-\|heavy-metal-translocating-P-type-ATPase	gnl\|CDD\|319783	cd02094, P-type_ATPase_Cu-like, P-type heavy metal-transporting ATPase, similar to human copper-transporting ATPases, ATP7A and ATP7B. The mammalian copper-transporting P-type ATPases, ATP7A and ATP7B are key molecules required for the regulation and maintenance of copper homeostasis. Menkes and Wilson diseases are caused by mutation in ATP7A and ATP7B respectively. This subfamily includes other copper-transporting ATPases such as: Bacillus subtilis CopA , Archeaoglobus fulgidus CopA, and Saccharomyces cerevisiae Ccc2p. This subclass of P-type ATPase is also referred to as CPx-type ATPases because their amino acid sequences contain a characteristic CPC or CPH motif associated with a stretch of hydrophobic amino acids and N-terminal ion-binding sequences. This subfamily belongs to the P-type ATPases, a large family of integral membrane transporters that are of critical importance in all kingdoms of life. They generate and maintain (electro-) chemical gradients across cellular membranes, by translocating cations, heavy metals and lipids, and are distinguished from other main classes of transport ATPases (F- , V- , and ABC- type) by the formation of a phosphorylated (P-) intermediate state in the catalytic cycle.	5.9111e-146
NZ_CP033459.1\|WP_111897381.1\|1351684_1352953_-\|nucleotide-sugar-dehydrogenase	gnl\|CDD\|185104	PRK15182, PRK15182, Vi polysaccharide biosynthesis UDP-N-acetylglucosamine C-6 dehydrogenase TviB.	3.46602e-174

>NZ_CP033459.1|WP_111897374.1|1338298_1338811_+|hypothetical-protein
MTQQDNDKKKKIFLIIGVGAVLLLFILPAKYAANSRHTAADKSSAENAPIAIPDVEETDTDSIPFVSSSIPDSTLHNDSRTPETMGLEDGYRSGMADGKSRLSSGKNDDKGPQKSPQEQKTYTDNYRRGYQEGIAKSKEGEQALDAKNDTRTIEEMAAEASSTIQGAVMD
>NZ_CP033459.1|WP_111897373.1|1336792_1338268_+|rod-shape-determining-protein-RodA
MSTPLQTLTARKSTFSVDWLVLLLYLTLIVFGWLSVCGASHEFGDTDIFSWSSRSGKQLVWIICSFGLGFCLLMIDEKYFDMLAAFLYVSMMLLLLITPLLATNTKGSLSWIKLGPVSLQPAEFAKCATSLAVAKMFSQFGFSLGKRKDLLRAVGLVMLPMVLIVMQRETGSALVYLAFFLVFYREGMYGSVLFCVFAAVLYFVVGLRYANDIMPATTASVGEYVVLVLIFFFTIGFIHTYLPRERLRKPLIYGVGCSIAAYLFSWIVKPFDVSIVQIIILVMMIFYLLWQGLTLHKRAYHLIAVFAIGSVCFLYASDFALNNVLQEHQQQRINVLLGIDSSVTGAGYNVHQSKIAIGSGGLHGKGFMNGTQTKLKYVPEQDTDFIFCTVGEEQGFIGSAAVLSLFLALILRLIWLAERQSTIFGRVYGYCVLSILFFHVFINVGMVMGLTPVIGIPLPFFSYGGSSLWGFTILLFIFLRMDACDRVRLHV
>NZ_CP033459.1|WP_111897372.1|1334851_1336765_+|penicillin-binding-protein-2
MPNTLKFTNRKYVIGGIAICIIAIYVIRLFALQMLDNTYKQSADSNAVRRDVLFPSRGQIRDRNDSLLVYDESSYNIMVNMMEQHGVDTLEFCKTLGITKQDYINKMLDIKDDKKNPSYSRYKPQVFMTQIKPEDISVLREKLFRFKGFYVERRSMRHYAGSVGAHILGDVGEASENDIREDFYYQNGDLIGKLGVERSYEKELRGEKGVQLMMRDVRGRTLGRYKDGLYDTKPVPGKDIKLTIDIKLQELAERLLQNKLGAIVAIEPQTGEVLCMASSPTFDPQRMVGRERGKYVQELTKDSMRPMFNRAIMGAYPPGSTFKPTQGLIGLQEHIITPNTSFSCNHGFEMKGLHLNCHSHPAPLSLVPALGTSCNAFFCWNLYRMFKDREHFTSQDEAMTRWKDHLVSMGYGYRLGIDLPGEKRGMIPNAQYYDKYLKKWGPLSVISISIGQGEVTATPLQIANLAATIANRGYFYTPHVVKEVAGGRIDPKFSEKRNTTIDAGYYRYIVAGMRSAVMKGTCVNAAIPGIEVCGKTGTAQNHGKDHSAFMGFAPMNEPKIAVAVYVENGGFGAVFGVPIGKLIMEQYLNGELSSESKSQASEIQHKRIDYSAQSMRREREKERQKKAARENKRRKQN
>NZ_CP033459.1|WP_146739318.1|1334311_1334839_+|rod-shape-determining-protein-MreD
MIKTVLYRVKWFFLLYFLQVILFNHIHIFGYATPMTYIFFFMMLPSNTRHWIYVALGFAMGFLIDLFTNTPGVGASAVCITGFCTPWLLKLFAPSGYAFEEPFEPSSRTMEWLPFIRFTVAMALVNTFAYYLIESFSFFNIGFLLLSTLLSTLITVVFVCGIEFLKNGTSKKKAP
>NZ_CP033459.1|WP_111897370.1|1333414_1334290_+|rod-shape-determining-protein-MreC
MRNLIELFHKYNYVFLFVLLQAVSMFMLFSFNDYQGSVALTSANSAVATVDRLYGDMEAYSKLKGTNASLTDSITRLQMENSVLRRELAAAKRDTAATEREVLNTLNKYRLIPALVVSNSNSDDLNNYIIIDKGERDGIKEYYGVVSGGGVIGIVSLVGERYSLVIPVVNRKSSISCRIRGKDYFGYLGWDGGKKLYGYVDDIPRYADVKVGDCIETNGYSEIFPPGIFIGRVTRIDDAPDGQSYRLIVNLGIDFANLRNVNVIASSFRAEVDTLRNHAAIIDGSAEEKKP
>NZ_CP033459.1|WP_111897369.1|1332162_1333251_+|rod-shape-determining-protein
MAKFSTFKIFEKFESLKNSRFLSNLFSFTQELAMDLGTANTVIISDGKIAVNEPSVVALDVHTDKMVSVGGQAKLMYEKTNSKIRVVRPLRDGVIADFNACEQMMRGLIRMANDGKHLFTPSLRMVIGVPSGSTEVELRAVRDSAEHAGGHDIFLLYEPMAAAIGIGLDVEAPEGNMIVDIGGGTTEIAVISLGGIVSNNSIKMAGDDFTTDIQEYMSRQHNVKVSERMAERIKINVGAALTDLGPNAPEDYLVHGPNRITALPMEVPVCYQEIAHCLEKSISKIEAAVLSALENTPPELYADIYNNGIYLTGGGALLRGLDKRLKDKVGINFIVADDPLLCVAKGTGIALKNTERFQFLMR
>NZ_CP033459.1|WP_111897368.1|1331519_1332116_+|IMP-cyclohydrolase
MAETKKIKTALISVFHKDGLDDLLSALHADGVEFLSTGGTQQFIESLGFPCRKVEDVTGYPSILGGRVKTLHPKVFGGILGRRGLEGDVEQMESYDIPAIDLVIVDLYPFEQTVASGASEADIIEKIDIGGISLIRAGAKNFNDVVIIPSKAEYKPLLEIVKAQGASTTLEQRREFATKAFGVSSHYDTAIHNWFSGK
>NZ_CP033459.1|WP_111897367.1|1329519_1330287_+|hypothetical-protein
MQLQRTFKESYKNKLRDAVKSGEAIELYSKDSFEIDNHFVKRLANVYEPDFDIGEKMLETYDDDFKSAITLYEAYKEISPLLASSETFWVYLTHTTLFNYTQQRWPNVLRKTATSSYILDHWFMGGNGLLRNAAASLWWSIKCTYDEERNNRYELSEILFNNYTLRVNTFGISTIIRHKEAMIGILEYIKENPEVMLSFENRGRFISKYFNRLGGSKNLSSLDRNYFKKICYSLHETIMSITTREQTLDETLYYE
>NZ_CP033459.1|WP_146739317.1|1328677_1329517_+|hypothetical-protein
MNLNNISLPYPVLGISDDISPLLPTDCVSVSMEQDLRDYTFSINLKFQNEDIERLIKEEKAEYTCEYSCARTMLRICLKSDEPSFTITIPRRSINARLEFNCFVSVKSPISQYANSGFNDDYLGFTFDLEEGDILVAFPQFHYDADIKFDRLQTAGSFMQIKESNLHTEVFYDISGDKIDICLPTSHYQLYCHPKVKGAMEIIHSSLVMNALTYALQNIHDHENTMWARAIDTRLRTEDGFSIDELEDVSKIPSLAQRLLKDPYNRLFNHLILTSTPED
>NZ_CP033459.1|WP_111897365.1|1326690_1328691_+|hypothetical-protein
MANLEKSCCWHFAEQAGGREDGPNNPMDGNFKKTPYASLIRESIQNSLDAALDDNQPVQVNFEIGRIRANEYERFFELKGHIQGCIDHYPSNDDAKETYNPMIEYLTSMERFDNLYYIKVSDFNTKGMNYKNRTQSDYTSEPFYAFVRAAGVSSKNDSSAGGSFGFGKAAYFYISPLRTILVSTKTQYGTHFFEGVASLCTHRFMNDGKKYVAVGYYDNNDGEPITKYDDIPEKFKRDETGTDIFIMGLKLSKDKEEANGEKTAIYKEMIEAVLRNFWLAIEFGKLEVKVEDTIINKENLPTIMEEYFPDKEDTKRRERQYNPRPYWEAVHNKECDRNHVYIEKTYPKLGLVKFYGLKVRGAQDKILYMRRLHMLVKARRTQSANGIYGLFLCDNKFGNKILRNTENPAHNEWAAGNWQIDGKKAKDGIDAIEEVDRFIIDVLEEIFAGREKNVQQIQGLEEFLYIPTEPTEDDDLDNDSLTGEPVDESDDGNSMSTELSDPIHTPIEGKTELGKVLISDTSAYIQRDEHGNVLSGHGIRKRRNQGGGGTGTRNIDGRYKSEDKGVNGEVLHEIPVTYRSFAQKINDRVFHTLVIHSEYEVEKGRIDLMVGGEQSDDVINIEYCSKGDVRDNTISNLTISKGKNLLTIRFADNMKHAVKLDAYESK
>NZ_CP033459.1|WP_111897375.1|1339227_1341132_-|heavy-metal-translocating-P-type-ATPase
MHQIFPVSGMACSACSANVERRLNALNGISYAAVNLVGRTATVDYDPAVITPEEMKTAVSDIGYDMVIEADRSAEQIEAQAYRRLKRLMIIAWTFAAVVMCTSMLPAFVSNATMANWMCLVFALACIVVCGRQFYVSALRQLRHFSANMDVLVAMSTFVAFCFSAFNTIWGERVWGARGMEWHTYFDAVTMIIAFVLTGRLLEEKAKDATSASIRLLMGLSPKTARLAEGGVLVPISTIEKGDLLEVRAGEKIPVDGKVVEAESFMTEDAVYVDESMISGEPTPVAKRKGDRVLAGTIPSQGRLHLRAQEVGEGTTLAHIIRMVEEAQNSKAPVQRIVDKAALVFVPVVIGITLLTFLLWWGIGGQAVLPRAILSAVSVLVIACPCAMGLATPTALMVGIGKAAERQVLVKDAAALELLRKVDAVVIDKTGTLTIPNQNVDFTKADNLPLEARESLKPHAAEAMRQLQEAGVEVYMMSGDKEDAARYWAEKAGVAHYSSQVLPQDKEKMVSELQSQGKVVAMVGDGINDTQALARADVSIAMGRGTDVAMDVAQVTLMTDDLRSIPAAVSLSRRTVSMIRQNLFWAFIYNIVCIPLAAGALCAFGIDLQITPMWAAALMALSSLSVVANSLRLR
>NZ_CP033459.1|WP_111897376.1|1341322_1341529_-|heavy-metal-associated-domain-containing-protein
MEKKIVNVQGMKCAHCKASVEAALMAIGGVSAAEADLEKKQVSVECADEVSQDAIVDAIEGAGRFYVE
>NZ_CP033459.1|WP_111897445.1|1341584_1342133_-|NUDIX-hydrolase
MELKDKSWTVIETEYLFRRPWLTARRDKLLLPNGKIHPEYYVLEYPDWVNVIAVTKDDDFVLVRQYRYGIRQTCFELVAGVVEQGEAPLDAAKRELLEETGFGGGRWTELMSIAPNASAMTNLSYSFLAVDVEKIDAQHLDETEDIDVFLYPKEKVYDMLSRGEFRQALMVAPLWKYFSGRM
>NZ_CP033459.1|WP_111897377.1|1342203_1345419_-|hypothetical-protein
MIRKFLLTLLCSAVIFGLEAQTISRTAARKKATQFLESKGHSASLKDAGNLKDAGEVAPYYIFNVKNNGGFVIVSGDERLEEIVGYSDQGNLSGDIPEALQEVLDGYAAFVESLGEAASTDDATTTANAPKLMAVTETAKKSISPLITTKWGQTAPYNNLCPKYYYSNGTQSSTNAVTGCVATAMAQLLNYWKTPNATTSAIPELTNTYNGSQDVTLPAVPAGTAIDWANMQDTYSSSATGAGATAVAQLMLYCGQSVNMSYANSSGASSERVPGALVNYFGFDASTTFHNASNFSIAKWENLVYGELAAGRPVYLSGQSDGGGHAFICDGYDGEGLYHINWGWKGSCDGYFRLVTLRPNSNAGTGASSSSDGYSMSRGGILGMRPAGVGTVPSYESDIDASTSGLRLTTKDMVVNNNRIAYSIYNETGGQREFDIAFGIYDQTTGAIEMIGQYAYSNLRNNVSIGVNSYYPSSYISSGGYSLSNLSSRANGTYWVIPVSRVSGTENWLWNEGNYYLPVTVNNGSVTYSSPQVHVVSLPITVSSLRDMSAAYVNIEQELKVSIDNSSDKEYSGTIYLFASTTAEKGNPVNRTGIAIKGNSSDEFELFFTPTSAATYNIWITADANGENVLYTTQISISENKSDYSALTVSYNVPSTAYNGVVKGTMTVTNNSTEVFVSPLVLLYLYPDGGYLNSFDNTSLEDVNIAPGGSQTFNVDYTVTDYNAIYLYLYSTTTGFIGTNSSAINIVSGRNIYGFDGTLTQGAFTSSYTVPASAAAVDLRGNGTVSVNATNANPNCLFYIKSTDNVTGLNGKNVIIDGTAANITLTDGQPFYAPETFTATNISYTRTPLLGTNGVGGWETLVLPFAATSVSKVADNTETALEWFKSESETGKNLWIKKFVGIDDNDSVYFDFVQELEANQPYIIAVPGNRWGSKWNLQNVPLKFAAQNAQVEGNSLAQAYTSLYCYKGCYYNTTPSNAYAIDAEGANFVLAATASVSPFRAFFDGEMVGSGAPKLCIANGSGTTTAIATIATDRQSAEDNVVYNISGQRVNAGSALPKGVYIKNGKKFVVK
>NZ_CP033459.1|WP_146739319.1|1345434_1345761_-|hypothetical-protein
MRKIFTVIFALSAFLSVGSLDAYADTAQVESTKKGDANNDGVVNVSDVVAAVNYILGINSADFVLTNADMDGDNTISVSDLVAMVNIILNGEETEPGGGDIQNPGTKS
>NZ_CP033459.1|WP_111897379.1|1346322_1350225_+|hypothetical-protein
MKKITFLLTFLLTAVVGMWGQTGPNGSTQVSSAEITTGYYYLYNNGAAKFLSGSTGAYQWVDETSLTGDAGLWYIQNEGAGSDGNIRYYVQVKGSNNYFGGVGPECPLNSSGVYQRISVRESGAYYTLSGHQVVSQIGNKTAIKYNGTSGNLIYRNGGDINSSSFPTESQWVIYKAAVSITYTIAVTGTNDANAGVQYQGTNYTNGSTFSTSDDISASDFTANEVTGYKATVTVNGTTIKVNYVEAKYAVDFTDLYVTNTSVATTTDPIVEGQWYVLTQIRNGESPAYDNGTGNNIKRAQTSVTANTLLVTNTPANDIKKYLIRFFSTGEGNGYKIQFGTGNFWYGTGSGNGAHLYANATNSTAFLVYNATQTSGNSTGWAINETTNGTTYGRKVDNNGAGETVAFWDNGQTSSGGNNVWKLYPVELGALVRDINFNLEITDGTVTKTFSSVTKPEGTTISAMDFLGISTQYATSTSHTLTTADDGQTVTLTVTPTAALPVANGAYYAWQTAVGNNPSYIHVDENGAAVNPNGYSINLTKPVTVDHVWQIEGNIINGFSLKNDKTSQYLGGRTAAAGYMAMEATPSLFAPVYNNATTFKWKNVDYGYWIDRASAKPYAHTSGNNNSLTQLYPVTFALSDATAGNIIVGGDTISDFTQTYYISSDATIALVAQDFSILDYNGSATVAEALAALGAAGGTLTINVTQEMSNVTINVVKDGQTVKTVTVENVAAGRAVDVAEAIGDVPYVTGYDPATITATADDQTVNVTYTSSLPFTLAADPTSSEAPTYAMTLREKYAHGNIALSTSQYDITDEYLWTFGGDEFNGVTVYNKDFGYMNVGSESDNSVATFSSTPTLFTIKPNSNQANGFNLNIPNTNAYINLRGDYVSTWLSDYADGEVGSCLVAIPEATHLANLINKLEDYFHTTDFVGALASADTAALRVDYEALKANPTKANYQTFKAELEANFIDITPGAYYIVRSAFSGFYTNQGEYKAWYYSASTGSVKWKNMDASPEYQVFQVVANDNGDNVFYNPMAGVYLTAADGSVSSDINAAKAFTLTALGGGQQNILLDGITTPIHAAGHNNGQGINGNLTNWSGSANSASSWYIIPQNIEEITLIAPTGVAEGEEVIQGFANATDAQLPTSIGVFTITEDLAAGAHLDTIASGKIAAGQGYLISGVKGAKVPLLPVASAVEAPVGNLLVAGQGTIVNGGYILAYKKGDTEAKFYQINGLTVPENRSYLPEGTPTRGLEFLFGGLGDDVTGINGITTGAENGAIYDLQGRRVNNAQKGVYIINGKKVIK
>NZ_CP033459.1|WP_146739320.1|1350307_1350490_+|hypothetical-protein
MKKTYITPATAIFEMRHENVIATTIPKDNSGEGIGDTNQDGFDFAPKDDNSWTDGSWTKP
>NZ_CP033459.1|WP_146739321.1|1350560_1350854_-|hypothetical-protein
MKKMLLALLAVMMFGMPVVTSAETNSQDEVMQVPNRKYRKSKYRRARRPLPPPPARRKVSVRPQEYRKGQPLPQHGVYGAPVNRGSCVDKVSKKRRR
>NZ_CP033459.1|WP_111897446.1|1351045_1351498_+|thioredoxin-dependent-thiol-peroxidase
MQTGDKAPDILGRNEKGEEIRVSDFKGRKLALYFYPKDNTPGCTAEACSIRDNYAALQAAGYAIVGVSVQDEKSHQKFIEKHELPFPIIADTDHTLVEAFGVWQEKSMCGRKYMGTVRTTFIINEEGIVEKIYGPKQIKTKIHGEQLLQG
>NZ_CP033459.1|WP_111897381.1|1351684_1352953_-|nucleotide-sugar-dehydrogenase
MEKTKICVIGLGYVGLPLARLFSTKYETVGFDMNQARVDALMKGHDATLEVADDLLQDAINNHGFICTTDLEKIRDCNFYVVAVPTPVDENNNPDLTPLYGASTTVGKVISKGDIVVYESTVYPGVTEDECIPVVEKVSGLKMNVDFYAGYSPERINPGDKKHTVEHIKKVTSGSTPEIGKKVNEVYASVITAGTHLAPTMKVAEAAKVIENSQRDINIAFVNELSKIFNKMGIDTTDVLEAASTKWNFLPFKPGLVGGHCIGVDPYYLAQCAQRYGYNPEIILAGRRMNDSMGEYVASETVKHMLKKGIQVLNSEIVILGFTFKENCPDVRNTKVIDIYKALQEYNLNITVYDPWAVPAIVEHEYGIKVTNQLPEGKFDAAILAVAHSKFDDLDVKALVKENHVIFDVKSFLPKEIVDGRL

You can click texts colored in the table to view more detailed information

Click the colored protein region to show detailed information

Crispr_ID: NZ_CP033459_5

CRISPR_ID

CRISPR_location

CRISPR_type

Repeat_type

Spacer_info

Cas_protein_info

CRISPR-Cas_info

NZ_CP033459_5

1515774-1515862

Orphan

Consensus_repeat	Method
TGGTTATGTTTTAGAAGAAAAAA	CRISPRCasFinder

1 spacers

The CRISPR arrays of NZ_CP033459_5

>merge|NZ_CP033459|5|1515774-1515862|CRISPRCasFinder
TGGTTATGTTTTAGAAGAAAAAACACCCGTTCTTGGTTATGTTTTAGAAAGATTTTGCCCTTTTTCTGGTTATGTTTTAGAAAGAAAAA

>NZ_CP033459|5|5|1515774-1515862|CRISPRCasFinder
TGGTTATGTTTTAGAAGAAAAAA	CACCCGTTCTTGGTTATGTTTTAGAAAGATTTTGCCCTTTTTC
TGGTTATGTTTTAGAAAGAAAAA

Protein	Signature genes	Signature genes Name	Protein_function
NZ_CP033459.1\|WP_111899046.1\|1526322_1527087_-\|M48-family-metalloprotease	unknown	unknown	gnl\|CDD\|320693
NZ_CP033459.1\|WP_111899050.1\|1520915_1522763_+\|hypothetical-protein	unknown	unknown	gnl\|CDD\|370821
NZ_CP033459.1\|WP_111899152.1\|1515143_1515578_-\|dUTP-diphosphatase	unknown	unknown	gnl\|CDD\|234802
NZ_CP033459.1\|WP_111899160.1\|1502595_1503891_-\|tyrosine--tRNA-ligase	unknown	unknown	gnl\|CDD\|235645
NZ_CP033459.1\|WP_111899154.1\|1512142_1512991_-\|DUF4292-domain-containing-protein	unknown	unknown	gnl\|CDD\|372917
NZ_CP033459.1\|WP_111899151.1\|1516670_1517921_+\|DNA-(cytosine-5-)-methyltransferase	unknown	unknown	gnl\|CDD\|365904
NZ_CP033459.1\|WP_111899158.1\|1506449_1506884_-\|type-II-3-dehydroquinate-dehydratase	unknown	unknown	gnl\|CDD\|376496
NZ_CP033459.1\|WP_151908889.1\|1510465_1511899_-\|peptidoglycan-DD-metalloendopeptidase-family-protein	unknown	unknown	gnl\|CDD\|366703
NZ_CP033459.1\|WP_111899153.1\|1513006_1514932_-\|hypothetical-protein	unknown	unknown	unknown
NZ_CP033459.1\|WP_151908877.1\|1517942_1518890_-\|IS30-family-transposase	unknown	unknown	gnl\|CDD\|225382
NZ_CP033459.1\|WP_111899159.1\|1504273_1505716_+\|amidophosphoribosyltransferase	unknown	unknown	gnl\|CDD\|223112
NZ_CP033459.1\|WP_111899048.1\|1524511_1525501_+\|glycosyltransferase-family-2-protein	unknown	unknown	gnl\|CDD\|366154
NZ_CP033459.1\|WP_111899044.1\|1529508_1530108_-\|non-canonical-purine-NTP-diphosphatase	unknown	unknown	gnl\|CDD\|237823
NZ_CP033459.1\|WP_111899156.1\|1507561_1509715_-\|anaerobic-ribonucleoside-triphosphate-reductase	unknown	unknown	gnl\|CDD\|274318
NZ_CP033459.1\|WP_111899045.1\|1527128_1529456_-\|T9SS-type-A-sorting-domain-containing-protein	unknown	unknown	gnl\|CDD\|225829
NZ_CP033459.1\|WP_111899049.1\|1523142_1524492_+\|dNTP-triphosphohydrolase	unknown	unknown	gnl\|CDD\|234897
NZ_CP033459.1\|WP_111899199.1\|1505796_1506420_-\|O-methyltransferase	unknown	unknown	gnl\|CDD\|226607
NZ_CP033459.1\|WP_111899047.1\|1525497_1526232_+\|SDR-family-NAD(P)-dependent-oxidoreductase	unknown	unknown	gnl\|CDD\|187608
NZ_CP033459.1\|WP_111899051.1\|1519144_1520923_+\|AAA-domain-containing-protein	unknown	unknown	gnl\|CDD\|183088
NZ_CP033459.1\|WP_111899157.1\|1506959_1507427_-\|anaerobic-ribonucleoside-triphosphate-reductase-activating-protein	unknown	unknown	gnl\|CDD\|274317

Protein	Function_ID	Function_description	E-value
NZ_CP033459.1\|WP_111899050.1\|1520915_1522763_+\|hypothetical-protein	gnl\|CDD\|370821	pfam10117, McrBC, McrBC 5-methylcytosine restriction system component. Members of this family of bacterial proteins modify the specificity of mcrB restriction by expanding the range of modified sequences restricted.	4.45198e-70
NZ_CP033459.1\|WP_111899152.1\|1515143_1515578_-\|dUTP-diphosphatase	gnl\|CDD\|234802	PRK00601, dut, dUTP diphosphatase.	7.07702e-86
NZ_CP033459.1\|WP_111899160.1\|1502595_1503891_-\|tyrosine--tRNA-ligase	gnl\|CDD\|235645	PRK05912, PRK05912, tyrosyl-tRNA synthetase; Validated.	0
NZ_CP033459.1\|WP_111899154.1\|1512142_1512991_-\|DUF4292-domain-containing-protein	gnl\|CDD\|372917	pfam14125, DUF4292, Domain of unknown function (DUF4292). This family of proteins is functionally uncharacterized. This family of proteins is found in bacteria. Proteins in this family are typically between 243 and 287 amino acids in length.	2.99764e-36
NZ_CP033459.1\|WP_111899151.1\|1516670_1517921_+\|DNA-(cytosine-5-)-methyltransferase	gnl\|CDD\|365904	pfam00145, DNA_methylase, C-5 cytosine-specific DNA methylase.	5.20753e-53
NZ_CP033459.1\|WP_111899158.1\|1506449_1506884_-\|type-II-3-dehydroquinate-dehydratase	gnl\|CDD\|376496	pfam01220, DHquinase_II, Dehydroquinase class II.	9.33861e-83
NZ_CP033459.1\|WP_151908889.1\|1510465_1511899_-\|peptidoglycan-DD-metalloendopeptidase-family-protein	gnl\|CDD\|366703	pfam01551, Peptidase_M23, Peptidase family M23. Members of this family are zinc metallopeptidases with a range of specificities. The peptidase family M23 is included in this family, these are Gly-Gly endopeptidases. Peptidase family M23 are also endopeptidases. This family also includes some bacterial lipoproteins for which no proteolytic activity has been demonstrated. This family also includes leukocyte cell-derived chemotaxin 2 (LECT2) proteins. LECT2 is a liver-specific protein which is thought to be linked to hepatocyte growth although the exact function of this protein is unknown.	2.13351e-21
NZ_CP033459.1\|WP_111899046.1\|1526322_1527087_-\|M48-family-metalloprotease	gnl\|CDD\|320693	cd07334, M48C_loiP_like, Peptidase M48C Ste24p loiP-like, integral membrane protein. This subfamily contains peptidase M48 Ste24p protease loiP (formerly yggG)-like family are mostly uncharacterized proteins that include E. coli loiP and ycaLG, considered to be putative metallopeptidases, containing a zinc-binding motif, HEXXH, and a COOH-terminal ER retrieval signal (KKXX). They proteolytically remove the C-terminal three residues of farnesylated proteins. They are integral membrane proteins associated with the endoplasmic reticulum and golgi, binding one zinc ion per subunit. In eukaryotes, Ste24p is required for the first NH2-terminal proteolytic processing event within the a-factor precursor, which takes place after COOH-terminal CAAX modification (C is cysteine; A is usually aliphatic; X is one of several amino acids) is complete. Mutation studies have shown that the HEXXH protease motif, which is extracellular but adjacent to a transmembrane domain and therefore close to the membrane surface, is critical for Ste24p activity. LoiP has been shown to be a metallopeptidase that cleaves its targets preferentially between Phe-Phe residues. It is upregulated when bacteria are subjected to media of low osmolarity, thus yggG was named LoiP (low osmolarity induced protease). Proper membrane localization of LoiP may depend on YfgC, another putative metalloprotease in this subfamily.	5.2035e-98
NZ_CP033459.1\|WP_151908877.1\|1517942_1518890_-\|IS30-family-transposase	gnl\|CDD\|225382	COG2826, Tra8, Transposase and inactivated derivatives, IS30 family [DNA replication, recombination, and repair].	9.85404e-80
NZ_CP033459.1\|WP_111899159.1\|1504273_1505716_+\|amidophosphoribosyltransferase	gnl\|CDD\|223112	COG0034, PurF, Glutamine phosphoribosylpyrophosphate amidotransferase [Nucleotide transport and metabolism].	1.83823e-80
NZ_CP033459.1\|WP_111899048.1\|1524511_1525501_+\|glycosyltransferase-family-2-protein	gnl\|CDD\|366154	pfam00535, Glycos_transf_2, Glycosyl transferase family 2. Diverse family, transferring sugar from UDP-glucose, UDP-N-acetyl- galactosamine, GDP-mannose or CDP-abequose, to a range of substrates including cellulose, dolichol phosphate and teichoic acids.	8.29633e-38
NZ_CP033459.1\|WP_111899044.1\|1529508_1530108_-\|non-canonical-purine-NTP-diphosphatase	gnl\|CDD\|237823	PRK14823, PRK14823, putative deoxyribonucleoside-triphosphatase; Provisional.	8.98846e-103
NZ_CP033459.1\|WP_111899156.1\|1507561_1509715_-\|anaerobic-ribonucleoside-triphosphate-reductase	gnl\|CDD\|274318	TIGR02827, conserved_hypothetical_protein, anaerobic ribonucleoside-triphosphate reductase. Members of this family belong to the class III anaerobic ribonucleoside-triphosphate reductases (RNR). These glycine-radical-containing enzymes are oxygen-sensitive and operate under anaerobic conditions. The genes for this family are pair with genes for an acitivating protein that creates a glycine radical. Members of this family, though related, fall outside the scope of TIGR02487, a functionally equivalent protein set; no genome has members in both familes. Identification as RNR is supported by gene pairing with the activating protein, lack of other anaerobic RNR, and presence of an upstream regulatory element strongly conserved upstream of most RNR operons. [Purines, pyrimidines, nucleosides, and nucleotides, 2'-Deoxyribonucleotide metabolism].	0
NZ_CP033459.1\|WP_111899045.1\|1527128_1529456_-\|T9SS-type-A-sorting-domain-containing-protein	gnl\|CDD\|225829	COG3292, COG3292, Predicted periplasmic ligand-binding sensor domain [Signal transduction mechanisms].	8.86608e-06
NZ_CP033459.1\|WP_111899049.1\|1523142_1524492_+\|dNTP-triphosphohydrolase	gnl\|CDD\|234897	PRK01096, PRK01096, deoxyguanosinetriphosphate triphosphohydrolase-like protein; Provisional.	5.64852e-133
NZ_CP033459.1\|WP_111899199.1\|1505796_1506420_-\|O-methyltransferase	gnl\|CDD\|226607	COG4122, COG4122, Predicted O-methyltransferase [General function prediction only].	1.08255e-55
NZ_CP033459.1\|WP_111899047.1\|1525497_1526232_+\|SDR-family-NAD(P)-dependent-oxidoreductase	gnl\|CDD\|187608	cd05350, SDR_c6, classical (c) SDR, subgroup 6. These proteins are members of the classical SDR family, with a canonical active site tetrad and a fairly well conserved typical Gly-rich NAD-binding motif. SDRs are a functionally diverse family of oxidoreductases that have a single domain with a structurally conserved Rossmann fold (alpha/beta folding pattern with a central beta-sheet), an NAD(P)(H)-binding region, and a structurally diverse C-terminal region. Classical SDRs are typically about 250 residues long, while extended SDRS are approximately 350 residues. Sequence identity between different SDR enzymes are typically in the 15-30% range, but the enzymes share the Rossmann fold NAD-binding motif and characteristic NAD-binding and catalytic sequence patterns. These enzymes have a 3-glycine N-terminal NAD(P)(H)-binding pattern (typically, TGxxxGxG in classical SDRs and TGxxGxxG in extended SDRs), while substrate binding is in the C-terminal region. A critical catalytic Tyr residue (Tyr-151, human 15-hydroxyprostaglandin dehydrogenase (15-PGDH) numbering), is often found in a conserved YXXXK pattern. In addition to the Tyr and Lys, there is often an upstream Ser (Ser-138, 15-PGDH numbering) and/or an Asn (Asn-107, 15-PGDH numbering) or additional Ser, contributing to the active site. Substrates for these enzymes include sugars, steroids, alcohols, and aromatic compounds. The standard reaction mechanism is a proton relay involving the conserved Tyr and Lys, as well as Asn (or Ser). Some SDR family members, including 17 beta-hydroxysteroid dehydrogenase contain an additional helix-turn-helix motif that is not generally found among SDRs.	4.03315e-50
NZ_CP033459.1\|WP_111899051.1\|1519144_1520923_+\|AAA-domain-containing-protein	gnl\|CDD\|183088	PRK11331, PRK11331, 5-methylcytosine-specific restriction enzyme subunit McrB; Provisional.	1.08858e-23
NZ_CP033459.1\|WP_111899157.1\|1506959_1507427_-\|anaerobic-ribonucleoside-triphosphate-reductase-activating-protein	gnl\|CDD\|274317	TIGR02826, hypothetical_protein, anaerobic ribonucleoside-triphosphate reductase activating protein. Members of this family represent a set of radical SAM enzymes related to, yet architecturally different from, the activating protein for the glycine radical-containing, oxygen-sensitive ribonucleoside-triphosphate reductase (RNR) as described in model TIGR02491. Members of this family are found paired with members of a similarly divergent set of anaerobic ribonucleoside-triphosphate reductases. Identification of this protein as an RNR activitating protein is partly from pairing with a candidate RNR. It is further supported by our finding that upstream of these operons are examples of a conserved regulatory element (described Rodionov and Gelfand) that is found in nearly all bacteria and that occurs specifically upstream of operons for all three classes of RNR genes. [Purines, pyrimidines, nucleosides, and nucleotides, 2'-Deoxyribonucleotide metabolism].	9.85382e-51

>NZ_CP033459.1|WP_111899152.1|1515143_1515578_-|dUTP-diphosphatase
MEIKIVNRSKHALPSYATPLSAGMDLRANLDAPVTLQPLERRLVPTGLFIALPAGYEAQVRPRSGLAIKKGIGVLNSPGTIDADYRGEICVILVNLSNEAFVINDGDRIAQMVVARHETVEWTPVEALDETERGAGGFGHTGKE
>NZ_CP033459.1|WP_111899153.1|1513006_1514932_-|hypothetical-protein
MRIVVFIFCVLLLAGCASTGDTVSSRKVAPKEEVDTLSPQDGASARTTRRAMDEIFESGVKNYLIGNYKLAIENLYKTMELVEAGADFPAGSAYYLGRIYAELAANPEGALEKYQLYLKSFMDDDIDLALNFENPFEEYANCADSANKYLKLAVDWEQGEKRYKKAYLDFLLNTYGDTVEARNVAKAILDLEKTEDNYIQVIQLCKTKEEQLQQYLKMEKDFGSSYETNKRIFQLYKESGDMKKALEALERLAKSDKSISDAEKNFNKIFYARQLLDNGKTKDAYNIAKGVLQNSPEDESAVCFMVYYYRMTGNDNAMYETIKSAMRSPTISNYSKYDVLNEMLEGYRADKEDKDVVLSHRAEMLDVLRIVLSEQTINNDILMLCEKLTEDESELSETTEQIFYDILMRDPENVRLRELLINYYIEENDSAKCIQLCEDGMRYMDPVSIFYYYEGLCYLRLQHYDEMFEALDKGIKLADEKDEADVLSRLYNLYGMGCYRVDPPNAPENYEKSLEYDTENIDCMKNYCNYLIDYWDGSRGDRLLELSKRAVELDPYDMETKTYYAMAMMLTGQKEAAKVQIDAVLSEDGENSVYDIVLEYAGDIYNSVGLIQEAKDFWKRAEAVTDDDSMKARINKKIEEN
>NZ_CP033459.1|WP_111899154.1|1512142_1512991_-|DUF4292-domain-containing-protein
MKIYKALLFVALIAAVCSCSTTKNIDKGNTPKNNQVSNHAPKNNAVANYLKQVEANRQTAKAVTASISLDIMLKGNGVSCSGKLKMRRNDVIQLSLSVLFMEVARFEFSPKEVLIIDKFHKQYVRASYDEVSFLKNAGLDFYALQALFWNEIFVPGEKTDVPASRFSMSSAGEHTVLTIADAPKLNYEFMTLTESQLFDRLNVEGKNSSDTGQFVWTYGDFTKLSGKQFPKSMTMKVTGVGSDMECEMSLSGLSNDNNWEGHSTPSSKYSQRSAESLLKSLF
>NZ_CP033459.1|WP_151908889.1|1510465_1511899_-|peptidoglycan-DD-metalloendopeptidase-family-protein
MSQNLQQRLSLSRRRSKIPYLSKSLQISQSPQPSRKRLSLPNLPLSRSQRLSQNHPLLSLLRQPSLQPSKSQQPRRRPLPLRSHLLNPNLPLSRSQRLSQNHPLLSLPLNRSRQHSRNQQPRRRPLPLPNLLLSKNYPLLSLQHNRKRLQPQNLQYSRSQPRLLNQQHSKNQLHHKSLPRHLNQQPSRNRQQLLNRLHNKRQAAQVRKQTIQSLLLNRNQLPSRSLQISQCPQPSRNRQQLLNRLHNKRQTTQARKQTIQSLLLNRKQLPSRSLLRTQNLRSKNKSLSPPSQRLTKRCNRRKVTNLQQRRKKQIESPITPVQSQPEDTKPIYRQADDSKQELSGGFAANKGRLPVPVTGKYAITKRFGSYNVSGLSNIILDNKGIDIVTDGGHARCVYDGTVSTIFSISNYYNVIVRHGNYLTMYCNLSNVKVKEGQRVKTRQELGKIAKDSNGKHTLHFQIRRETEKLNPEQWISK
>NZ_CP033459.1|WP_111899156.1|1507561_1509715_-|anaerobic-ribonucleoside-triphosphate-reductase
MSTENFIITKRDGGTESFSLDKIKSAILKAFTSSGEPIDAEGLQKVISHLRFCNGMSVEDIQNQVEVALMAERHFKVAKRFMLYRQQHTEDREIVDHINFVLDYVDSLNPATGSKYDANANVENKNIATLIGELPKKNFIRLNRRMLTDRIKKMYGKETADRYLFLLNNHYIYKNDETSLANYCASITMYPWLLEGTKSIGGNSSAPTNLKSFCGGFVNMVFIVSSMLSGACATPEFLMYMSYFLQKEYGEDYFERADEVVDLSTRKRTLDKVITDCFEQIVYSINQPTGARNFQAVFWNISYYDENYFKSIFGDFFFPDGTQPSWPAVNWLQKRFMRWFNAERTRTVLTFPVETMALLSKDGEVMDQEYADFTAEMYAAGHSFFTYMSDNADSLASCCRLRNEIQDNGFSYTLGAGGVSTGSKSVLTINLNRCVQQATREGQSYIDYLSRIIDICHKVQMAYNENLKMLQEKGMLPLFDSGYINIGRQYLTIGVNGLVEAAESLGITISDNEEYATFVSDILGLVETYNKKYRTKDVMFNCEMIPAENVGVKHARWDREAGYFVPRDCYNSYFYVVEDTNTDVIEKFRLHGRKYIEHLTGGSALHMNLDEHLSKAQYRQLLRVAAKEGCNYFTFNIPNTVCNDCGHIDKRYLHECPKCQSKNLDYLTRVIGYLKRVSNFSAARQKEASRRYYGNLRPDMSGETMMTEKVQNVEMKG
>NZ_CP033459.1|WP_111899157.1|1506959_1507427_-|anaerobic-ribonucleoside-triphosphate-reductase-activating-protein
MLKYVNTDIVFQEFPDEVTLAINLSLCPNGCPGCHSNYLQGDVGAVLDAVSLLSLLNDYRDEITCVGLMGGDNDPAAVMQLMDTIRLSYGNQLKTGWYSGRARLPEGFKPELFDYVKLGPYKSESGPLNAPTTNQRLYRIENGEFIDITSRFWKK
>NZ_CP033459.1|WP_111899158.1|1506449_1506884_-|type-II-3-dehydroquinate-dehydratase
MKILILNGPNLNRLGKREPDIYGSATMEECLATLRTDFPNVELEYAQSNHEGELIDIMQQASDGDMAGIVLNAGAYTHTSVALLDCIRSLSIPVVEVHLSNVHAREDFRHKSLISSACKGIVAGFGMNSYRLAVEALVRLAAAK
>NZ_CP033459.1|WP_111899199.1|1505796_1506420_-|O-methyltransferase
MSLDDYILQHITPEDPYLHDLYRATNLELLRPRMASGHLQGSLLRMLVNIAQPKHILEVGTFSGYATLCMAAALPEGGRITTFEINDEQEEFTRPWFDGSPYADRIEFVIGDVLDILPTRNDTFDMAYVDGNKRQYIDYYDLILPRLTSGGLFIADNTLWNGNVNDPAHHDAQTQAIRDFNDRVANDPQVETIILPIRDGLTLVRKK
>NZ_CP033459.1|WP_111899159.1|1504273_1505716_+|amidophosphoribosyltransferase
MGGFFGTISKKECATDLFYGTDYNSHLGTKRAGIVTFDKEKGFTRSIHSLERDYFRSRFEGELEAFKGNSGLGIISDTDPQPILVNSHLGRYAVVTVAKVNNLREIAEELKEKRMHLSEMSQNNINQTELIALLVNMGDTFVDGINLIFKKVKGSCSLLVLTEDGIIAARDALGRTPIILGRKDGAYAATSESTSLPNLGYDIVRNVGPGEIVKITAEGEEVLQKPFSRCQICSFLWVYYGFPVSEYEGINAEYVRETAGQKMGEEDDLEADCVCGIPDSGVGFALGYSDGHKIPYKRAVLKYTPTWPRSFTPSKQSRRQLVAKMKLIPNRAILDNQRVVFCDDSIVRGTQLRDNVKMFFDYGAREVHARISCPPLVYGCPFVGFTASKSEMELLTRQIIQDFEGDANKNLEKYATTDTPEYTRMVNEIGKRLGLTSVKFNKIETLIDAIGLPKDRVCTHCFDGTSYEFTDTLTEEETAE
>NZ_CP033459.1|WP_111899160.1|1502595_1503891_-|tyrosine--tRNA-ligase
MNFVEELQWRGMVHQMMPGTEEQLSKELTTAYLGIDPTADSLHIGHLCGVMMLRHFQRCGHKPLALVGGATGMIGDPSGKSQERNLLTPEILEHNKACIKQQLAKFLDFDTNLPNGAELVDNYEWMKDYGFLDFVREIGKHITVNYMMAKDSVKRRLNGEASDGLSFTEFSYQLLQGYDFLHLYETKNCKLQMGGSDQWGNITTGTELIRRTLGTEAQAFALTCPLITKSDGKKFGKTEQGNVWLDRRYTTPYRFYQFWLNVADDDAERYIKIFTSLPQEEINALIEEHRADPGRRTLQKRLGEEVTCMVHSREDYEMAIEASNILFGKATKDNLLKLDEETLLQVFDGVPQFEVSKDQALGVKAVDLFAETTKCFASKGEMRKLVQGGGVSLNKEKLAAFDQVIEQKDLLDGKYLLVQRGKKNYFLITVK
>NZ_CP033459.1|WP_111899151.1|1516670_1517921_+|DNA-(cytosine-5-)-methyltransferase
MAKKELIIRLGTLFSGIGAFEHALKQLKIKHEILFACDNGERELYLSYGNIKCLTKNLSKNALRTFCEDYINKIGVRREYREVEIDLLFKAVKNSSNKKDDDNVVLTYYKEGRKSPIKHKLILTQDMIAALTPNSTMKERERFVKSLYDNLGEHNYVKDAYFANYQIEEAKWHEDIRFLDANDYRNKIDILIGGSPCQSFSNYGKKLGLEDVRGTLFYDYARIINECRPKIFIYENVENVTKNDGGKTWKVMFQVWQSLGYHIEWSILDAKDYNHPQLRSRLFLIGFREDIYKKPYKFPQKQTLHKKSTDFLQSNVENVYYLGKKGFEWITSPEKNLRRSRINQDVIGCQTAYQQDNWIGDFRVEHPQKRHYDDPRIYIGKHDFNDGKGLVDAVGRKMTPRECLNLMGFDETFNIA
>NZ_CP033459.1|WP_151908877.1|1517942_1518890_-|IS30-family-transposase
MKYKQLTSQQRYTIQNGLKQGLTKKMIAALIEVNESTLYREIHRNGGAKVYNAEKAQREADRRKTRLQKPRRFTHALKREVISLLQKKWSPEQICGYIKRQGRECVSHETIYAFIRTDRKCGGMLWKLCRHAMKKRRKTDKGKRIPIKDRVSIDLRPEEADGTRFGDWEMDTIVGKDGKGALVTLYERRTGYGMVKRLPDGKEAKGVEEAVYRMLIPYKKQVLTITTDNGTEFARHSQLAKKLSTKIFFAHPYSSWEKGGVENYNKLVRQYIPKGTNLEQYTDKYLMEVQKQINSRPRKKLNFNNPKNEFYKLLD
>NZ_CP033459.1|WP_111899051.1|1519144_1520923_+|AAA-domain-containing-protein
MKWNDFDVNKNAYPEYIRIISDWLWFISSRWENIEDKNKFIEQNLQPLITGTFREPKIKDGQIKYPSPALGTFIRNLGFIDDNYNLSPLLTLIATNKLTLSEYALINLSKHRGWSNDTPVVNFLALLCLYLQKNDYCDITIEMLENLSKVEGYSLNRTPSNDSNRNDLLFNYINGTGLFKEVNETGRSRFLTLKEDASPIIDFIADNKDKIEVDTRVSKNDRYIYYGDLTSGIFMLDGIKLPSVWTRYYPNLLNSNSPSYKYMHIESSKYLDDISPIIFYGAPGTGKTRYAQEEIFSKYHSANRIFTTFHQSYTYEEFVEGLKPELDNDSKEVKYYIETGVFYNACERAAILAGYDNLEDCIADSSQNRKIKFKEAQDSHRTMLLCIDEINRGNVAAIFGDLISLIEPSKRLGSGTYEMTVVLPYSKKEFGVPANLFIVGTMNTADRSIQLLDSALRRRFRFEELLPNYKAFDIKDGDAVKVLKRINSRIRSLLNKDIIEAITTKIIPLLEEYFYNDINKVRFVLNEDDTTTTNNAFYVEDKDAKEAFKTYLQSEDIDEEDKSFFTLNRSIANLTSEEECSKYIKHLLGESE
>NZ_CP033459.1|WP_111899050.1|1520915_1522763_+|hypothetical-protein
MSKKNPIITYEFGTLYIEGQVHKEGDIPIEETTFNNLWDFILSNKATDDTDVIMSVHTRGGRKFIKTGRYVGTIQTKNGQVIEVLPKIFKASGQQEKDKVVCRSVFLNMLRHFTDIKARSFQNVTLSTKKGFPILEVYISNYINAVEQLVLGGLKKNYAPVEENQRFLKGKLDITKQITKNITNKARFAIKYNKYIEDIPQNRIIVTTLRKLISDSHSTTNKAHISVLLTILADIPSSPNIENDLRIASTSNRLFTSYDMLIKWSKQFLLNRGFTTFAGSYVNQSLLFQAERLFEDFVAYLFRKYAPTYNVDAQNTRFFLVDRHNGKRMFQLRPDILVETDKNSPKYECIIIDTKWKAIDSSRPDRHYLIDMKDMYQLYAYGQKYRQGQTKEIGLDVIPKLVLVYPYSEKFTEYLPEFVYEDIKDKIGLKLMVVPFDLTDPFTYEKQIHNIIHCLDVKPEIQPIYRYEYDWKDNTIPLVAAEPTPLYVQTMLVGCYRSKEHLEWIKQNRLYNIRLGDRNGAISKSGLVVSASRLLLYDYKNPKEYQIFELDSSNHIIAKNDLMKSKGYPDLKPDREYLLYVITQEVGVKPYFDVESLRQTYAPKLRKGSPFFVNL
>NZ_CP033459.1|WP_111899049.1|1523142_1524492_+|dNTP-triphosphohydrolase
MNWIDLISSERFGKEGTSKPDVERRTQFQRDYDRLIFSAAFRRMQNKTQVFPLPGSIFVHNRLTHSLEVASVGRSLGNDVGERLVEKYIRLRPDLTHRLNPRFESLGDIVSAACLAHDMGNPPFGHSGENAIRTFFTETKAQSLRHHFSDQQWSDMAHFDGNANTLRLLSHQFEGRRPGGFVMTYPTLASIVKYPYSSTLATKSKFGFFASEQEGYCRIAKKLGIPVVRQTDKGIEFARHPLVYLVEAADDICYEIMDIEDAFKLRILSFEETCDLLLDFFDYDARCDIATTYSEDSDRNDRIVFFRACVINLLERECVRIFMEHEEEILAGSFEGSLISHLPERQLHAYKHCSEVAKQRIYNCKEVTDIDLAGFHIIYTLLNLMVDAVMSPEKAYSKLLISQASSQYALQKGPIAERIISVVDYLTGMTDVFALDLYRKIEGHSLPVV
>NZ_CP033459.1|WP_111899048.1|1524511_1525501_+|glycosyltransferase-family-2-protein
MTRFSILVACYNAEPYLRQTLDSLLSQTLTDIEVICIDDCSTDSTPQILNEYAAKDRRVKMLKTSENSGQAVARNLGLRHATGVLTTMVDADDWLAPDALEKMWQTFSTREDIDSLAFRLQMVEERGITHPFKEDETIPPLMTGEEACLLAINWRLHGFAAVRTELHRRYPYDETTRVYSDDNTSRIHYLKSRFVAQTDADYFYRQHPASVTHQRDTKRLDFLRANDSLRQTLESEGANDQILQTCEDYCWRIFLGICKDMLNQRGKMTENEWKTTEKRLQEAYDNMQLKRLDPKLRKSLRIGPLFGFGSFIMREKFIASLKKHKTTDA
>NZ_CP033459.1|WP_111899047.1|1525497_1526232_+|SDR-family-NAD(P)-dependent-oxidoreductase
MTTKRAIIIGASSGIGREVARLLLREGYDIGIAARRENQLIAFKEEFSQSGRVEIMPIDVTADNAAERLEALIEKLGGMDLYFHAAGIGKQNRELEPDTELQTVQTNALGFTRMIGAAYRYFAKQGTGHVAAITSIAGTKGLGPAPAYSATKAMQATYLEALEQQARNRKLNIHFTDIRPGFVDTDLLSGDFRYPMMLKPEKVARQIVRAIKHRRHVCIIDWKYRLLTMAWRCIPRCIWRNIKL
>NZ_CP033459.1|WP_111899046.1|1526322_1527087_-|M48-family-metalloprotease
MRFLRILTALMLVLAVCHAPATAQMDWLKVLTGTVKAGKAATISDADLAKAVRQEVAKMDAKNKVCSSNSNYARRLSRITSGMTSADGIKLNFKVYLTKDINAFACPDGSVRVYSALMDELSDDELLGVIGHEIGHVALRHSKKAWRSALIRSAASDFMGAASSTWSALSDSYLGSLTSAALSAKHSRYHETQADEYAYKFLKKCHKDPTAMIDALKKLKNMSEGSSSKYSTILHAFSSHPDFDERIRHLEDMD
>NZ_CP033459.1|WP_111899045.1|1527128_1529456_-|T9SS-type-A-sorting-domain-containing-protein
MRKLLLFLITSIIALSSPAQRIGDWTMYQSYYNATASVVADDYVFGIYGGNLLRYTPEDTEVKFYTRNDGLNGKNITLTGYSSTQQTLVLVYDDNNIDLLDVTTDDVVNMAQLKNNTSTVGTVTELSVNGDYAILGSTAGVTVINLARTELRGFYAKKSAVTATAFYDGTVYAALESGGILAGRLEDNLNEDAQWKTIDSHGATVLKPFAGGLYLLTASEGLWRITKDAEGNHSVTKINGASYNKNMFANRTQCVLFNPGGVTIFESSSPNYPKHEIPLTNSWQSVAKAADGTFWVADGGNGLVGYSFNGTSFKTTGTSVGNYGPQNDNCGFLKFEGERLLVSGGIFDYYERNFYDPAVSYYENDTWNSMQTGGISAVTGMPFRSVTSMAQDPKDPNHHFAATGDYGLYEFKNGKYVNYYNLHNSPLKAFSGNQPFYVRVDGLAYDKNGYLWMTNEQVDTIFRILKPNGTWTKLYSPQLANSRHINPIMFDSDGRLWAASRSFIGTHRGGLYCIDYNGTIDNTSDDKATFRYSMINEDGATIDLSGGVFCMAQDKTGQIWFGGSAGIFVVENPADYASSDFQVLQVKVPRNDGTNYADYLLTGISCTAVAVDGANRKWIGTSGYGLYLVSPNGQEIIEQFNTENSPLPSDNILSIAVHPSSGEIFIGTDKGLVSYHSEATEAMETLDKDNVKVYPNPVRPGYNGNVIVSGLTDAADVKIMTTGGQAVATGTSTGGTFVWNVRNFKGEPVAAGVYYILVATADGKEHIAAKVVVVR
>NZ_CP033459.1|WP_111899044.1|1529508_1530108_-|non-canonical-purine-NTP-diphosphatase
MRKQILFATNNAHKLSEIRAILGKDFHVLSIADIDCHGELPETCDTLEGNARQKARYIFDNYGIDCFADDTGLEVEALGGAPGVHTARYAYPDRNDTEANTAKLLSELKGERNRNARFRTVIALINGEGEHLFEGIVRGEITTEKRGTDGFGYDPVFAPYEIGKTFAEVGPEVKNNISHRARAVRKLCEYLKDANLNEL

You can click texts colored in the table to view more detailed information

Click the colored protein region to show detailed information

Crispr_ID: NZ_CP033459_6

CRISPR_ID

CRISPR_location

CRISPR_type

Repeat_type

Spacer_info

Cas_protein_info

CRISPR-Cas_info

NZ_CP033459_6

2131995-2132092

TypeII

Consensus_repeat	Method
CTTTCGCGAGAGCAAAAGACAACGAA	CRISPRCasFinder

1 spacers

The CRISPR arrays of NZ_CP033459_6

>merge|NZ_CP033459|6|2131995-2132092|CRISPRCasFinder
CTTTCGCGAGAGCAAAAGACAACGAAGAGAGAGGCAAACGGAACTGGTTCCGAATTGCCCGAACGCACCAGACTTTCGCGAGAGCAAAAGACAAGGAA

>NZ_CP033459|6|6|2131995-2132092|CRISPRCasFinder
CTTTCGCGAGAGCAAAAGACAACGAA	GAGAGAGGCAAACGGAACTGGTTCCGAATTGCCCGAACGCACCAGA
CTTTCGCGAGAGCAAAAGACAAGGAA

Protein	Signature genes	Signature genes Name	Protein_function
NZ_CP033459.1\|WP_111899410.1\|2134917_2136321_+\|DUF935-family-protein	unknown	unknown	gnl\|CDD\|368731
NZ_CP033459.1\|WP_111899414.1\|2130770_2131721_-\|peptidase	unknown	unknown	gnl\|CDD\|370822
NZ_CP033459.1\|WP_151908867.1\|2127989_2128505_-\|hypothetical-protein	unknown	unknown	gnl\|CDD\|223092
NZ_CP033459.1\|WP_151908919.1\|2138412_2138793_-\|hypothetical-protein	unknown	unknown	unknown
NZ_CP033459.1\|WP_111899411.1\|2134419_2134839_+\|DUF1320-domain-containing-protein	unknown	unknown	gnl\|CDD\|369176
NZ_CP033459.1\|WP_111899406.1\|2126679_2127159_-\|hypothetical-protein	unknown	unknown	unknown
NZ_CP033459.1\|WP_111899407.1\|2127158_2127647_-\|hypothetical-protein	unknown	unknown	unknown
NZ_CP033459.1\|WP_111899405.1\|2126446_2126641_-\|hypothetical-protein	unknown	unknown	unknown
NZ_CP033459.1\|WP_111899412.1\|2134178_2134409_+\|hypothetical-protein	unknown	unknown	unknown
NZ_CP033459.1\|WP_111899415.1\|2132117_2132540_+\|terminase	unknown	unknown	gnl\|CDD\|222859
NZ_CP033459.1\|WP_111899404.1\|2121412_2121886_-\|hypothetical-protein	unknown	unknown	unknown
NZ_CP033459.1\|WP_151908862.1\|2139822_2139999_-\|molecular-chaperone-DnaJ	unknown	unknown	gnl\|CDD\|237668
NZ_CP033459.1\|WP_151908895.1\|2129136_2129352_-\|hypothetical-protein	unknown	unknown	unknown
NZ_CP033459.1\|WP_151908898.1\|2139510_2139795_-\|hypothetical-protein	unknown	unknown	unknown
NZ_CP033459.1\|WP_151908893.1\|2127643_2128033_-\|hypothetical-protein	unknown	unknown	gnl\|CDD\|366443
NZ_CP033459.1\|WP_111899413.1\|2132573_2134136_+\|hypothetical-protein	unknown	unknown	unknown
NZ_CP033459.1\|WP_111899403.1\|2117259_2121342_-\|hypothetical-protein	unknown	unknown	unknown
NZ_CP033459.1\|WP_151908896.1\|2138075_2138474_-\|hypothetical-protein	unknown	unknown	gnl\|CDD\|238038
NZ_CP033459.1\|WP_151908897.1\|2138987_2139551_-\|phage-morphogenesis-protein	unknown	unknown	gnl\|CDD\|227338
NZ_CP033459.1\|WP_151908894.1\|2128528_2129140_-\|N-acetylmuramoyl-L-alanine-amidase	unknown	unknown	gnl\|CDD\|119407

Protein	Function_ID	Function_description	E-value
NZ_CP033459.1\|WP_111899415.1\|2132117_2132540_+\|terminase	gnl\|CDD\|222859	PHA02535, P, terminase ATPase subunit; Provisional.	0.00113172
NZ_CP033459.1\|WP_111899410.1\|2134917_2136321_+\|DUF935-family-protein	gnl\|CDD\|368731	pfam06074, DUF935, Protein of unknown function (DUF935). This family consists of several bacterial proteins of unknown function as well as the Bacteriophage Mu gp29 protein.	3.8025e-29
NZ_CP033459.1\|WP_111899414.1\|2130770_2131721_-\|peptidase	gnl\|CDD\|370822	pfam10123, Mu-like_Pro, Mu-like prophage I protein. Members of this family of proteins comprise various viral Mu-like prophage I proteins.	3.27331e-06
NZ_CP033459.1\|WP_151908867.1\|2127989_2128505_-\|hypothetical-protein	gnl\|CDD\|223092	COG0013, AlaS, Alanyl-tRNA synthetase [Translation, ribosomal structure and biogenesis].	0.0039268
NZ_CP033459.1\|WP_151908894.1\|2128528_2129140_-\|N-acetylmuramoyl-L-alanine-amidase	gnl\|CDD\|119407	cd02696, MurNAc-LAA, N-acetylmuramoyl-L-alanine amidase or MurNAc-LAA (also known as peptidoglycan aminohydrolase, NAMLA amidase, NAMLAA, Amidase 3, and peptidoglycan amidase; EC 3.5.1.28) is an autolysin that hydrolyzes the amide bond between N-acetylmuramoyl and L-amino acids in certain cell wall glycopeptides. These proteins are Zn-dependent peptidases with highly conserved residues involved in cation co-ordination. MurNAc-LAA in this family is one of several peptidoglycan hydrolases (PGHs) found in bacterial and bacteriophage or prophage genomes that are involved in the degradation of the peptidoglycan. In Escherichia coli, there are five MurNAc-LAAs present: AmiA, AmiB, AmiC and AmiD that are periplasmic, and AmpD that is cytoplasmic. Three of these (AmiA, AmiB and AmiC) belong to this family, the other two (AmiD and AmpD) do not. E. coli AmiA, AmiB and AmiC play an important role in cleaving the septum to release daughter cells after cell division. In general, bacterial MurNAc-LAAs are members of the bacterial autolytic system and carry a signal peptide in their N-termini that allows their transport across the cytoplasmic membrane. However, the bacteriophage MurNAc-LAAs are endolysins since these phage-encoded enzymes break down bacterial peptidoglycan at the terminal stage of the phage reproduction cycle. As opposed to autolysins, almost all endolysins have no signal peptides and their translocation through the cytoplasmic membrane is thought to proceed with the help of phage-encoded holin proteins. The amidase catalytic module is fused to another functional module (cell wall binding module or CWBM) either at the N- or C-terminus, which is responsible for high affinity binding of the protein to the cell wall.	5.62766e-31
NZ_CP033459.1\|WP_111899411.1\|2134419_2134839_+\|DUF1320-domain-containing-protein	gnl\|CDD\|369176	pfam07030, DUF1320, Protein of unknown function (DUF1320). This family consists of both hypothetical bacterial and phage proteins of around 145 residues in length. The function of this family is unknown.	3.98059e-12
NZ_CP033459.1\|WP_151908862.1\|2139822_2139999_-\|molecular-chaperone-DnaJ	gnl\|CDD\|237668	PRK14301, PRK14301, chaperone protein DnaJ; Provisional.	0.000223157
NZ_CP033459.1\|WP_151908897.1\|2138987_2139551_-\|phage-morphogenesis-protein	gnl\|CDD\|227338	COG5005, COG5005, Mu-like prophage protein gpG [General function prediction only].	3.57351e-07
NZ_CP033459.1\|WP_151908896.1\|2138075_2138474_-\|hypothetical-protein	gnl\|CDD\|238038	cd00085, HNHc, HNH nucleases; HNH endonuclease signature which is found in viral, prokaryotic, and eukaryotic proteins. The alignment includes members of the large group of homing endonucleases, yeast intron 1 protein, MutS, as well as bacterial colicins, pyocins, and anaredoxins.	2.50135e-09
NZ_CP033459.1\|WP_151908893.1\|2127643_2128033_-\|hypothetical-protein	gnl\|CDD\|366443	pfam01060, TTR-52, Transthyretin-like family. TTR-52 was called family 2 in, and has weak similarity to transthyretin (formerly called pre-albumin) which transports thyroid hormones. The specific function of this protein is as a bridging molecule in apoptosis cross-linking dying cells to phagocytes. TTR-52 bridges by cross-linking surface-exposed phosphatidylserine (PtdSer) on apoptotic cells to the CED-1 receptor, a transmembrane receptor, on phagocytes. TTR-52 has an open beta-barrel-like structure.	0.00160645

>NZ_CP033459.1|WP_111899414.1|2130770_2131721_-|peptidase
MSKTKRVRISNERLNSYGTRVLTTGMDVEQYNRNPVLLYMHERGQVIGYVKDLKVEGDEVTGELMFDEATELSQRCKKQWEFGSLKMVSVGIDILELSEDPKHLVQGQTSPTISKSKLFEVSLVDIGANDDAIVLQKDGQRIELGKDAARVLPLLHINNNKNQKPNQMDQEKLALELGLPKDADESAINEKLAKLKAEGAEAETLRQERDTLRAARIETLVNSAIAEKKIGEDKKQQFLDLGKKIGADELKQTFDAMSPQVKLSNIVTGGGAPAGGHAEYKKLSDVPSDELAKLREDNPAQYKKLYKAEYGIECEI
>NZ_CP033459.1|WP_151908895.1|2129136_2129352_-|hypothetical-protein
MRLIVKKIFRDKTDHVTVYEPGSILEMDDQARASDLIVRGLCAEHKDKSDASVASAEVVKQAVVKPKVRQS
>NZ_CP033459.1|WP_151908894.1|2128528_2129140_-|N-acetylmuramoyl-L-alanine-amidase
MSKVVILGTAHGSNVAGKCSPDGRFREYRFSREIISMLKPRLESLGLTVFVDMPQDVVPLPMSTELSQRCKIVNGICGKYGKENCVYVSIHVNAAGGDGKWHDARGFAVYVSRSCSSSSKRLAKLLCDLALVRGLRGNRSVPGEHYWQAGFYVLKHTVCPAVLSENLFQDNRADVEFLMSPSGKEAVAALHLDALKQYFGINQ
>NZ_CP033459.1|WP_151908867.1|2127989_2128505_-|hypothetical-protein
METDLSQILNWLLGGSLVGALISIVTIRSALKKARAEAERAIAESDTVKITNTEQATRILIQNIVEPLKQELNETRKELSSLKREVARFRKAVDSANSCRYSDDCPVLERMRDTPKERSSVKPRASVCNASHGQRDSPVDRQRKRACGDPDGTCDCSDVVGDADDSDGQPP
>NZ_CP033459.1|WP_151908893.1|2127643_2128033_-|hypothetical-protein
MSSVTLTIATDSLLSLPSGASYSDRSGQASVKVSRKAATATDPEYIYIYATCDSLQLQCERYERYIRNLHKDYGEQLNGMVTRLAEARQEVQEVKEKSPNGIGTALKWYLAGLVSGIIGTIIIFIKLKK
>NZ_CP033459.1|WP_111899407.1|2127158_2127647_-|hypothetical-protein
MNKNFIYGIAAVKFGTAVIGYIEKGSWDWGGTKPETTDVEAEQVPDAPVLTLVQKNGQISPTFNLIQLDYENLHNVLGGELVGTSPNYTGWKAPTSLVEKSGQWTIDFVSGQTMTIPNGTILANLGGKLTLTEVSKVECQLKVNKPANGGAPYEINDTPGEG
>NZ_CP033459.1|WP_111899406.1|2126679_2127159_-|hypothetical-protein
MDARIIQEIQREGAEALLNVGVSLPLKDFKVPFRKSPLRMRLTMRRPTMACQIRIARTWLSVGMTLAEFEGLDYDGQMQFLAKHGKKLSRMIALTMPHWWLPTCVLSWFIRHFMKWEYQKGAFEKFVTLIGTESFTPIIRSAEIANPMKLRLSRREKGS
>NZ_CP033459.1|WP_111899405.1|2126446_2126641_-|hypothetical-protein
MWQIASATGWSVDYILHGVNYQTLIMMIADAPRYVDQKKKENDNRSAEEEAGDIVGFFRSELSK
>NZ_CP033459.1|WP_111899404.1|2121412_2121886_-|hypothetical-protein
MATGQHILSGQVLVNGTDIWQEYGVFLTEEKKGGRENLTAIMTASKVKGHVGVNIREQNGKRYSQSLVVANEERDVTLHFAQYAATKSDWLQNYMEFIQFLKAGTNGWLNITFTELNLTLRVFYVESSAYRPLTYLWKEGVQASRYKVKFREPNPII
>NZ_CP033459.1|WP_111899403.1|2117259_2121342_-|hypothetical-protein
MLLTLYDQTGSVKTALSPNDTSTQDKEIQGDNVLSLSFTLYEYVSIDVNDYVDFEGERYWAVEKYLPNEKSTVEWEYNVKLYGIESLIKRFLVLKTVDDANEAVFTLTARPIEHMCLIVQNINDGMDHTTNFKVGTVEGTDNVVIDYTGKYCDEGLKELAEAVGVEWWIEGETVNLCRCEHGEELALAYGAGLTSLDRDVADNAKFYTRLFPIGSSRNIDPERYGASRLQLPGGVKYVDVNAERYGVIHHYEQEAFSGIYPRRVGVISSVRSENVQDSDGNPFTIYYFKDNSLTFDPNDYEIGGLVKHVSFQEGSELAGLGVDDDHYFEVNYNSETREFEIITIWPYDDDTQLPGGTLVPEVNDRYILWNIRMPDEYYGLAEREFQSAVEEYNRKHALDVSRYKAPTDHVWIEDEGVDLYIGRRIRLESQEYFPDTGYRASRITRISRQVTLPSQMDLEISDALSTRTLEKIDDAISDVKNYAGTLVGSVNVPDIIRSWDTTRPTDNNLYSARRSHKEFLSKNNADRAKKKIIFDEGIDIGDFEAGEEGGRIDGLGNAELLTLVVRQLLRSARFVDGFGGEGWQLWIDQNELANLTIDKLTVRQVMTVFELLVEKIRSVGGQIVVSAANGKIKTVEELDGYYKITFEQENTFQAHDLMRCQTFTGGNLKSYWVEVAAVACNSILVAKSEFEASLPAAADECVLMGNSENPLRQNLILISATEDGQPRIDVMDGVKAKNFTDCLRARLGNLDGINDDWFPADNQPQGNGLYSDNAYLRGTFLLATGEDIKTKFEITEGKIESSMSALRQDFAQEKGYLNNPSFDEGLSKWLTENETLFWLVGNQWIWANRNLLSKKGDGVSVTKDDGRVVVRIKNKYIIQKNASLRSKPTMETNADGTKAAKPVYLSFLYRCASAGTLRVRFENVDKTGFENFNPIDVEEQLAVTDGYKQYTCDGLWNGTGDFKLSFTGDIFLCMLILSTDKTEALAYKYRTLFEQSEKLIKLSAQNFDQNGNVLAESGIMVKANGTGIYAQGPDGRLALIGVGVQETYIDGEGHEQTRTVIKLTADNIALEGLVTANRNFRIKADGSIEAVNGKFAGSIDSKSGYIGGFVIADDHIGVGSVTYEEDEHGNLQPVIHDDTNGLFLYDSMIGFNDTDRQAIFGTWNSMGQPMLCRLVDTGDNLLPKYGILFDIRNSRSANLAFAGTGNGALNGFIDGYKFKKVAVSQANKIYDVGLADSNRIIVNCSAANAGIALPRLSSVRNALSIGTSTPFAVRLIVTSDLGSLNFYIYGRNSLPDGSNNTPWNSEDYPLITHWNGGCWTNIEIGQGGTVEVLLVYDPARTATIDGFTTEFTARIINMQD
>NZ_CP033459.1|WP_111899415.1|2132117_2132540_+|terminase
MSGMELTEIADQLGVSRQSVSKWCSNDGWKEARAAKNISRPELVNKLLLAIDNLIAQVNASGDPEAIGALADKLSKLSSTIEKLDKKANVIDAIEVFMAFNRWIQDQACYDPEITPELIKAINKYQNKFLMEKMASPSAL
>NZ_CP033459.1|WP_111899413.1|2132573_2134136_+|hypothetical-protein
MATISEFRKIQEEWREHCRQIQNLTDTKSLVRENATQKEQRIRRLQRDYAAFCEYYFPHFLTLRDKVTGEAIRTIHNAPFHNAAATKVKNTPNLKAVFKWPRGHAKSTHFDIFMPLWLMFQPKRLINFMVIVGKSEDSADRLLGDIQAELQYNKRIIADFGKQMSIGNWTEGEFTTKDGVYFLACGRGQSPRGLRKRESRPDYIVIDDLDDDELCRNERRVRELTDWVKEALFGALDVGRGRFLMVGNLISKTSVLANICATKGVHVSTVYAVDNDGNPVWKEKWTKEEAREYMEFVGYRAWNKEMMHNPIVEGTVFHQEWIRWAKRPAWKDFTEFVLYIDPSWKSKKSNDTKAAKLWAKHKTHLWHLRAFVRKASLAEMVRWCYDLYEWSLDVGISIRFAMEASFMQDILLDEFTTEGNLRGYQLPITGDTRKKPDKFQRIEAISPLWERGFVFYDLAQKEDPDMQAGLEQLLAFEKGMSGNDDAPDADEGAIYILQKSTRQQTYKPRFGKRPTSKNLW
>NZ_CP033459.1|WP_111899412.1|2134178_2134409_+|hypothetical-protein
MLQLIKQLIFSIRFRQAVKKADRLQHITHRKYMVLVINRRLEVLSKQELKKFIAGGVFRKGTTTRDIEAKALYITL
>NZ_CP033459.1|WP_111899411.1|2134419_2134839_+|DUF1320-domain-containing-protein
MFVTDQDYKIVIGDQALKVVSQVSLENRANAETEAVEEISGYLRPKYDTEAVFSATGTGRNRLVVMYTCDIALYHMAASAPQKMGMEIRKERYERAVKWLEGVQSGKIVPDLPLATDEDGNATGLPFTYGSQKPLRHNW
>NZ_CP033459.1|WP_111899410.1|2134917_2136321_+|DUF935-family-protein
MGKSKKNNKNKTTVQTPFGTVRLARKDAPKVRKVVMQLQRTTDSLTRKDIGDWRMAWQLAINIDSPNRQRLYDIYRDVEVDLHLSGCIQQREGFVLSRSFKLVNEKGDEDKEAVNYFNTSWFKLLMKLALDANYWGHSLIELGNITNDINGRQTYDGVKLIPRKHVIPEYHRVITDLGQDWHTGIDYREPPFADWLIEVGQPDSLGLYLKAATQTIPKKNALAFWDTFAEIFGMPMRIARTTTRDEKERKKIEDMLEKSGLAGYMLADQGTELEFVESSKGDAFNVYDRRIDRANSELSKLIIGQTMTIEDGSSLSQSETHLEVFQNLVEADCDNIRDMVNNQLIPHMIRHGFPLTGIHFDWDYSVDYTPEQQAAYEQLVLNNYEVDPAYFSEKYNMPVGERRQMLPPVAPPEPPQDDEDPKGNKTPKPDKKTRQEQNNRASESHQVRLNGRVQPIEGEANARPFFD
>NZ_CP033459.1|WP_151908896.1|2138075_2138474_-|hypothetical-protein
MRILLRTLRVTNAWQLNRCDEIATYKTIMTMEIFKSFRLFGLYFYISNVRMKRRRTIDEQLRNRRNALLRKKRLLYQMRGGCCELCGKHFALEALEIHHLVPVSQNPGLALQTKNLVLLCHDCHVKVHQKES
>NZ_CP033459.1|WP_151908919.1|2138412_2138793_-|hypothetical-protein
MKHIDLWNHNVEFIEQEENWERPAVFVEFQPIQWNAIQPGAEYRAEPIVHLHVVTDWQGSSSADSEFREQGLKVFDLLEAIHLQLACRRGKTFLEFDLVGSSTNHNHEDIIENIESYQCVAIKSLR
>NZ_CP033459.1|WP_151908897.1|2138987_2139551_-|phage-morphogenesis-protein
MKSEIQAILRRILKDIEVEMSDEFDRNFERQAFFSEAWQRRKSATRPGGHILVDTGRLRRSIQSRTTENSITFFTTEPYAAIHNEGGEIVVTTRMKKYFWHKYYEATGSFGRKKDGSRRNDKRTVQLSGEAEFWKFMALKKAGTTIKIPRRRFLGTSPEVERAVRTIIEENLNGYIEESINFTIRES
>NZ_CP033459.1|WP_151908898.1|2139510_2139795_-|hypothetical-protein
MKKRKGKSYAKRVADINQIYDTYAKTGLPNREIWKRYVYPKYGISERTFYNLLKASANPHLEERVELSAQGFLFPELLYPEDEVRDPGYFKKNP
>NZ_CP033459.1|WP_151908862.1|2139822_2139999_-|molecular-chaperone-DnaJ
MKTRSITKPEKVALCRECHGRGTVSKLGFSRLCPNCEGSGRVLVSCEMTLHVRPYKVH

You can click texts colored in the table to view more detailed information

Click the colored protein region to show detailed information

Crispr_ID: NZ_CP033459_7

CRISPR_ID

CRISPR_location

CRISPR_type

Repeat_type

Spacer_info

Cas_protein_info

CRISPR-Cas_info

NZ_CP033459_7

2153332-2154022

TypeII

Consensus_repeat	Method
GTTGTGGTTTGATGTAGGAACCAAGGATATAACAAC	CRISPRCasFinder
GTTGTGGTTTGATGTAGGAACCAAGGATATAACAAC	CRT
GTTGTGGTTTGATGTAGGAACCAAGGATATAACAAC	PILER-CR

10 spacers

cas2,cas1,cas9

The CRISPR arrays of NZ_CP033459_7

>merge|NZ_CP033459|7|2153332-2154022|CRISPRCasFinder,CRT,PILER-CR
GTTGTGGTTTGATGTAGGAACCAAGGATATAACAACGAGTGTGATGGAGTGTGAGTCGTGTGTGGTGTTGTGGTTTGATGTAGGAACCAAGGATATAACAACCCGACTGCTGGGTGACATTCAGGCGGAGCTGTTGTGGTTTGATGTAGGAACCAAGGATATAACAACTCTTGTGAGAGACAACTATAATGAAGATTGTTGTGGTTTGATGTAGGAACCAAGGATATAACAACTGACCTGCGTCGTCCCGTCGCAGCCGAGACGTTGTGGTTTGATGTAGGAACCAAGGATATAACAACACGTGCACCCGCATCATACTGCTCCTGTGGTTGTGGTTTGATGTAGGAACCAAGGATATAACAACCTTTCGACCAGCAGTAAGGACAGCGGACATGTTGTGGTTTGATGTAGGAACCAAGGATATAACAACGTAACGCGCGGCTGTGTCTTCCACCACTTGTTGTGGTTTGATGTAGGAACCAAGGATATAACAACGATTTTGAGTATTTAGACGATGCCGATTTAGTTGTGGTTTGATGTAGGAACCAAGGATATAACAACCGCTCGAAACACTTATGCTTAGTATGAATGTTGTGGTTTGATGTAGGAACCAAGGATATAACAACAGTAATCGTGCCACCCTTGCCTGCAATAGGTTGTGGTTTGATGTAGGAACCAAGGATATAACAAC

>NZ_CP033459|7|7|2153332-2154022|CRISPRCasFinder
GTTGTGGTTTGATGTAGGAACCAAGGATATAACAAC	GAGTGTGATGGAGTGTGAGTCGTGTGTGGT
GTTGTGGTTTGATGTAGGAACCAAGGATATAACAAC	CCGACTGCTGGGTGACATTCAGGCGGAGCT
GTTGTGGTTTGATGTAGGAACCAAGGATATAACAAC	TCTTGTGAGAGACAACTATAATGAAGATT
GTTGTGGTTTGATGTAGGAACCAAGGATATAACAAC	TGACCTGCGTCGTCCCGTCGCAGCCGAGAC
GTTGTGGTTTGATGTAGGAACCAAGGATATAACAAC	ACGTGCACCCGCATCATACTGCTCCTGTG
GTTGTGGTTTGATGTAGGAACCAAGGATATAACAAC	CTTTCGACCAGCAGTAAGGACAGCGGACAT
GTTGTGGTTTGATGTAGGAACCAAGGATATAACAAC	GTAACGCGCGGCTGTGTCTTCCACCACTT
GTTGTGGTTTGATGTAGGAACCAAGGATATAACAAC	GATTTTGAGTATTTAGACGATGCCGATTTA
GTTGTGGTTTGATGTAGGAACCAAGGATATAACAAC	CGCTCGAAACACTTATGCTTAGTATGAAT
GTTGTGGTTTGATGTAGGAACCAAGGATATAACAAC	AGTAATCGTGCCACCCTTGCCTGCAATAG
GTTGTGGTTTGATGTAGGAACCAAGGATATAACAAC

>NZ_CP033459|7|1|2153332-2154022|CRT
GTTGTGGTTTGATGTAGGAACCAAGGATATAACAAC	GAGTGTGATGGAGTGTGAGTCGTGTGTGGT
GTTGTGGTTTGATGTAGGAACCAAGGATATAACAAC	CCGACTGCTGGGTGACATTCAGGCGGAGCT
GTTGTGGTTTGATGTAGGAACCAAGGATATAACAAC	TCTTGTGAGAGACAACTATAATGAAGATT
GTTGTGGTTTGATGTAGGAACCAAGGATATAACAAC	TGACCTGCGTCGTCCCGTCGCAGCCGAGAC
GTTGTGGTTTGATGTAGGAACCAAGGATATAACAAC	ACGTGCACCCGCATCATACTGCTCCTGTG
GTTGTGGTTTGATGTAGGAACCAAGGATATAACAAC	CTTTCGACCAGCAGTAAGGACAGCGGACAT
GTTGTGGTTTGATGTAGGAACCAAGGATATAACAAC	GTAACGCGCGGCTGTGTCTTCCACCACTT
GTTGTGGTTTGATGTAGGAACCAAGGATATAACAAC	GATTTTGAGTATTTAGACGATGCCGATTTA
GTTGTGGTTTGATGTAGGAACCAAGGATATAACAAC	CGCTCGAAACACTTATGCTTAGTATGAAT
GTTGTGGTTTGATGTAGGAACCAAGGATATAACAAC	AGTAATCGTGCCACCCTTGCCTGCAATAG
GTTGTGGTTTGATGTAGGAACCAAGGATATAACAAC

>NZ_CP033459|7|1|2153464-2154022|PILER-CR
GTTGTGGTTTGATGTAGGAACCAAGGATATAACAAC	TCTTGTGAGAGACAACTATAATGAAGATT
GTTGTGGTTTGATGTAGGAACCAAGGATATAACAAC	TGACCTGCGTCGTCCCGTCGCAGCCGAGAC
GTTGTGGTTTGATGTAGGAACCAAGGATATAACAAC	ACGTGCACCCGCATCATACTGCTCCTGTG
GTTGTGGTTTGATGTAGGAACCAAGGATATAACAAC	CTTTCGACCAGCAGTAAGGACAGCGGACAT
GTTGTGGTTTGATGTAGGAACCAAGGATATAACAAC	GTAACGCGCGGCTGTGTCTTCCACCACTT
GTTGTGGTTTGATGTAGGAACCAAGGATATAACAAC	GATTTTGAGTATTTAGACGATGCCGATTTA
GTTGTGGTTTGATGTAGGAACCAAGGATATAACAAC	CGCTCGAAACACTTATGCTTAGTATGAAT
GTTGTGGTTTGATGTAGGAACCAAGGATATAACAAC	AGTAATCGTGCCACCCTTGCCTGCAATAG
GTTGTGGTTTGATGTAGGAACCAAGGATATAACAAC

Protein	Signature genes	Signature genes Name	Protein_function
NZ_CP033459.1\|WP_111898217.1\|2162971_2164462_+\|type-II-toxin-antitoxin-system-HipA-family-toxin	unknown	unknown	gnl\|CDD\|377920
NZ_CP033459.1\|WP_111898224.1\|2155062_2155896_-\|phospholipase	unknown	unknown	gnl\|CDD\|226584
NZ_CP033459.1\|WP_146739396.1\|2158142_2158679_-\|hypothetical-protein	unknown	unknown	gnl\|CDD\|240291
NZ_CP033459.1\|WP_151908902.1\|2146140_2146344_-\|hypothetical-protein	unknown	unknown	unknown
NZ_CP033459.1\|WP_111898226.1\|2152904_2153240_+\|CRISPR-associated-endonuclease-Cas2	cas2	COG3512_cas2_CAS-II-A:CAS-II-B:CAS-II-C	gnl\|CDD\|226043
NZ_CP033459.1\|WP_111898227.1\|2152020_2152908_+\|type-II-CRISPR-associated-endonuclease-Cas1	cas1	cd09720_cas1_CAS-II-A:CAS-II-B:CAS-II-C	gnl\|CDD\|274694
NZ_CP033459.1\|WP_111898223.1\|2155904_2156996_-\|mannose-1-phosphate-guanylyltransferase	unknown	unknown	gnl\|CDD\|133003
NZ_CP033459.1\|WP_151908900.1\|2142832_2143708_-\|AAA-family-ATPase	unknown	unknown	gnl\|CDD\|379165
NZ_CP033459.1\|WP_151908858.1\|2145741_2146134_-\|hypothetical-protein	unknown	unknown	unknown
NZ_CP033459.1\|WP_111898231.1\|2147226_2148432_+\|peptidase	unknown	unknown	gnl\|CDD\|223689
NZ_CP033459.1\|WP_111898220.1\|2159484_2160861_+\|DNA-repair-protein-RadA	unknown	unknown	gnl\|CDD\|236994
NZ_CP033459.1\|WP_111898219.1\|2160875_2162531_+\|FAD-binding-protein	unknown	unknown	gnl\|CDD\|225307
NZ_CP033459.1\|WP_151908901.1\|2143733_2145731_-\|hypothetical-protein	unknown	unknown	unknown
NZ_CP033459.1\|WP_111898241.1\|2158905_2159250_+\|MerR-family-transcriptional-regulator	unknown	unknown	gnl\|CDD\|133393
NZ_CP033459.1\|WP_111898230.1\|2148439_2148637_+\|hypothetical-protein	unknown	unknown	unknown
NZ_CP033459.1\|WP_111898243.1\|2146455_2147157_+\|S24-family-peptidase	unknown	unknown	gnl\|CDD\|119397
NZ_CP033459.1\|WP_111898222.1\|2157465_2157930_-\|transcription-elongation-factor-GreA	unknown	unknown	gnl\|CDD\|234693
NZ_CP033459.1\|WP_111898228.1\|2149279_2152024_+\|CRISPR-associated-protein-Csn1	cas9	cd09643_cas9_CAS-II-A:CAS-II-B:CAS-II-C	gnl\|CDD\|375967
NZ_CP033459.1\|WP_111898218.1\|2162666_2162975_+\|helix-turn-helix-transcriptional-regulator	unknown	unknown	gnl\|CDD\|197775
NZ_CP033459.1\|WP_111898242.1\|2154266_2155019_+\|four-helix-bundle-protein	unknown	unknown	gnl\|CDD\|275085

Protein	Function_ID	Function_description	E-value
NZ_CP033459.1\|WP_111898224.1\|2155062_2155896_-\|phospholipase	gnl\|CDD\|226584	COG4099, COG4099, Predicted peptidase [General function prediction only].	2.41611e-22
NZ_CP033459.1\|WP_146739396.1\|2158142_2158679_-\|hypothetical-protein	gnl\|CDD\|240291	PTZ00146, PTZ00146, fibrillarin; Provisional.	0.000638943
NZ_CP033459.1\|WP_111898217.1\|2162971_2164462_+\|type-II-toxin-antitoxin-system-HipA-family-toxin	gnl\|CDD\|377920	pfam07804, HipA_C, HipA-like C-terminal domain. The members of this family are similar to a region close to the C-terminus of the HipA protein expressed by various bacterial species. This protein is known to be involved in high-frequency persistence to the lethal effects of inhibition of either DNA or peptidoglycan synthesis. When expressed alone, it is toxic to bacterial cells, but it is usually tightly associated with HipB, and the HipA-HipB complex may be involved in autoregulation of the hip operon. The hip proteins may be involved in cell division control and may interact with cell division genes or their products.	1.14934e-48
NZ_CP033459.1\|WP_111898223.1\|2155904_2156996_-\|mannose-1-phosphate-guanylyltransferase	gnl\|CDD\|133003	cd02509, GDP-M1P_Guanylyltransferase, GDP-M1P_Guanylyltransferase catalyzes the formation of GDP-Mannose. GDP-mannose-1-phosphate guanylyltransferase, also called GDP-mannose pyrophosphorylase (GDP-MP), catalyzes the formation of GDP-Mannose from mannose-1-phosphate and GTP. Mannose is a key monosaccharide for glycosylation of proteins and lipids. GDP-Mannose is the activated donor for mannosylation of various biomolecules. This enzyme is known to be bifunctional, as both mannose-6-phosphate isomerase and mannose-1-phosphate guanylyltransferase. This CD covers the N-terminal GDP-mannose-1-phosphate guanylyltransferase domain, whereas the isomerase function is located at the C-terminal half. GDP-MP is a member of the nucleotidyltransferase family of enzymes.	1.4745e-101
NZ_CP033459.1\|WP_111898227.1\|2152020_2152908_+\|type-II-CRISPR-associated-endonuclease-Cas1	gnl\|CDD\|274694	TIGR03639, cas1_NMENI, CRISPR-associated endonuclease Cas1, subtype II/NMENI. The CRISPR-associated protein Cas1 is virtually universal to CRISPR systems. CRISPR, an acronym for Clustered Regularly Interspaced Short Palindromic Repeats, is a prokaryotic immunity system for foreign DNA, mostly from phage. CRISPR systems belong to different subtypes, distinguished by both nature of the repeats, the makeup of the cohort of associated Cas proteins, and by molecular phylogeny within the more universal Cas proteins such as this one. This model is of type EXCEPTION and provides more specific information than the EQUIVALOG model TIGR00287. It describes the Cas1 variant of the NMENI subtype of CRISPR/Cas system.	1.37017e-103
NZ_CP033459.1\|WP_111898226.1\|2152904_2153240_+\|CRISPR-associated-endonuclease-Cas2	gnl\|CDD\|226043	COG3512, COG3512, CRISPR-associated protein, Cas2 homolog [Defense mechanisms].	3.16953e-26
NZ_CP033459.1\|WP_151908900.1\|2142832_2143708_-\|AAA-family-ATPase	gnl\|CDD\|379165	pfam13401, AAA_22, AAA domain.	3.71974e-09
NZ_CP033459.1\|WP_111898222.1\|2157465_2157930_-\|transcription-elongation-factor-GreA	gnl\|CDD\|234693	PRK00226, greA, transcription elongation factor GreA; Reviewed.	1.30822e-55
NZ_CP033459.1\|WP_111898231.1\|2147226_2148432_+\|peptidase	gnl\|CDD\|223689	COG0616, SppA, Periplasmic serine proteases (ClpP class) [Posttranslational modification, protein turnover, chaperones / Intracellular trafficking and secretion].	1.03933e-10
NZ_CP033459.1\|WP_111898219.1\|2160875_2162531_+\|FAD-binding-protein	gnl\|CDD\|225307	COG2509, COG2509, Uncharacterized FAD-dependent dehydrogenases [General function prediction only].	2.68848e-105
NZ_CP033459.1\|WP_111898242.1\|2154266_2155019_+\|four-helix-bundle-protein	gnl\|CDD\|275085	TIGR04258, hypothetical_protein, four helix bundle suffix domain. This domain occurs as a suffix domain to some members of the much broader protein family TIGR02436, a few of whose other members are encoded within intervening sequences of bacterial 23S ribosomal RNA. Some proteins with this domain, in turn, are followed by a predicted DNA topoisomerase type C4 zinc finger.	2.3011e-13
NZ_CP033459.1\|WP_111898241.1\|2158905_2159250_+\|MerR-family-transcriptional-regulator	gnl\|CDD\|133393	cd04765, HTH_MlrA-like_sg2, Helix-Turn-Helix DNA binding domain of putative MlrA-like transcription regulators. Putative helix-turn-helix (HTH) MlrA-like transcription regulators (subgroup 2), N-terminal domain. The MlrA protein, also known as YehV, has been shown to control cell-cell aggregation by co-regulating the expression of curli and extracellular matrix production in Escherichia coli and Salmonella typhimurium. These proteins belong to the MerR superfamily of transcription regulators that promote expression of several stress regulon genes by reconfiguring the spacer between the -35 and -10 promoter elements. Their conserved N-terminal domains contain predicted HTH motifs that mediate DNA binding, while the dissimilar C-terminal domains bind specific coactivator molecules.	2.19363e-27
NZ_CP033459.1\|WP_111898220.1\|2159484_2160861_+\|DNA-repair-protein-RadA	gnl\|CDD\|236994	PRK11823, PRK11823, DNA repair protein RadA; Provisional.	0
NZ_CP033459.1\|WP_111898243.1\|2146455_2147157_+\|S24-family-peptidase	gnl\|CDD\|119397	cd06529, S24_LexA-like, Peptidase S24 LexA-like proteins are involved in the SOS response leading to the repair of single-stranded DNA within the bacterial cell. This family includes: the lambda repressor CI/C2 family and related bacterial prophage repressor proteins; LexA (EC 3.4.21.88), the repressor of genes in the cellular SOS response to DNA damage; MucA and the related UmuD proteins, which are lesion-bypass DNA polymerases, induced in response to mitogenic DNA damage; RulA, a component of the rulAB locus that confers resistance to UV, and RuvA, which is a component of the RuvABC resolvasome that catalyzes the resolution of Holliday junctions that arise during genetic recombination and DNA repair. The LexA-like proteins contain two-domains: an N-terminal DNA binding domain and a C-terminal domain (CTD) that provides LexA dimerization as well as cleavage activity. They undergo autolysis, cleaving at an Ala-Gly or a Cys-Gly bond, separating the DNA-binding domain from the rest of the protein. In the presence of single-stranded DNA, the LexA, UmuD and MucA proteins interact with RecA, activating self cleavage, thus either derepressing transcription in the case of LexA or activating the lesion-bypass polymerase in the case of UmuD and MucA. The LexA proteins are serine proteases that carry out catalysis using a serine/lysine dyad instead of the prototypical serine/histidine/aspartic acid triad found in most serine proteases. LexA sequence homologs are found in almost all of the bacterial genomes sequenced to date, covering a large number of phyla, suggesting both, an ancient origin and a widespread distribution of lexA and the SOS response.	1.57112e-11
NZ_CP033459.1\|WP_111898228.1\|2149279_2152024_+\|CRISPR-associated-protein-Csn1	gnl\|CDD\|375967	pfam18541, RuvC_III, RuvC endonuclease subdomain 3. Cas9 proteins are abundant across the bacterial kingdom, but vary widely in both sequence and size. All known Cas9 enzymes contain an HNH domain that cleaves the DNA strand complementary to the guide RNA sequence (target strand), and a RuvC nuclease domain required for cleaving the noncomplementary strand (non-target strand), yielding double-strand DNA breaks (DSBs). The crystal structures of type II-A and II-C Cas9 proteins highlight the features in Cas9 enzymes that support their function as RNA-guided endonucleases. Cas9 enzymes adopt a bilobed architecture composed of a nuclease lobe containing juxtaposed RuvC and HNH nuclease domains and a variable alpha-helical lobe likely to be involved in nucleic acid binding. The RuvC domain forms the structural core of the nuclease lobe, a six-stranded beta sheet surrounded by four alpha helices, with all three conserved subdomains (I, II, III) contributing catalytic residues to the active site.	7.64539e-29
NZ_CP033459.1\|WP_111898218.1\|2162666_2162975_+\|helix-turn-helix-transcriptional-regulator	gnl\|CDD\|197775	smart00530, HTH_XRE, Helix-turn-helix XRE-family like proteins.	1.99574e-08

>NZ_CP033459.1|WP_111898226.1|2152904_2153240_+|CRISPR-associated-endonuclease-Cas2
MSEIRLNAYHIMWLFVFFDLPVTTKKERKQAAQFRKELMKDGFAMMQFSVYIRHCASYESQNVHLKRIKAIVPPKGKISVLSVTDKQYGNILNFWGKEKKVISEPVQLELF
>NZ_CP033459.1|WP_111898227.1|2152020_2152908_+|type-II-CRISPR-associated-endonuclease-Cas1
MIKQTLIFTTPVSLSLKDCQLVISKKEDDTIVTRPIEDIGFVVVDNPMVKMTVPLINALTENNVATIFCDSRQMPSSMLLTLEGNSTQQESYRFQIEAKKSTNKQLWKQIIEAKIKNQSALLKLVGKDGDKLKPYYMNVKSGDSDNREGIASQIYWKTLFGKDFLRSRDGFSPNNLLNYGYAILRAAVARALVGSGLLPAFGIYHRNRYNAFPLADDIMEPYRPFVDEIVYHQYMDEEVDSLNKEVKIQLLKCLTSDVKMNKIVRPLQIALSMTTASLVRVYKGQEGKLVLPEMK
>NZ_CP033459.1|WP_111898228.1|2149279_2152024_+|CRISPR-associated-protein-Csn1
MNGFLCFSSPLSLIRFVLCPIEKSKIIPKFKRKSKKKFPFEDIAKELAGKKNYCYFKDKEQKPYKFNYPMDTSVSGSVVNAQLEEIFGSDWKNAVCEVYTLSDGKTQDEIVNDVWHALFFYDDEEKLKGFAKNRLQLSDEESEKFCKITLPSDYAALSMKAIRKILPYMRDYGLIYSKAVYLANLGEVIPQEIWENEEARKSVIDEVKDVMENVEIGKLSGNLGTVVREYLSQKYGVDENALNRLYHPSMLEHYPQQRSNSDGIFQLGSPRINSVRNPMAMHSLFRLRKVVNLLLKEGKIDEKTIIHIEFARELNDANKRKAIKFLQKINENDRDACRKKIEELGYTSVSDTDILKYQLWEEQGHQCLYTGEQIGVKDFLGENPKYDIEHTIPRSAGGDSTKENMTLCSSKFNREVKRTKLPTALPDYDEILMRIEFMREKYESLDKQIRAIKRKSATTKEQRDSDIQKRHQLKMQRDYWKGKYDRFTMEEVPEGFARRQGAGIGLISRYARLYLKSVFEKVYVVKGNATAEFRKIWGIQEEYTKKERVNHVHHCIDAITIACIGLDEHNKLAHFYHQVEEYRNNEKNRPQFVKPWPTFTEDVMKIQDELLVAHYSQDNMPKHTRKRVGKTYIQGDTARTSLHNETYYGAIEKDEEVKYVVRKPLDGMEEKDVKNIVDDVVRQKVEDAIAKHGSLKKAVESTIWMNEQLQIPIKKVRIYAKNVVRPLQIRQQRDQSRKEYKRQYHVENDRNYLMAIYIGKDKKGKEKRDFVVVNNLEAAKYYRRSNNAEGGLVPDVSEKNGFSLAYCLKIGTMVLLYEKSPEEIWLSDKKAWQRRLYKVTGLSSLVISSYVYGTISLIHHQEARRSSEVKLKNGAYASNEELRSGIKMYHTQINALVEGVDFVLNDLGEIKRLR
>NZ_CP033459.1|WP_111898230.1|2148439_2148637_+|hypothetical-protein
MEKNDKQPKGFSEVLDFIENTKDGKFTEGGVSITELMKCTISREEIAYIQNENFQHNEIILYGLS
>NZ_CP033459.1|WP_111898231.1|2147226_2148432_+|peptidase
MASIISKYISQRMSVLDLKKELSRLRSEYNRLTGRNLFIYAADFNKGKQGIDVSLMQDDFYMIQDILRESDKKQIDIYLETPGGSGESAEEIARFLHSKFEEVNFVIAGEAKSAGTILAMCANNIYMCSTGSLGPIDAQVRVGRSTISAYDYKTWVDERREEAAKKGKLNPFDALLISQISPGEIYGIMNSLQFAQDLVEEWLPKYKFKDWITTETRGLPVTQEMKEKRAKQISEKLCNHMDWHTHGRSLKIEDLNAELRIENIDDNPTLANIVYRIKTVIRLIFDTSTDFKLYFWEDCELARSANVASTPFNKPAAQNDVKSIEVVEFGVPCPKCGKEHKIKGYPNLSSADIRRLHLQVNPLVKDNDLLVCDTPGCGFTIDLKPIKNMFENQFKKRVTLK
>NZ_CP033459.1|WP_111898243.1|2146455_2147157_+|S24-family-peptidase
MSEKLTVKRKILSFLEKIGIQKEEYYKKIGVAPSNFKGVGLQSMPGGEIIVKTLTLYPQLSADWLLRDKGDMLIQNFETNKENERKISEKNKNSSEKIPVSNSKAIPLIPFSAMAGALTGEKSVLEYECERYVVPAFSGADFLMPVKGNSMMPTYISGDIVACQRVPMSGLFFQWNKPYVLDTAQGAIIKRIKPGSDKQHVLIVSDNKEYDPFELPYEDIYAVALVIGIIRLE
>NZ_CP033459.1|WP_151908902.1|2146140_2146344_-|hypothetical-protein
MCEIKEWQTQSVKHKVATLLMVDGVSFSYNEEDGIVFSAPELYVKNMVRRLMNSYGVSLRPIITEIK
>NZ_CP033459.1|WP_151908858.1|2145741_2146134_-|hypothetical-protein
MAKVKSVRTIKVSKENKARLAKLFGCTERMVYKALCFESQTLLARKIQHVARQEMGGWVEAAVPEDEIFYDTMDSGERFMRQYFNNGAVLEVSLTTGEGVVRFKGSPRHRYEEVLVRDIPTIQNYARNLK
>NZ_CP033459.1|WP_151908901.1|2143733_2145731_-|hypothetical-protein
MEYYGNRLCISARELVDSGVMSIPNYKAMASRGRIDVVRRGGGAAGQYALVAVESLPRYYRAKVQALYPDGDLTHLKGWVCSNYEVDQAAVAFFHSREQAGLDLPPEKIKEYVVNASVLNCCIRLYERAATAQKLFGGKYNWEQMAKAIEALREEYGHTLPASTLRFRKKVNEYKRNGYGCLISGKFGNQCARKVDYRTERLILGLAVLPNKPFNTNIAEMYNMFVCGELDVYDPKTGELMNPEDFVDKKTGEPKELSESTITNYLNKPANKTLIEHSLMSWTTFMHEQMPHVHRHGGNFSLSQITMDDVDLTRKLKDTKQRVHAYYAYDVVSQCVVGASYSRKKDEGLVVDCFRDMFRLIEKNGWGMPAGIEVENHLMSQYKDGFLQAGVAFPFVHFCAPQNSQEKYAEPLNGAKKRSVIHKNHEGIGRFYGKGKWRQEYKKVSDETNELYEDKEYFSWDQLVAEDRRDSYEWNHQLHPNQKKFPGMTRWDVLCERINPTLQPLDKLTLARYIGERVETSIRRNSTVRVAHEDWWLSDTSVLEKLRPNDYQVTAYYMPDEEGKPSEVHIFQGDKYIDQVEKVQTYNRVMAEQTEEDTVNYIEQRKKIAKFSKYVKENAIDELGVIKPSVAPVMQTEAVALPPQQTEQELLYVPVDVESKALADM
>NZ_CP033459.1|WP_151908900.1|2142832_2143708_-|AAA-family-ATPase
MIKDWQKQRILEAIAQNRKNYPSDAKHAASLGISASVYNSLKKGQTDKALSDANWVNIARRLDVNLRDSIEWKGARTATFDYITTQLEACQERSLSVILCDLPNIGKTYTARWYVNEHRNAVYIDCSQVKTKRALVKKIANEFGVGATGKYQDTYEDLVYYLRSMERPLVVLDEAGDLAYEAFLELKALWNATEMCCGWYMMGADGLAAKINRNVEGKKVGYAEIFSRYGGKYSRVTPDQGDDRKAFLMEQARVVASVNAPEGTDIGQIVRKSQGGLRRVYTEIEKLKKGA
>NZ_CP033459.1|WP_111898242.1|2154266_2155019_+|four-helix-bundle-protein
MVSKEKNKSKEKNISLERYEDGTPSVMRKATVYTELYFYRKSDVLVQLTKEFCNRFLPRYGDRTKDQMIQAARSIKQNIAEGLTDGQTSFEMEIKLLGTAKGSNRELLEDYQDYIKQHNIPEWAKENTGRYNVMRNFCYEHHDEKDYRPYFTRWTDEEMANVAICLCHMVDKALTTFLKKRDREFVEEGGIRERMTAARLDERGTQKQIIAQQEREIAELKAKIASQQREIEVLKAQINKAEADSNDFSG
>NZ_CP033459.1|WP_111898224.1|2155062_2155896_-|phospholipase
MQRSFIRLLLLSTFFASLQVSAQERGQLAAMKATAEGGYNFWLYAPPEYVVDGERVPVLVFLHGRSLCGTDMQKVRRYGPLDALQRGLYFPCFIIAPQNPGGPWKPEKIMQCLEWVEQNYDVDSNRFYAIGMSLGGYGVMDFAGTYPDRIAAAMPICGGTTLKDKSGLGRLPLWILHGTADRAINIEESKKVVRALQESGQDKLLRYSWWAGASHGDLARLMYSHQAYDWLFWHNLADNPRETYREIDITLSDLKDVYQQLVPEWTQFDIVRKITTP
>NZ_CP033459.1|WP_111898223.1|2155904_2156996_-|mannose-1-phosphate-guanylyltransferase
MIKHNDYCIILAGGSGKRLWPVSRQIYPKQFMDLFGIGRSLLQQTYDRFAEIIPPEHIFVATYAGYVDLVLEQLPELRRDQILEEPVQLSTAPPVAWAAFHIEQIDPKANIIVSPADQIIINQERFKEDVREGLNYVEDHEEILALGAKPTMPNTSYGYIQKGELTSEEAPIYKVKSFSEKPSEEYARMFVDCGEFVWNTGLFLCQLPTLTRRLEQLMPGVAEHWREEKRVLTAEEERRLINQYYPASLRISIDLVILDQSTNVCVRECDFGWADVGSWDSVRNVMKKDVDGNAVDKGAIAMLSNCKDNVISVPNGTLVCLKDLSGYLVAMQQGVIVVCPNNNTDILRTYINQAQMDDEGKFV
>NZ_CP033459.1|WP_111898222.1|2157465_2157930_-|transcription-elongation-factor-GreA
MEYMSQEGYDKLVEELRQMIHEELPKVKDAIAEARDKGDLSENFEYHAAKREQARLLSRIRFKQNVLKYARVMDKSRLNSDSIALLSKVEMTNLTTGAKMNYTIVSPHEANLREGKISIKSPIGQALLNKKAGDTIEVAVPAGLLKLRIDKVDL
>NZ_CP033459.1|WP_146739396.1|2158142_2158679_-|hypothetical-protein
MKKLLLIMAVALFATSMSAQNDQGGRRGRGDRKEMIGRMAEQKAKEMKLDGDTKQWFISLYTEYRDTLMGTQFPGGFGNRDRDNDKKKKELTDEEATAKVLEGFAREEAAVRLKREYYKKFSEKLTPQQVYSVFNDRGMRRGGNRPNMNGGGFQGGPGGFGGPGGFGGPGGFGGPDGF
>NZ_CP033459.1|WP_111898241.1|2158905_2159250_+|MerR-family-transcriptional-regulator
MANEKDLKLYYSINEVAEMFGIKDTTLRFWEREFPKQINPKKTSRNVRQYTKDDIEQIRVIHNLVKVRGLKISAARELLKKNKSGVQQEAELVARLQKIRAELIAIKKNLEELE
>NZ_CP033459.1|WP_111898220.1|2159484_2160861_+|DNA-repair-protein-RadA
MAQKSKTVFVCSNCGYDAPKWQGKCPSCGQWNTFKEMTIMPERRSEKIASGVLDNGHKSEPVRLSSISAAEEPRIDTHDTELNRVLGGGLVPGSLTLLGGEPGIGKSTLLLQTILGMRDKNVLYVSGEESERQIKLRADRLNHQGTDCLLLCETELERIFAHIKNTQPDMVVIDSIQTIFTSTIDSAPGNITQIRECTAAILKYAKESSVPVILIGHITKDGTIAGPKVLEHIVDTVLQFEGDRHYFYRILRSIKNRFGSTAELGIYEMRSDGLIAVENPSQVLVNEDNAELSGVAVAAAIEGARPFLIETQALVSTAAYGTPQRSSTGFDTRRLNMLLAVLEKRVGFKLGQKDVFLNIAGGIRVSDPAIDLSVIAAVLSSNVDTGIERSVCLTGEVGLSGEIRPVTRIAQRISEAQKLGFERMIVPAANVKGLDKKGITIELVPVKRVEEALRALFG
>NZ_CP033459.1|WP_111898219.1|2160875_2162531_+|FAD-binding-protein
MISLRLPPEIAYTPSRLKAACADEMGVDVASIKDVRILRRSIDARQRQIFVNLSLEVFIDEPAPELYFAPIVYPDVNGKPAVIVVGAGPGGLFAALRLIELGLRPIVLERGKDVHERRKDIALISREHTVNSESNYSFGEGGAGAFSDGKLYTRSKKRGNVEKILRVFCQHGASTDILCDAHPHIGTDKLPRIIERMREQIIAAGGEVHFQTRADALIIEKQEVRGVVASDGRAYEGPVILATGHSARDVYQMLHRSQVAIEAKGLAVGVRLEHPSHLIDQIQYHSREGRGKYLPAAEYSFVAQCTGAVQQKAKKRGASVQKGGGVSRGVYSFCMCPGGFVVPAASGAEQLVVNGMSPSNRGSAWSNSGMVVELHPEDIDNNFSELFANCEMEVPATDDPLRMMHLQSALERMTWQQGGCKQTAPAQRMYDFLNGRLSGELPATSYAPGVIASPLHFWMPGFIVTRLQEGFRIFGQRSKGFLTNEAVLIASETRTSSPVRILRDQDSLQSPHLQGLFPCGEGAGYAGGIVSSAIDGERCAEAVAQMLAREK
>NZ_CP033459.1|WP_111898218.1|2162666_2162975_+|helix-turn-helix-transcriptional-regulator
MIDYSELSAVELVRMLSGRFKEYRLRANMTQKEVAEMSGLSVQTVHRFENGTVTDIALSSFLLLIKAVGCINDLNELMPEQPESPYLYKENKKVQRIRHKRA
>NZ_CP033459.1|WP_111898217.1|2162971_2164462_+|type-II-toxin-antitoxin-system-HipA-family-toxin
MKEILKVFLWGQEIGRLTWHEARKTTFFMYNLEFLKGTLDIAPLVASIHHPLSTRAIFGETERIYQKLPSFIADSLPDAWGNQLFEQWRKANNITERTVTPLEKLAFIGRRGMGALEFVPAVERDAVADRIDIKALVDLANKIVSERESVRIMPDESVTLQSLIAVGTSAGGRQPKGIIAIDKETREIRSGQIDAEPNLEYYILKFGNKERSTAEIEQTYYEMALAAGINMMQSRIIEVEGEKHFLTKRFDRNETGKLHTQTLAAMNPEADSYEKLFSVCRKLHLPEVDCQELFRRMVFNILANNTDDHNKNFTFVMNRQGKWRLSPAYDMTYIFDLGGYLPNKEHCLMVGGKLQDITREDILHFARENSIHRADAVICEVAAALRQFRSVAKKNGVPEQWAGRIETTIIDHLKSWGEWEGENAMPEQIISGHTVSNLRIEQAYKGNFHLLATIDGSERKFIIGKNKEEYALIEKTGIANLTFTQLKAMAEKFFKT

You can click texts colored in the table to view more detailed information

Click the colored protein region to show detailed information

Crispr_ID: NZ_CP033459_8

CRISPR_ID

CRISPR_location

CRISPR_type

Repeat_type

Spacer_info

Cas_protein_info

CRISPR-Cas_info

NZ_CP033459_8

2488117-2488249

Orphan

Consensus_repeat	Method
GCAGATGATGTAGTAAAAATCTGTGAAATCAGCGAAATCAGCGAG	CRISPRCasFinder

1 spacers

The CRISPR arrays of NZ_CP033459_8

>merge|NZ_CP033459|8|2488117-2488249|CRISPRCasFinder
GCAGATGATGTAGTAAAAATCTGTGAAATCAGCGAAATCAGCGAGCGAAGACTTTGATTGAAAACTCTCGCAGATCTCGCAGATTTAGGCAGATGATGCAGTAAAAATCTGTGAAATCAGCGAAATCAGCGAG

>NZ_CP033459|8|8|2488117-2488249|CRISPRCasFinder
GCAGATGATGTAGTAAAAATCTGTGAAATCAGCGAAATCAGCGAG	CGAAGACTTTGATTGAAAACTCTCGCAGATCTCGCAGATTTAG
GCAGATGATGCAGTAAAAATCTGTGAAATCAGCGAAATCAGCGAG

Protein	Signature genes	Signature genes Name	Protein_function
NZ_CP033459.1\|WP_111897587.1\|2506090_2507629_-\|glycine--tRNA-ligase	unknown	unknown	gnl\|CDD\|235240
NZ_CP033459.1\|WP_111897577.1\|2488257_2489295_-\|aspartate--ammonia-ligase	unknown	unknown	gnl\|CDD\|235456
NZ_CP033459.1\|WP_111897569.1\|2476037_2476340_-\|hypothetical-protein	unknown	unknown	unknown
NZ_CP033459.1\|WP_111897578.1\|2489437_2494096_-\|hypothetical-protein	unknown	unknown	gnl\|CDD\|367909
NZ_CP033459.1\|WP_111897584.1\|2503374_2504121_+\|3-oxoacyl-[acyl-carrier-protein]-reductase	unknown	unknown	gnl\|CDD\|273824
NZ_CP033459.1\|WP_146739338.1\|2469211_2475604_+\|hypothetical-protein	unknown	unknown	unknown
NZ_CP033459.1\|WP_111897571.1\|2477498_2480852_+\|SusC/RagA-family-TonB-linked-outer-membrane-protein	unknown	unknown	gnl\|CDD\|274948
NZ_CP033459.1\|WP_111897570.1\|2476506_2477475_+\|hypothetical-protein	unknown	unknown	unknown
NZ_CP033459.1\|WP_111897573.1\|2482332_2483622_+\|DUF4843-domain-containing-protein	unknown	unknown	gnl\|CDD\|374383
NZ_CP033459.1\|WP_111897575.1\|2485329_2487543_+\|sel1-repeat-family-protein	unknown	unknown	gnl\|CDD\|276807
NZ_CP033459.1\|WP_111897581.1\|2498125_2499643_+\|DUF4301-family-protein	unknown	unknown	gnl\|CDD\|372920
NZ_CP033459.1\|WP_111897576.1\|2487667_2488045_+\|GxxExxY-protein	unknown	unknown	gnl\|CDD\|372581
NZ_CP033459.1\|WP_111897574.1\|2483673_2485320_+\|hypothetical-protein	unknown	unknown	gnl\|CDD\|374525
NZ_CP033459.1\|WP_111897572.1\|2480872_2482291_+\|hypothetical-protein	unknown	unknown	gnl\|CDD\|185760
NZ_CP033459.1\|WP_111897583.1\|2502533_2503142_+\|TetR/AcrR-family-transcriptional-regulator	unknown	unknown	gnl\|CDD\|366102
NZ_CP033459.1\|WP_111897579.1\|2494156_2496505_-\|AAA-family-ATPase	unknown	unknown	gnl\|CDD\|273429
NZ_CP033459.1\|WP_111897567.1\|2468248_2468893_+\|hypothetical-protein	unknown	unknown	gnl\|CDD\|338744
NZ_CP033459.1\|WP_111897586.1\|2505394_2506078_-\|FKBP-type-peptidyl-prolyl-cis-trans-isomerase	unknown	unknown	gnl\|CDD\|223619
NZ_CP033459.1\|WP_111897580.1\|2496692_2497961_+\|MFS-transporter	unknown	unknown	gnl\|CDD\|340866
NZ_CP033459.1\|WP_111897582.1\|2500014_2502342_-\|NADP-dependent-malic-enzyme	unknown	unknown	gnl\|CDD\|235976

Protein	Function_ID	Function_description	E-value
NZ_CP033459.1\|WP_111897587.1\|2506090_2507629_-\|glycine--tRNA-ligase	gnl\|CDD\|235240	PRK04173, PRK04173, glycyl-tRNA synthetase; Provisional.	0
NZ_CP033459.1\|WP_111897577.1\|2488257_2489295_-\|aspartate--ammonia-ligase	gnl\|CDD\|235456	PRK05425, PRK05425, asparagine synthetase AsnA; Provisional.	0
NZ_CP033459.1\|WP_111897576.1\|2487667_2488045_+\|GxxExxY-protein	gnl\|CDD\|372581	pfam13366, PDDEXK_3, PD-(D/E)XK nuclease superfamily. Members of this family belong to the PD-(D/E)XK nuclease superfamily.	1.04305e-54
NZ_CP033459.1\|WP_111897578.1\|2489437_2494096_-\|hypothetical-protein	gnl\|CDD\|367909	pfam04357, TamB, TamB, inner membrane protein subunit of TAM complex. TamB is an integral inner membrane protein that forms a complex - the translocation and assembly module or TAM - with the outer membrane protein, TamA. TAM is responsible for the efficient secretion of the adhesin protein Ag43 in E.coli K-12.	5.25644e-32
NZ_CP033459.1\|WP_111897579.1\|2494156_2496505_-\|AAA-family-ATPase	gnl\|CDD\|273429	TIGR01073, ATP-dependent_DNA_helicase_PcrA, ATP-dependent DNA helicase PcrA. Designed to identify pcrA members of the uvrD/rep subfamily. [DNA metabolism, DNA replication, recombination, and repair].	0
NZ_CP033459.1\|WP_111897580.1\|2496692_2497961_+\|MFS-transporter	gnl\|CDD\|340866	cd06177, MFS_NHS, Nucleoside:H(+) symporter family of the Major Facilitator Superfamily of transporters. The prototypical members of the Nucleoside:H(+) symporter (NHS) family are Escherichia coli nucleoside permease NupG and xanthosine permease. Nucleoside:H(+) symporters are proton-driven transporters that facilitate the import of nucleosides across the cytoplasmic membrane. NupG is a broad-specificity transporter of purine and pyrimidine nucleosides. Xanthosine permease is involved in the uptake of xanthosine and other nucleosides such as inosine, adenosine, cytidine, uridine and thymidine. The NHS family belongs to the Major Facilitator Superfamily (MFS) of membrane transport proteins, which are thought to function through a single substrate binding site, alternating-access mechanism involving a rocker-switch type of movement.	2.42271e-136
NZ_CP033459.1\|WP_111897573.1\|2482332_2483622_+\|DUF4843-domain-containing-protein	gnl\|CDD\|374383	pfam16132, DUF4843, Domain of unknown function (DUF4843). This family consists of uncharacterized proteins around 220 residues in length and is mainly found in various Bacteroides species. Distant homology analysis suggest distant relation between this family and other families of proteins with immunoglobulin-like folds, which are often involved in substrate binding. However, specific function of this family is unknown. There is distant homology to the Calx-beta family pfam03160.	2.49106e-06
NZ_CP033459.1\|WP_111897575.1\|2485329_2487543_+\|sel1-repeat-family-protein	gnl\|CDD\|276807	sd00010, SLR, Sel1-like repeat. Sel1-like repeats (SLRs) share similar alpha-helical conformations with Tetratricopeptide repeats (TPRs), but with different consensus sequence lengths and superhelical topologies. SLRs contain 36 to 44 amino acids and are present in bacteria and eukaryotes but not in archaea. SLR proteins are involved in a variety of functions, and many serve as adaptor proteins for the assembly of macromolecular complexes. The SLR family was named after the Caenorhabditis elegans Sel1 protein which is predicted to fold into 11 SLRs, a transmembrane domain, and an N-terminal signal sequence. The human Sel1L protein contains an additional fibronectin type-II domain and an N-terminal PEST sequence. Its downregulation is associated with the development of breast and pancreatic carcinomas.	1.3077e-39
NZ_CP033459.1\|WP_111897581.1\|2498125_2499643_+\|DUF4301-family-protein	gnl\|CDD\|372920	pfam14134, DUF4301, Domain of unknown function (DUF4301). This family of proteins is functionally uncharacterized. This family of proteins is found in bacteria. Proteins in this family are typically between 505 and 516 amino acids in length.	0
NZ_CP033459.1\|WP_111897567.1\|2468248_2468893_+\|hypothetical-protein	gnl\|CDD\|338744	pfam13441, Gly-zipper_YMGG, YMGG-like Gly-zipper.	0.00040059
NZ_CP033459.1\|WP_111897574.1\|2483673_2485320_+\|hypothetical-protein	gnl\|CDD\|374525	pfam16407, PKD_2, PKD-like family. This is a PKD-like family of proteins found in various Bacteroides species.	1.59676e-10
NZ_CP033459.1\|WP_111897572.1\|2480872_2482291_+\|hypothetical-protein	gnl\|CDD\|185760	cd08977, SusD, starch binding outer membrane protein SusD. SusD-like proteins from Bacteroidetes, members of the human distal gut microbiota, are part of the starch utilization system (Sus). Sus is one of the large clusters of glycosyl hydrolases, called polysaccharide utilization loci (PULs), which play an important role in polysaccharide recognition and uptake, and it is needed for growth on amylose, amylopectin, pullulan, and maltooligosaccharides. SusD, together with SusC, a predicted beta-barrel porin, forms the minimum outer-membrane starch-binding complex. The adult human distal gut microbiota is essential for digestion of a large variety of dietary polysaccharides, for which humans lack the necessary glycosyl hydrolases.	1.5705e-20
NZ_CP033459.1\|WP_111897583.1\|2502533_2503142_+\|TetR/AcrR-family-transcriptional-regulator	gnl\|CDD\|366102	pfam00440, TetR_N, Bacterial regulatory proteins, tetR family.	7.23459e-14
NZ_CP033459.1\|WP_111897582.1\|2500014_2502342_-\|NADP-dependent-malic-enzyme	gnl\|CDD\|235976	PRK07232, PRK07232, bifunctional malic enzyme oxidoreductase/phosphotransacetylase; Reviewed.	0
NZ_CP033459.1\|WP_111897586.1\|2505394_2506078_-\|FKBP-type-peptidyl-prolyl-cis-trans-isomerase	gnl\|CDD\|223619	COG0545, FkpA, FKBP-type peptidyl-prolyl cis-trans isomerases 1 [Posttranslational modification, protein turnover, chaperones].	1.11152e-14
NZ_CP033459.1\|WP_111897571.1\|2477498_2480852_+\|SusC/RagA-family-TonB-linked-outer-membrane-protein	gnl\|CDD\|274948	TIGR04056, OMP_RagA_SusC, TonB-linked outer membrane protein, SusC/RagA family. This model describes a distinctive clade among the TonB-linked outer membrane proteins (OMP). Members of this family are restricted to the Bacteriodetes lineage (except for Gemmatimonas aurantiaca T-27 from the novel phylum Gemmatimonadetes) and occur in high copy numbers, with over 100 members from Bacteroides thetaiotaomicron VPI-5482 alone. Published descriptions of members of this family are available for RagA from Porphyromonas gingivalis, SusC from Bacteroides thetaiotaomicron, and OmpW from Bacteroides caccae. Members form pairs with members of the SusD/RagB family (pfam07980). Transporter complexes including these outer membrane proteins are likely to import large degradation products of proteins (e.g. RagA) or carbohydrates (e.g. SusC) as nutrients, rather than siderophores. [Transport and binding proteins, Unknown substrate].	2.73665e-154
NZ_CP033459.1\|WP_111897584.1\|2503374_2504121_+\|3-oxoacyl-[acyl-carrier-protein]-reductase	gnl\|CDD\|273824	TIGR01830, 3-oxoacyl-_reductase_FabG, 3-oxoacyl-(acyl-carrier-protein) reductase. This model represents 3-oxoacyl-[ACP] reductase, also called 3-ketoacyl-acyl carrier protein reductase, an enzyme of fatty acid biosynthesis. [Fatty acid and phospholipid metabolism, Biosynthesis].	1.28985e-123

>NZ_CP033459.1|WP_111897576.1|2487667_2488045_+|GxxExxY-protein
MNEDEITYKIRGAIFKVYNELGPGLLESVYEAALLYQLRKDGLYVESQKRLDVYFDGNLLPVDFRLDIVVEDKVIIELKSVEMLKDVHKKQLLTYLKISGRKIGLLVNFNTTDLTKDIVRIVNGL
>NZ_CP033459.1|WP_111897575.1|2485329_2487543_+|sel1-repeat-family-protein
MKQKLILVFFSLFALNMVRAQHIADLSRLVMEAEKGDALAMTQLGKLYLQGERIKPDTAKAYAYFQNAARQGLPEAAYYQAKCLENGYGIVVDEERAVRLYETAFEWIVQQADSGNLECQLFLVRRYAEGIGTERDMLKAAVWMAKAAEAGSPEAQYALSHCYNSGEGVNKDDQLAARWCLTAAENGLAEAQYETAQRFFRGEGLNKSESKAVSWLTKAAAQNYGPAQYALAQCYEEGTGVKRQAEKAKLLYEQAAQNGVNEAVLKTAQTYATKGDEAAKAVEWLRQAAAQGDDAAMCELAKRYMKGDGVEKDVAKAAELYRKAAQKGNPEAQNAWGDCLLNGVGTEKDVEQAATMYARAAEKGYAVAQRNLADCYLEGIGVDKNSALAAAHYLSAANQGDIQAQSALGECYLSGVGVDKNPVQAVLWLTKAADAGDPAAQESLGECYYNGDGVKKDLKKAFRLYEKAAEAGDADAQYSLGWCYEKGEGTGRDMKKAVEWYTKSAMQDNAEAQCCLGNRYYNGEGVERNLQKAAEWYEKAADEGVAEAQYNLALCYLNGEGVEKNESMARRYLEDAAEQDLADAQFRLGECYANGIAVTKDMEEAVACYEDAAEQNHAEALNALGDCYYLAKGVSQDYNRAFSYYQKAAELGNMAAVNNIGDCYLNGRGTPSDHKRAVQLFRQAAEKNVPDAMYNIGWCYEYGKGVSQSKTMAKYWYEKAAKAGQKNAVIALQRNNL
>NZ_CP033459.1|WP_111897574.1|2483673_2485320_+|hypothetical-protein
MKRITYCLTILTALLLSSCYEDKGNYDYDFENLNSVDGITFSPTPYRGIHGETVEFIQPMGNDTVGRLLATVEQSIGESIDNLDFKWTVTGEDFSGVFYTKGYVDLPLKAGQTTTYNVMLEVKDPVTTLAHYAKVYVSTRPLYKNSLFVLHGTGPGAMKLGNVSQIGDQHQLYADAWEYAHPGSENPFAYAVGMTYGAYYDFKIGESVNLAVFNNNGTSGIYNPYGLVQKYSANYVLPQTGEAFIVSKYGQAGDATTLTDYHYVIARDGRVAMARSFLCYHIPALQTTDPLDVGTDYEVTAGAILGSNTVFWDAKNQRFIYVGKGDFFGMDEANAREQAQMTMPMLDAEVDFSKLSATLSPKGKTALYAYVNDRENYEYAHAFFIFADAAGNMYRYELTPKDTKGGAGADEPAYTIEAMRLPNIRTTQLRTGTLTYNALFSTNYLFYANGGEVVRYNAQNGDKQTVYQAPDGWSVSCIKFRTGDPNAFSGDLGRWLSIGMTKGSEGAVAEMRLTNSADIDNTVAPVLHTGFGPVVDVQFAPLYYYQSE
>NZ_CP033459.1|WP_111897573.1|2482332_2483622_+|DUF4843-domain-containing-protein
MNKLLNYILSTVIVLTFFSACTQEEVDVFAPGNDGAYFRPNSNGSMDTTVNFANHLLDETPEVSIPIDVSILGYINGTGTRRAVIKTKPVEGYDMADVAVDELVFEAGEYQKSVNVRVSPPDTMGKVYAVCLYFDSEDPASQLGMGINGRTEFTIYVTESYSRPSNWNSSLSLYLGAWSVEKHKFMVHVLHDDQYTQSSNWGDFSNFNKLAVDSARKYNQAHPDDPLPFAIPFVEYCTYDTPPYYWGPQQEKFFGTYTSQHFVSLAKALNMTTQNEVALVGTNDEAVLAENNRQAVRGMMVQYNEYYSWYYLNATDYEDFINIPVLPNIDYDVVKPKMWSEEPSAEVVRNYYGEYSPEKYRFILRTLSAALGSNFTLARLFPMDIFYDFNGQLNVNWNSKLDGENLMKQYHDIVKAAYDNTPGLGFEIP
>NZ_CP033459.1|WP_111897572.1|2480872_2482291_+|hypothetical-protein
MKKYILSSILMATALLTSGCSDWFDVSPKTDIKAEELFTTENGFRSALAGLYISMTDDDAYGDNLSFGMLDQMAQLYDMIPDGTTSRDAIYIYDVHTNGYDTKTKLERSWLKAYNIIANCNNLLKWLDANGAEVIRSSQDRDNLRAEALAIRAYLHFDLLRGWGPIYKNDSTARCIPYRTIADASRQPLLTANEVAHKVLNDLNEAMRLLSYEKNLSLAADKERRFRFNYYAVEALMARVYCWMDDADNAVLHAQNVIANSGLTLQTSNAGDPVLFNECLCALNLYRMSDNMSAKFAEGPKFTTQYYIGTQSLNTIFESTGTSSDVDFRAKSAAFIRYDAQQQAISRKYIDNPNGAIPLIRLPEMYYILAQMSPLEEGAKYVNAVRNARGYSTSTNISEFFDELYRDDVMDAEVRKEFYAEGQYFFFLKQHEITWFYNCPAGFSAEKFVFPLPDAEIEYGWTADSATQETDK
>NZ_CP033459.1|WP_111897571.1|2477498_2480852_+|SusC/RagA-family-TonB-linked-outer-membrane-protein
MNRLRYILVLAALAICSLGTFAQTDAGWKDRKVTLRVSNETMGDILVKLARQAGADVVFEGVTIEGINEPTTLNVKDMPLDKAVLRLIGDQPVSVNYETAGRIVFRPLAEDAAAQAEDAAQYHPVSAVVTSMEDGEPIVGAMVMITDGGKNGRSGGVTDSNGKFSLRVPNNASVRISCIGYASQSFQVKQPMLNEKVVLEPNRTEEEKAVVTGMSKRSMTSFTGNFVSVKGEELRRMNPNNILEGLQFFDPSFKIVENNATGSDPNATPQFNIRGDQTLGNNVDLNSMDLLLDNVSSRPNTPLFVLDGFIVPLRRILELDPQRVENITILKDASATAIYGSRASNGVVVVETKVAPDGALSVTYNGSLTIQSPDLTGYNMMNASQKLAMEKMAGVYNENDPYQKNTYNKYLRNILAGVDTYWLSQPLRTAVQTRHTLTAAGGTDKFRYNLGLNAGFMPGVMKGSQNDTKGVTFSMSYRKDKFTVGADINLSETNGKNSPYGSFSSYTQANPYYPMKNAEGGYDLILDNHTGTGSVLITNPLYNATTGVKDISRNTTIATTMNIEYRLLPNLRFTEQLSYTRGMARTEVFYPADHTMFATETDLTKKGSYSKNTGEMTSWSSNLGVNWNAPVGKHLFSLFGNWTVNEDRNNYVNLYATGFPDRHMDDFIFGYTMSTNPTGTEALSRAMGLITQFSYSYDNRYSFDFNLSAENSSRYGDDHSMTPFWSTGVRWNAYREKFLQGRVSNLVFRANYGVTGEQNYNPYQAIEFYTYSQTMKPYTSFTTLGAMLAGLNNTELGWAKTHNLSLGVDIGFWKNRINATFNYYNNITKQLLTEYDLAPSTGFRSQVMNAGELQNRGFDITLNVIALQNVKKQLYWTISANANHNRNKIRKISDYLRKLNEAQLATAGAPLPVYQEGQSTSTLYTVRSLGIDPVTGQEVYLKRDGTKTFTWDAADKVPVGHTTPDVSGTISSSLSWRDFTATVGFTYHWGGVQYNQTLVDKLENRSIAFNMDERAAENRWTTPGDVAMYRPIDPAGSQTPQSSRFIMDDNELKCSTISLGYRFSSNRYKFLRPLSIDMASLSFTTNELFRLSSIKMERGLGYPFARSFTFSLNIIFK
>NZ_CP033459.1|WP_111897570.1|2476506_2477475_+|hypothetical-protein
MNILRTITLSAFLATALSAAGQGKTVLTAETIDYTGQKIYIDCIQTPAYSAEFDYAAGETATYTFAPTRQVGMLINSRTLVIVAPGDSIHAKVRYTDPKNVSVTFSGTPSAVAANRLYQKVQALKKSMRYRSQLLSCVTLDEKPAQRIAQSRQLLEKTAAFVETAKDKVTPEAAAYVMAESEGLAYLSFMEYPKMYAELRKLPIAEQEIGDYWALMDSVELRADAASLSCPEYVSMLMRYVAYTNEKAADGTYTMPQKLEDIYREMAEGLEGAQRDAVLFHLLTNFIRGGKEVERAEPLIAEYRQKYNINKDYIAIIDGLME
>NZ_CP033459.1|WP_111897569.1|2476037_2476340_-|hypothetical-protein
MLHPKFIISENGELRLGRVRLHEDLVRKGEKDCYGGGYYEIDIINNVMLLYDESGDYGEPMWNVFDTIKVSKAYRGLRIVYRPEKDSQAGEIEITNFCYV
>NZ_CP033459.1|WP_146739338.1|2469211_2475604_+|hypothetical-protein
MKRITLLFVFLLSWLVVPVSAQTYAITPGTRVALSDLVVGNNYVIFSTAVNSSDLSALSWAGYVYDTGSAFKMRRPGELPKDHTSASDEVWTLMAKEGSTVTFKNVSTGRYISSNTSSPLSSEEASVKFYEYSSLPSGVNKTGSDVSSVSDDGTSSINCANGDLSGTNVYGIVNTDETKGLKMVPGTSVVEYGSFCYPFTVYQASELATVTFNYVKDGVTYYTTTDNSVSLGDTYTFLVPNAYKGYAITSATDGTNTATVGNNLSFTTTSGGNTITVTLGQQNSIRDFKEITTDLTLTEITSIDNISEGQQIVMQINRGGTWAYMMWDGNGQIGKMPNMNGFEGNVFTITKAVANGDAKTVQIMGETGSYFPDLTNVANTSVITLGTAADYTLSKNSDGYFHLKNGSKGVDNNGGFGLAKISVWNYEETGQNQQIRIYEVTKGMPNLSVSSIPTDVLGNPVTNGGRYAIRVPALGNNPSLGITQPYRYLTSSTSSEKISNSTVTYDDAMLWTLSYSSQGLIIKANKNGKYVSYDLYDYSNTNDKNFLTATTSDAAEVWFPASDTRSPYSGYSLKTTSGNMVSTYLSQNSASYSTVGYYPSLHNGTLFQFVPVYDVNFVDENGDPVSTTLNGVASAAGEFVVPHRGYYTYSTVIFPELTGITTLENTYFDINGTEWDFQGLCDALAKVTGNMTITVKTNQIDYTATGALTRINDKNDDKVVTGSRYFLKMRQNASGTTDAEIDANVAYQTKNASGQIAPLAWNGDVAQTWHPYGTLKNIVLKNGDNAYLKVVDYPTSGIGYGTSFGFDVTLANATPFSAWPCDATLLRYYLTTSKLDGSIYQYTSDVVNSANTAGLNTEIVTTDVGEKIQFVPAIKLSFVVKDANGDEMTDASITYNGVTFDNTTMKAIYVEKGKGFSSLTITEVSGDNIGTHNFDAGYYTYLVGSANMKPNRLSGTISTLTGDATIYIQRKALTGYEVEGLRDVNGEVVQSNQIYRLQLVARTNTSKQQNSQDYYLTQVHNSDSLMASNAIIGNGKQHWYAQPSTTAGKIQLFAANETGYVGNSADATGNAYGEAAVVANALDFAYTSVGDESSNEWVYTLKASVNGADTYLGNPTGVNKKIGFWQSGGNICQFSFIPIGLAYGVFGQEITNGKYRIELPGRATNTSGPVTLTMNGGVGQAANLSDREQYYLNPQRMEDYRRYYWLSEIDDNVKYRNDSTQVWEFEFNGIAGVWIKNINGKYLKAESFEAGARMITDTVSRRENATLWAIRPVAISGKTNTYNLIAANDTIDTPTNWYLSNNGGGNNNMGFYNSATDGGYYFTFTPVRKISRAEAYSQGIVNGYGYTCYGLGYKNMTYAPGDNRDSIQGYMLPENLWLPYNPMSNSFSTVTFHQPDLIGYNYDKGITEPNHSDHVIRYTCYEIDNYPIESSDAPTMVNGQWTFDENTHWYAITVRACDGDANPYVMRQDFWRYDQLSDINTPFCDRYLWCFVGDSISGYLVYNKAEGAGRYMGSVNEDHIATTGIHNITWLPNDNSDAVKLYSKHLFQITQHTQSGHYMLMDRYSNLSFDAYNTGPHYGFSNYWHSRHQSNGAYIKNVLGTEEWTGGQTFQAASYEPSIYHVGGSFYARTMTFPRLTDIYKQTFTPAYFNGFVGFVGMHENTDSVDLNFRRLNANLASIGTVNPADYNTTAAFKAALAHAQSDSLAAYDIFLENLYENGVKYDEHKAYRLVNEKTGQWLSVSGDNNDGPITLKGVANFSEDTDPGSLWKFIEVDDAHPADNHTMNNKIYKMHNIYRSANLNIANDGTITLVREPYANRSSYGHDSGIGTNIDFVNDMVYMQSWGEFVFKPAAAPITGSGTGLLLSSTESNSFSTGYDLGDNDVAARWFMKGFSLDSISLTMPTTGSSEASQVYSSAVDPDHDFTWPYEHGLSAWRMTWRHADVIRGQKITPNTSTDRPFIHAGTGILFRGPKGVKFPLLPCSSTTAISSLLVSPDETVEKDTIEGVPGFKLPAGSGFVIDYANSEDVVRCCLIGSAGYTSSNYIALDDGYVFLPKTKPYIPNDGDHYGSENYTLELEDEFGNVTKIGTVDTNGNVNLNDDNAFIDLQGRRVTQPVKGQIYIHKGQKIYFK
>NZ_CP033459.1|WP_111897567.1|2468248_2468893_+|hypothetical-protein
MKKLTALLLATALVTTSCESYEQFWGTATGAGIGGMFGSAIGGIMGGPRGSDAGAVIGMVTGAVVGAAATSPEVMDETARRPSSKGDVRYDNDYAYTTPTSLYNYIEVQNVSFSDKNNNHMIDAGEVAYVTMEIYNRSSETMYDVAPQVTCDNKRVLISPTAIVSQLDSGKGVKYKAMVKGADNLRNGTAKFTVAFGSGSNRVVAKTFTLNTGK
>NZ_CP033459.1|WP_111897577.1|2488257_2489295_-|aspartate--ammonia-ligase
MSKLIKPEGYRPLLDKYETEQGIKLIKDFFQENLSTGLHLRRVTGPLFVQSGLGINDDLNGTERPVRFPVKDLNDAQAEVVHSLAKWKRLTLADFKVKPGYGIYTDMNAIRADEELDNIHSLYVDQWDWEQVITAEQRTLDYLKGVVKNIYYAMLRTEFLIRERFPQLGSVLAPKITFIHSDELCRMYPDMTPKERENAICRAHKSVFIIGIGGELSDGKPHDGRAPDYDDYSTPNAEGFKGLNGDLLVWNDVIGQGLELSSMGIRVDKEALLRQLHESGKEDRLELYFHKRLLNGDLPLSIGGGIGQSRLCMHYLQKAHIGEIQASIWPQAMREECSAANIPLI
>NZ_CP033459.1|WP_111897578.1|2489437_2494096_-|hypothetical-protein
MHKFLRNTARIVLATILGAYLLLLLAVNYGPVQEWLGREAAKMLSEKVGAPVEIGRAELGLFNKVTLHDVKMQDRDHRDMLDAKWISGKIEIRPLLEGKVRLRSIGLLDAKVNLSKADADSPLNCQFVIDAFKKKEEGPSELDLRINSLIIRRVSVHYNQQDTPRQSNRLDPRHLYVSDIDANLSLKRLTNDSIHLRVRSFSAHEQSGFDIKRLRMDLHAKKGYVHLARLLLELPQTRIEQDEFTATFSESDIAGTLRLNTTLKNAIVSTDDIAPLVPRLANLHETFTINTKLGLNPALLQLTNLDLANAGNTFHVSGNFDLLRKGNGIGGIKADVGEMRINRAFLSKAYTFATNAELPVMAARLGDVAFKGKAEWQNGGATHVAGDAETALGNVKADVTFNGNDISGKASTDRFALASLLDRSDLPDNLAVSIEGKTTLRGSAFPLTDADVNLSQATFRGRTYRNIHVKGRTDGEHIEADIDSKDPSAVLTASLQGTISANDVRDGRITANISHLAPEDFGISTGLGAPIFNLEGTAQFNTLNLAQAKADLNLSRFSVKSARLNYALNSVALSISPSELGHHLLLDTDFASADIDGPLAPEAFKACVNHIMNTALPQFASYSPFPQANNLATYAGANPQWKFRIDYKNDEVFNALVRLPVKFSGPISAYGHLRSNGRTTLNVESEKVDIDGNSIDNASLYLNGEGLDYTLLAQGEKALGRMHMKMSVEALTRNEDLDITVNWADMASKKFHGEISTITSIDESNGEQRMFTMLRPSEVFYNDSVWDIASGNFIWDAHSFEVQRFKLSHEDQILTVNGRFSKDSEDAITANLQRIDLDYVFNFVHLKPLKFDGIASGQALITFKDGAPDIRSSIHIEDFMLNDGLLGEADITGGINLSNMVVDLHGIIRDGKNRSEVEGTIPIADNRLDIGINADNMNIRFLQRYIGGILKNIEGRATGYAHIGGTFKDVEITGDLIGSATGELPINGCEYVIDKVHAVLEPTRMSFSDGVAHSPKGGTATIEGTVLHDYLRNWRYTFNFNADNMLIYDRPRTSDLPFSATAYGSGLISIDGKPGDLTANFDMRPEKKTTFTYYIDSPDDYSASSSLLTFRETPSKFAASGTDSLLMAALHAKESTGTATHAKNQNDIKQQDEKTLDIHMNMLIDMQPDVGLRIIMDEKSGDDILIYGSSPISATYYNKGNFQMFGTFNVDHGTYRMSIQDVIRKDFTFEEGSSVEFNGKPFDGILHLNAVYTVPSASLGDLNLGTGVGTGNVRADCTLAFNGKVSSPEVKFGLRLPTVSDDVSQMVKSLISTDEEMNRQILYLLAVGRFYTYDYANTTAAATQSQSTGAVNSFISNTLSGQINNVISNAMGSSNWTFGTNVSTGNYGWTDMQALGLMSGRLLNNRLLVNGNFGYRSTQTNTDNFVGDFDVQYLLTKRGEIRLKAYNETNDRYFTKNSLTTQGVGIVVQRNFNNISELFSRKTKRNKKKDKTTKKEKGTTKKADRQTIKTKSATPGEKGGPQPEKTPNAPAPAAMQPQPLLQIQQRGKGKND
>NZ_CP033459.1|WP_111897579.1|2494156_2496505_-|AAA-family-ATPase
MLELEKELNASQIKAVTLTDAPLLVIAGAGSGKTRVLTYKVAYLLENGYKPWEILSLTFTNKAAREMNRRIEQLIGEGRTRHIWSGTFHSIFARILRQEAANIGYSPNFTIYDTTDSQSVIRRIVKEMGLDDKTYKPARILSCISEAKSRLVLPDAYAADTAIMRRNAARNISETHRIYKRYNELLQQSDAMDFDDLLLMTFLLFRDHDDIRRKYADRFRYILVDEYQDTNYAQHRIVMQLAPGGCICVVGDDAQSIYSFRGANIGNILSFSDQFKDTKIVKLERNYRSTKNIVRAANSIIAHNKRQIHKDVFSEEAEGEKIKVISAYSDKEEAIIVSKFIGNYHLRDHTELNDIAILYRTNAQSRAIEEALRDKNIPYRIYSGLSFYQRKEIKDVIAYLRLIINPHDDEALRRVINYPARGIGSTTLGKLQQAASDNGCSLWEACQHPTEMGADLNKGTLGKLGIFLQLIDDFREKEKTLDIVEATKYVVTTSGIQNDLLTDDDSESKRQNVDELLASIAHFAEERREMSGEESASLSQYLTEVSLLTDTDKTDDGSPKVTLMTVHAAKGLEYDTIFITGMEEGLFPSESHFASSAELEEERRLFYVAVTRAKKRCILTWCKNRFRYGKTEICDPSPFLDEIDASCLDKSSKTEGAGKNVFMNSTGSYGTGSFSIFGTRSSKSNNWHRATGSSSSGGTVPPRSTTGLQRLRKSDDTARNVDSISTPNGIVSVGQRIEHGRFGEGRVKTIEEEGSNSKITVVFDNVGEKKLLIKYAAFRIIG
>NZ_CP033459.1|WP_111897580.1|2496692_2497961_+|MFS-transporter
MNNSFIKIRLTAMNFMQFAAWGAYLTSMGGYLFASGNPDIIGWFYSIQGIVSIFMPAIMGIIADRWINAEKLLGLCHLIAGGLMIAAGVYGVQAGDAMDKWTLFTLYSFSVAFYMPTLALSNSVAFTALTKAGLDTVKSFPPIRVFGTVGFICTMLAVDFAGYQHTAMQFVVSGAISVLLGLYAPTLPTCPTSKDKGKSLAEALGLKAFALFKDYRMALFFIFSFLLGLQLQISNGFANGFISSFAEIPEFADTFGAKHANALISLSQISETLCILLIPFFMKRFGIKRVMAIAMAAWVLRFGLFGLGNPGSGVSLFILSCIVYGVAFDFFNISGALFVDKNTNADIRSSAQGLFMLMTNGLGATVGSLAAQAVVDKYVNTQTEALAKVEGWQTSWFIFAAYALVVLVLFLLFFREKKEKAA
>NZ_CP033459.1|WP_111897581.1|2498125_2499643_+|DUF4301-family-protein
MFTEEDKKQLTEKGITEEQVMHQLDCFKTGFPFLKLVSAASVGNGILTPGEYEANEYLAAWDEYLAGDHRIVKFVPASGAASRMFKDVFAFVDAPYDVPTTDFEKYFFDNIGKAAFKPTLDATCVRLYGKNVDALVAEGKYKEVVKALLGAEGMNYGQLPKGVLHFHSYGGGARTPVEEHLVEGALYARQQNGKVNIHFTVSPEHKQLFENLVSSIVPKYEEKYGVKYVVSFSEQKSYTDTIAVTPDNEPFRNDDGSLLFRPAGHGALIVNLNDINADVIFIKNIDNVVPDRLKEDTIRYKKLIAGVLVSLQKQIFAYLEELESGVAEDKYREMLSFIENKLMCRNEKTATMSDAELREYIAGKLNRPLRVCGMVRNVGEAGGGPFIAVNPDGSASLQILESSQINVNDPKEKEMFNLGTHFNPVDLVCATTNYKGQSFNLPDYVDPATGFISSKSKNGRELKALELPGLWNGSMSDWNTVFVEVPLTTFNPVKTVNDLYREEHR
>NZ_CP033459.1|WP_111897582.1|2500014_2502342_-|NADP-dependent-malic-enzyme
MVKITKEAALTYHAQGRPGKIEVVPTKPYRTQTDLSLAYSPGVAFPCLEIQENPHEAYKYTSKGNLVAVISNGTAVLGLGDIGAMSGKPVMEGKGLLFKIYGGIDVFDIEINEKDPDKFIEVVKRIAPTFGGINLEDIKAPECFEIERRLKEELDIPVMHDDQHGTAIVSAAGLLNALDVAGKKIEDVRIVVSGAGAAAISCTRLYCAFGARHENIVMCDSKGPIRTDRPGLTEQKREFATSRTDVNTLAEALEGADVFVGLSKGNILSQDMVRSMSDHPIIFALANPEPEITYEDAMAARPDVLMSTGRTDYPNQINNVIVFPYIFRGALDVASSAINEEMKMAAARAIAELARRPVPDIVNRTYDVRKFEYGPDYFIPKPIDPRLITEVSMAVAKAAMDSGVARRPIKDWKAYKQQLRELMGQETKFTQNLYDTARSDPKRVVYAEGTHTTMLQAAVKAKEEGFCKPILLGNVDRIYKLANDLQLNMDGVEVIDLRRDDQANRRHRYAHILAEKKQREGYTYQEANDKMYERNYFGMMMVETGEADAFITGLYTKYSNTIKVAEEVIGIQPEYKHFGTMHIINSKKGTFFVADTLINRHPDLETLLDITKLSADTVRFFNRTPVMAMLSYSNFGTDKAGSPTVVHEVVRRMQEEFPHLAIDGEMQLNFALDKTLRDDKYPFTRLKGLDVNTLIFPCLNSANSSYKMLKTMSDDVSVIGPIQMGLNKPIHFTDFESSVDDIVNITAVAVLDAIVEERRICIVPQDRRKLKVVES
>NZ_CP033459.1|WP_111897583.1|2502533_2503142_+|TetR/AcrR-family-transcriptional-regulator
MSVSKTRQKLVDVAREMFARKGFDNTTMNDVAQASQKGRRTLYTYFRNKEELYNAVVECELDRLSETMDELANRNIAPERKLFMLCYAHLNSIKETVLRNGTLRAQFFRNIWMVEKVRRTFDREERDIFKRVLAEGVENGTFKVDSIILMADIFHFSLKGLEVPFIYDRLGPGVSEEQAEPIVMRLISRVLGMEPAEMWELK
>NZ_CP033459.1|WP_111897584.1|2503374_2504121_+|3-oxoacyl-[acyl-carrier-protein]-reductase
MGLLTGKTALITGAARGIGKAIALKFAEEGANIAFTDLVIDENGKATEAEIAAKGVKCIGYASNAADFAQTEEVVNTVKEEFGSIDILVNNAGITKDGLMMRMTEQQWDAVIAVNLKSAFNFIHACTPIMMRQRSGSIINMASVVGVHGNAGQSNYAASKAGLIALAKSVAQEMGSRGIRANAIAPGFIETAMTASLPDEVRKEWVQKIPLRRGGQVEDIANVATFLASELSSYVSGQVIQVDGGMNM
>NZ_CP033459.1|WP_111897586.1|2505394_2506078_-|FKBP-type-peptidyl-prolyl-cis-trans-isomerase
MTTTTSAWLRNLGRVLLVILLASPLLTSCEETNEDVVDEYSNWTARNDSAFASRLQQAKQAIKNAQANYGTDWEDHCNWRILRNYTIPTDGTFNTSDSIPVEIIAKGTGTVVPLYSDSVRANYVGRLIPTSGHPNGYLFANTGTSVNEDETFSDKLCTPALLLVSNNVQGFATALQHMHIGDLWRIYIHPELGYGESATNSIPKHSMLTFTIQLKGIYRKGQIAGDW
>NZ_CP033459.1|WP_111897587.1|2506090_2507629_-|glycine--tRNA-ligase
MAEDVFKKIVSHCKEYGFVFPSSEIYDGLGAVYDYAQNGVELKNNIKQYWWQSMVLLHENIVGIDSAIFMHPTIWKASGHVDAFNDPLIDNRDSKKRYRADVLIEEQIGKYEEKIAKEITKARKRFGEAFDEAQFRATNPRVLDNQKKRDDLHQRFSDAMNANDLEGLKQIILDEGIVCPISGTRNWTDVRQFNLMFKTEVGSTAEGASTIYLRPETAQGIFVNYLNVQKTGRMKIPFGIAQIGKAFRNEIVARQFIFRMREFEQMEMQFFVKPGTEIEWFNKWKEMRMKWHQALGFGAENYRFHDHEKLAHYANAACDIEFKMPFGFKEVEGIHSRTDFDLKQHETYSGRSIKYFDPETNESYTPYDIETSIGVDRMFLSVMCHSYMEEQLENGETRTVLKLPAALAPTKLAILPLVRKDGLPEKAREILDDLKFHFNCKYEEKDTIGKRYRRQDAVGTPYCITVDHDTLKDDTVTLRNRDTMEQQRVKISELRELIEDKVSITSLLKKLV

You can click texts colored in the table to view more detailed information

Click the colored protein region to show detailed information

Crispr_ID: NZ_CP033459_9

CRISPR_ID

CRISPR_location

CRISPR_type

Repeat_type

Spacer_info

Cas_protein_info

CRISPR-Cas_info

NZ_CP033459_9

2753129-2753281

Orphan

Consensus_repeat	Method
TCAGCGCCCCTATCGTCCAAGATTTAA	CRISPRCasFinder

2 spacers

The CRISPR arrays of NZ_CP033459_9

>merge|NZ_CP033459|9|2753129-2753281|CRISPRCasFinder
TCAGCGCCCCTATCGTCCAAGATTTAACCCTAATGGACAAAGAAACAACGATGGTTATGGTCAGCGCCCCTATCGTCCAAGGTTTAATCCGTCCGACGGAAGGAATACAGGCGGTGATGACTATAGTCCACGCCCATATCGTCCCCGTTTCAA

>NZ_CP033459|9|9|2753129-2753281|CRISPRCasFinder
TCAGCGCCCCTATCGTCCAAGATTTAA	CCCTAATGGACAAAGAAACAACGATGGTTATGG
TCAGCGCCCCTATCGTCCAAGGTTTAA	TCCGTCCGACGGAAGGAATACAGGCGGTGATGACTATAG
TCCACGCCCATATCGTCCCCGTTTCAA

Protein	Signature genes	Signature genes Name	Protein_function
NZ_CP033459.1\|WP_111898863.1\|2760618_2763018_+\|capsule-biosynthesis-protein	unknown	unknown	gnl\|CDD\|224512
NZ_CP033459.1\|WP_111898795.1\|2739287_2741216_+\|cadmium-translocating-P-type-ATPase	unknown	unknown	gnl\|CDD\|319847
NZ_CP033459.1\|WP_111898779.1\|2765332_2766700_-\|Fic-family-protein	unknown	unknown	gnl\|CDD\|376885
NZ_CP033459.1\|WP_111898778.1\|2766787_2767714_-\|tRNA-(adenosine(37)-N6)-dimethylallyltransferase-MiaA	unknown	unknown	gnl\|CDD\|234626
NZ_CP033459.1\|WP_111898783.1\|2756685_2759418_+\|methionine-synthase	unknown	unknown	gnl\|CDD\|236539
NZ_CP033459.1\|WP_111898789.1\|2746961_2748608_+\|diphosphate--fructose-6-phosphate-1-phosphotransferase	unknown	unknown	gnl\|CDD\|235930
NZ_CP033459.1\|WP_111898793.1\|2742597_2742981_+\|large-conductance-mechanosensitive-channel-protein-MscL	unknown	unknown	gnl\|CDD\|234795
NZ_CP033459.1\|WP_111898784.1\|2756185_2756662_+\|SsrA-binding-protein-SmpB	unknown	unknown	gnl\|CDD\|376590
NZ_CP033459.1\|WP_111898781.1\|2763028_2764201_+\|chain-length-determining-protein	unknown	unknown	gnl\|CDD\|225747
NZ_CP033459.1\|WP_111898782.1\|2759446_2760367_+\|hypothetical-protein	unknown	unknown	unknown
NZ_CP033459.1\|WP_111898788.1\|2751408_2752758_+\|adenylosuccinate-lyase	unknown	unknown	gnl\|CDD\|236452
NZ_CP033459.1\|WP_111898865.1\|2748738_2749551_+\|glycoside-hydrolase-family-25-protein	unknown	unknown	gnl\|CDD\|119384
NZ_CP033459.1\|WP_111898864.1\|2750635_2751322_+\|formylglycine-generating-enzyme-family-protein	unknown	unknown	gnl\|CDD\|224182
NZ_CP033459.1\|WP_111898794.1\|2741300_2742326_-\|type-I-glyceraldehyde-3-phosphate-dehydrogenase	unknown	unknown	gnl\|CDD\|273675
NZ_CP033459.1\|WP_111898792.1\|2743077_2743515_-\|Hsp20/alpha-crystallin-family-protein	unknown	unknown	gnl\|CDD\|223149
NZ_CP033459.1\|WP_111898790.1\|2746046_2746892_+\|ATPase	unknown	unknown	gnl\|CDD\|225518
NZ_CP033459.1\|WP_111898785.1\|2755658_2756162_+\|DMP19-family-protein	unknown	unknown	gnl\|CDD\|379547
NZ_CP033459.1\|WP_111898786.1\|2754253_2755648_+\|asparagine--tRNA-ligase	unknown	unknown	gnl\|CDD\|235176
NZ_CP033459.1\|WP_151908912.1\|2764215_2765178_-\|hypothetical-protein	unknown	unknown	unknown
NZ_CP033459.1\|WP_151908911.1\|2744435_2745296_+\|hypothetical-protein	unknown	unknown	gnl\|CDD\|206754

Protein	Function_ID	Function_description	E-value
NZ_CP033459.1\|WP_111898863.1\|2760618_2763018_+\|capsule-biosynthesis-protein	gnl\|CDD\|224512	COG1596, Wza, Periplasmic protein involved in polysaccharide export, contains SLBB domain of b-grasp fold [Cell wall/membrane/envelope biogenesis].	2.42845e-20
NZ_CP033459.1\|WP_111898795.1\|2739287_2741216_+\|cadmium-translocating-P-type-ATPase	gnl\|CDD\|319847	cd07548, P-type_ATPase-Cd_Zn_Co_like, P-type heavy metal-transporting ATPase, similar to Bacillus subtilis CadA which appears to transport cadmium, zinc and cobalt but not copper out of the cell. Bacillus subtilis CadA/YvgW appears to transport cadmium, zinc and cobalt but not copper, out of the cell. Functions in metal ion resistance and cellular metal ion homeostasis. CadA/YvgW is also important for sporulation in B. subtilis, the significant specific expression of the cadA/yvgW gene during the late stage of sporulation, is controlled by forespore-specific sigma factor, sigma G, and mother cell-specific sigma factor, sigma E. This subfamily also includes Helicobacter pylori CadA an essential resistance pump with ion specificity towards Cd(2+), Zn(2+) and Co(2+), and Zn-transporting ATPase, ZiaA(N) in Synechocystis PCC 6803. Transcription of ziaA is induced by Zn under the control of the Zn responsive repressor ZiaR. This subclass of P-type ATPase is also referred to as CPx-type ATPases because their amino acid sequences contain a characteristic CPC or CPH motif associated with a stretch of hydrophobic amino acids and N-terminal ion-binding sequences. This subfamily belongs to the P-type ATPases, a large family of integral membrane transporters that are of critical importance in all kingdoms of life. They generate and maintain (electro-) chemical gradients across cellular membranes, by translocating cations, heavy metals and lipids, and are distinguished from other main classes of transport ATPases (F- , V- , and ABC- type) by the formation of a phosphorylated (P-) intermediate state in the catalytic cycle.	0
NZ_CP033459.1\|WP_111898779.1\|2765332_2766700_-\|Fic-family-protein	gnl\|CDD\|376885	pfam02661, Fic, Fic/DOC family. This family consists of the Fic (filamentation induced by cAMP) protein and doc (death on curing). The Fic protein is involved in cell division and is suggested to be involved in the synthesis of PAB or folate, indicating that the Fic protein and cAMP are involved in a regulatory mechanism of cell division via folate metabolism. This family contains a central conserved motif HPFXXGNG in most members. The exact molecular function of these proteins is uncertain. P1 lysogens of Escherichia coli carry the prophage as a stable low copy number plasmid. The frequency with which viable cells cured of prophage are produced is about 10(-5) per cell per generation. A significant part of this remarkable stability can be attributed to a plasmid-encoded mechanism that causes death of cells that have lost P1. In other words, the lysogenic cells appear to be addicted to the presence of the prophage. The plasmid withdrawal response depends on a gene named doc (death on curing) that is represented by this family. Doc induces a reversible growth arrest of E. coli cells by targetting the protein synthesis machinery. Doc hosts the C-terminal domain of its antitoxin partner Phd (prevents host death) through fold complementation, a domain that is intrinsically disordered in solution but that folds into an alpha-helix on binding to Doc.This domain forms complexes with Phd antitoxins containing pfam02604.	1.26144e-20
NZ_CP033459.1\|WP_111898778.1\|2766787_2767714_-\|tRNA-(adenosine(37)-N6)-dimethylallyltransferase-MiaA	gnl\|CDD\|234626	PRK00091, miaA, tRNA delta(2)-isopentenylpyrophosphate transferase; Reviewed.	6.45419e-108
NZ_CP033459.1\|WP_111898783.1\|2756685_2759418_+\|methionine-synthase	gnl\|CDD\|236539	PRK09490, metH, B12-dependent methionine synthase; Provisional.	0
NZ_CP033459.1\|WP_111898789.1\|2746961_2748608_+\|diphosphate--fructose-6-phosphate-1-phosphotransferase	gnl\|CDD\|235930	PRK07085, PRK07085, diphosphate--fructose-6-phosphate 1-phosphotransferase; Provisional.	0
NZ_CP033459.1\|WP_111898793.1\|2742597_2742981_+\|large-conductance-mechanosensitive-channel-protein-MscL	gnl\|CDD\|234795	PRK00567, mscL, large-conductance mechanosensitive channel protein MscL.	5.93164e-67
NZ_CP033459.1\|WP_111898784.1\|2756185_2756662_+\|SsrA-binding-protein-SmpB	gnl\|CDD\|376590	pfam01668, SmpB, SmpB protein.	9.76073e-72
NZ_CP033459.1\|WP_111898781.1\|2763028_2764201_+\|chain-length-determining-protein	gnl\|CDD\|225747	COG3206, GumC, Uncharacterized protein involved in exopolysaccharide biosynthesis [Cell envelope biogenesis, outer membrane].	0.00416628
NZ_CP033459.1\|WP_111898788.1\|2751408_2752758_+\|adenylosuccinate-lyase	gnl\|CDD\|236452	PRK09285, PRK09285, adenylosuccinate lyase; Provisional.	0
NZ_CP033459.1\|WP_111898865.1\|2748738_2749551_+\|glycoside-hydrolase-family-25-protein	gnl\|CDD\|119384	cd06524, GH25_YegX-like, YegX is an uncharacterized bacterial protein with a glycosyl hydrolase family 25 (GH25) catalytic domain that is similar in sequence to the CH-type (Chalaropsis-type) lysozymes of the GH25 family of endolysins.	1.0691e-71
NZ_CP033459.1\|WP_111898864.1\|2750635_2751322_+\|formylglycine-generating-enzyme-family-protein	gnl\|CDD\|224182	COG1262, COG1262, Uncharacterized conserved protein [Function unknown].	2.59087e-48
NZ_CP033459.1\|WP_111898794.1\|2741300_2742326_-\|type-I-glyceraldehyde-3-phosphate-dehydrogenase	gnl\|CDD\|273675	TIGR01534, Glyceraldehyde-3-phosphate_dehydrogenase, glyceraldehyde-3-phosphate dehydrogenase, type I. This model represents glyceraldehyde-3-phosphate dehydrogenase (GAPDH), the enzyme responsible for the interconversion of 1,3-diphosphoglycerate and glyceraldehyde-3-phosphate, a central step in glycolysis and gluconeogenesis. Forms exist which utilize NAD (EC 1.2.1.12), NADP (EC 1.2.1.13) or either (1.2.1.59). In some species, NAD- and NADP- utilizing forms exist, generally being responsible for reactions in the anabolic and catabolic directions respectively. Two Pfam models cover the two functional domains of this protein; pfam00044 represents the N-terminal NAD(P)-binding domain and pfam02800 represents the C-terminal catalytic domain. An additional form of gap gene is found in gamma proteobacteria and is responsible for the conversion of erythrose-4-phosphate (E4P) to 4-phospho-erythronate in the biosynthesis of pyridoxine. This pathway of pyridoxine biosynthesis appears to be limited, however, to a relatively small number of bacterial species although it is prevalent among the gamma-proteobacteria. This enzyme is described by TIGR001532. These sequences generally score between trusted and noise to this GAPDH model due to the close evolutionary relationship. There exists the possiblity that some forms of GAPDH may be bifunctional and act on E4P in species which make pyridoxine and via hydroxythreonine and lack a separate E4PDH enzyme (for instance, the GAPDH from Bacillus stearothermophilus has been shown to posess a limited E4PD activity as well as a robust GAPDH activity). There are a great number of sequences in the databases which score between trusted and noise to this model, nearly all of them due to fragmentary sequences. It seems that study of this gene has been carried out in many species utilizing PCR probes which exclude the extreme ends of the consenses used to define this model. The noise level is set relative not to E4PD, but the next closest outliers, the class II GAPDH's (found in archaea, TIGR01546) and aspartate semialdehyde dehydrogenase (ASADH, TIGR01296) both of which have highest-scoring hits around -225 to the prior model. [Energy metabolism, Glycolysis/gluconeogenesis].	1.29818e-161
NZ_CP033459.1\|WP_111898792.1\|2743077_2743515_-\|Hsp20/alpha-crystallin-family-protein	gnl\|CDD\|223149	COG0071, IbpA, Molecular chaperone (small heat shock protein) [Posttranslational modification, protein turnover, chaperones].	5.05084e-26
NZ_CP033459.1\|WP_111898790.1\|2746046_2746892_+\|ATPase	gnl\|CDD\|225518	COG2971, COG2971, Predicted N-acetylglucosamine kinase [Carbohydrate transport and metabolism].	2.14199e-14
NZ_CP033459.1\|WP_111898785.1\|2755658_2756162_+\|DMP19-family-protein	gnl\|CDD\|379547	pfam14300, DUF4375, Domain of unknown function (DUF4375). This family of proteins is found in bacteria. Proteins in this family are typically between 156 and 204 amino acids in length. There is a single completely conserved residue G that may be functionally important.	1.57022e-37
NZ_CP033459.1\|WP_111898786.1\|2754253_2755648_+\|asparagine--tRNA-ligase	gnl\|CDD\|235176	PRK03932, asnC, asparaginyl-tRNA synthetase; Validated.	0
NZ_CP033459.1\|WP_151908911.1\|2744435_2745296_+\|hypothetical-protein	gnl\|CDD\|206754	cd06223, PRTases_typeI, Phosphoribosyl transferase (PRT)-type I domain. Phosphoribosyl transferase (PRT) domain. The type I PRTases are identified by a conserved PRPP binding motif which features two adjacent acidic residues surrounded by one or more hydrophobic residue. PRTases catalyze the displacement of the alpha-1'-pyrophosphate of 5-phosphoribosyl-alpha1-pyrophosphate (PRPP) by a nitrogen-containing nucleophile. The reaction products are an alpha-1 substituted ribose-5'-phosphate and a free pyrophosphate (PP). PRPP, an activated form of ribose-5-phosphate, is a key metabolite connecting nucleotide synthesis and salvage pathways. The type I PRTase family includes a range of diverse phosphoribosyl transferase enzymes and regulatory proteins of the nucleotide synthesis and salvage pathways, including adenine phosphoribosyltransferase EC:2.4.2.7., hypoxanthine-guanine-xanthine phosphoribosyltransferase, hypoxanthine phosphoribosyltransferase EC:2.4.2.8., ribose-phosphate pyrophosphokinase EC:2.7.6.1., amidophosphoribosyltransferase EC:2.4.2.14., orotate phosphoribosyltransferase EC:2.4.2.10., uracil phosphoribosyltransferase EC:2.4.2.9., and xanthine-guanine phosphoribosyltransferase EC:2.4.2.22.	0.000137291

>NZ_CP033459.1|WP_111898788.1|2751408_2752758_+|adenylosuccinate-lyase
MELNELTAVSPIDGRYHNKTKRLSDYFSEKALMRYRVKVEIEYFIWLCNMPLPQLQGVNTDNFAKLRFLYENFSDEDARRVKEIESVTNHDVKAIEYYIKENLDKIGGFEQQKEFVHFGLTSQDINNTSFPMMLKDAIVNVYLPLLDEILQQLKDYEVEWHDVPMLARTHGQPASPTRLGKEIAVYRYRLEEARRMLVSVQVTAKFGGATGNFNAHHVAYPEINWKEVANQFVEEALELQREQFTTQISNYDALAAVFDAMKRIHTILIDLDRDFWQYISEEYFKQKIKKGEVGSSAMPHKVNPIDFENSEGNLGIANAILEHLSRKLPVSRLQRDLTDSTVIRNIGVPMGHAVIAFESTLKGLRKLVLNEAAILADLDNQWAVVAEAIQTILRREGYPNPYETLKQLTRTNTHVTEESIHAFIETLNVSDSVKEELRQISPRTYVGIY
>NZ_CP033459.1|WP_111898864.1|2750635_2751322_+|formylglycine-generating-enzyme-family-protein
MKAVGGGNFTQGATSDQGGACENDEKPAHKVFLRSFLIGETEVTQELWQIVMGSNPSRFVGINRPVERVSWNACQVFIQKLNALTGLRFRLPTEAEWEYAARGGNKSRQTKYAGSNDLSNIAWWQTNSGSSTHQVAQKQPNELGLYDMSGNVWEWCNDRYAEKYYSMLVEGTDGMISNPEGPKTGTNRVCRGGGWFFGPTFCRNAFRFNFNPADSSYYIGLRLALDAE
>NZ_CP033459.1|WP_111898865.1|2748738_2749551_+|glycoside-hydrolase-family-25-protein
MAPFDGLQNDARLGLWLQKDGKRAKSAKVVAAVAVLYLVAQFFFVAPYDRLWQAIYNNIGIPDGYSIRGVDVSHHQGAINWEKLSRAIIKDEPVSFVFIKATEGVSVSDDDFKHNFEQAKKYGILRGAYHFFSPTVPAAKQADHFIKTAQLQPGDLAPVLDIEEVGDLSDEAVRTEALIWLKAVEKKYGVKPILYTYLKMKEEYFSTPEFDDYHFWLAHYYLPEIRYKGKWKFWQHTDRGRLPGIKGSVDLNVYNGSMYNLREHTIQHVN
>NZ_CP033459.1|WP_111898789.1|2746961_2748608_+|diphosphate--fructose-6-phosphate-1-phosphotransferase
MKKSALQIAREAYQPKLPLGLRGNVSVKEGEPTQSVADQEEIKKLFPNTYGLPLVEFVPSEEKKDYAPINVGVILSGGQAPGGHNVICGIFDMLKKQNPESKLYGFLMGPGGLVDHDYKELTADIIDEYRNTGGFDLIGSGRTKLELEGQFEKGLEILKQLNITALVIIGGDDSNTNACVLAEYYAAKNAGVQVIGCPKTIDGDLKNEQIETSFGFDTACKTYAEVIGNIQRDANSARKYWHFIKLMGRSASHIALECALQCQPNVCIVSEEVEAKEQTLDEIVEYIAGVVAKRAAAGNNFGTILIPEGLIEFVPAIKKLIAELNDLLAEHAAEVDGLDVADIREWLCKNLTPANAATFKSLPEGVGNQLALERDPHGNVQVSLIETEKLLSEMVGKKLAEWKKEGKYVGKFAPLHHFFGYEGRCAAPSNYDADYCYALGSSAAQLIANGKTGYMAIVKNTTAPAENWVAGGVPITMMLNMERRSGAMKPVIKKALVRLDGAPFKTFAAQREEWAENTCFIYPGPIQYFGPSEVCDRTTVTLALEQNA
>NZ_CP033459.1|WP_111898790.1|2746046_2746892_+|ATPase
MKTILIADSGSTKTNWTLCRNNQDTLRLQTQGINPYQLSESQIKDILYGELLPQLDGAQVDEVYFYGAGQRDEMRGMTTRLLKEVLTASVVEVHSDLIGAARALCGKDEGIACILGTGANSCVFDGKEITWQVSPLGFILGDEGSGAVIGKRLVGDVLKAQLPDDICKAFFEETPHTADDIIRNVYRNTFPNRFLAQYTHFVSRHITHPAVEELVTTEFERFFKRNIANYNRPDLAVNFVGSVAEVFLPQLRQAAERCGFRVGKVMKDPMEALVGYHLQNR
>NZ_CP033459.1|WP_151908911.1|2744435_2745296_+|hypothetical-protein
MTKKIIKLTKSKLNDIISEEVKKVLKEGIDIDTNSTPHTVGFNPNHQEYVDTNDPWNPQPIYNKVNGYNVISVFMRKKTNDKYDANPLLKALKGHKDWELKNEHYDIMSLLRRFVAVTKELNDSFDVIITTPSNNSLNNSIFNIVKRIIPHSTAVKHFFTKYEANYVFDYMIDDDLIAQMTNTEEEYKICKKEIERSILKMNRKNDGIFSYKYIEEKYRQYVIQSMFISDEVKSNLELANDINGKRILVLDDTVTSGKTISDSAEALMETFDPSDITFLTLFSPLT
>NZ_CP033459.1|WP_111898792.1|2743077_2743515_-|Hsp20/alpha-crystallin-family-protein
MRIMSTIRHYNNWVPSLFDEFFDTNYPRRQSYSTPAVNVIEKENGYTVEVAAAGMTKEDFQIHVDHENNLVVSMEKKQEKQEGDEKKHYLRREFNYSKFQQSLILPDNVDKAAISARVSDGVLTIEIPKLAPEKTLPQKLQIDIE
>NZ_CP033459.1|WP_111898793.1|2742597_2742981_+|large-conductance-mechanosensitive-channel-protein-MscL
MGFIKEFKEFAMKGNVMDMAVGVIIGGAFGKIVSSLVDDVIMPLVGMLTGGVDFTKLSAKIGEAEVMYGSFIQNIIDFLIIAFCIFLMIKGMNKLSRKKEEEPEAPAEPSNEEKLLGEIRDLLKKQA
>NZ_CP033459.1|WP_111898794.1|2741300_2742326_-|type-I-glyceraldehyde-3-phosphate-dehydrogenase
MTKVAINGFGRIGRLAFRQMFESEGYEVVAINDLTSPKMLAHLLKYDTAQGGFAGKFGENKHTVEAGEDYIVVDGKKITIYAKPNAAELPWGELDVDVVLECTGFYTSKEKASAHIQAGAKKVVISAPAGNDLPTIVYNVNHKTLTPADTVISAASCTTNCLAPMTKALNDFAAIQSGIMTTVHAYTGDQMILDGPQRKGDVQRARAGAQNIVPNSTGAAKAIGLVIPELNGKLIGAAQRVPTPTGSTTILHAVVKGEVTVEDINAAMKAAANESFGYTEEKLVSSDIIGMKFGSLFDANQTMVSKTGDGNSLVQVVAWYDNENSYTSQMVRTIKYLAELK
>NZ_CP033459.1|WP_111898795.1|2739287_2741216_+|cadmium-translocating-P-type-ATPase
MTSKQKKVLFRILLSAVLMVGLALLPDKSVLPFGAVGKGLAYYLAIYLIIGYDILRKACYGILNRRVFDENFLMTVATLGAFALALFEDSGDYNEAIAVMLFYQVGEFFQSYAVGKSRNSIAKLMDIRPDYANLCQPDGTIRRVDPDDVEVGTVIVVNPGERVPIDGVVIEGASSLNTSALTGESLPKEIAEGEEIISGSINMTGVLKIRTTKEFGESTVSKILEMVEDSASHKSKSEDFIARFARVYTPIVCYSALALAIIPPIVRILFIGNGAEWSVWIYRALTFLVISCPCALVVSIPLSFFAGIGGASRRGILVKGANILENLSKVKTVLFDKTGTLTLGVFEVTAMHDKEDHDNNDEEEKARLLEIAAIAECASSHPISKSLQRAYNRPIDHSRVSDIKEIGGQGITAVVDGQKVAVGNEKLMEQMGVQYCHCHTAGTIVHVAVEGKYAGHVVLGDVVKQHAAEAVKALGAVGVARTVVLTGDADAVARQTAETLGVGEVYTELLPNEKVEKVEAIISETKNGKVAFIGDGINDAPVLSRADIGIAMGGVGSDAAIEAADVVLMDDDPRKIAKAMRISNKCMNIVWQNIILAVGVKVVCLFLGAFGIANMWLAIFADVGIMIIAVLNAIRAMYIKEQ
>NZ_CP033459.1|WP_111898786.1|2754253_2755648_+|asparagine--tRNA-ligase
MKRIKIIDVLKSQDFGQSVNVKGWVRTKRGSKAVNFIALNDGSTIKNVQIVADVEKFDAELLKQITTGACLSVVGTLVQSQGAGQTSEIQATEIQVLGLCDAEYPMQKKGQTFEYMRQHAHMRLRTNTFGAVMRIRHNMAIAIHKFFHDHGFFYFHTPIITASDCEGAGEMFQVTTKNLYDLKMDEEGKIDYSDDFFGKMTSLTVSGQLEGELGATALGAIYTFGPTFRAENSNTPRHLAEFWMIEPEVAFNDINDNMDLAEEFIKYCVQWALDNCQDDLEFLNKMIDKTLLERLHFVVEHDFVRLKYTEGIRILEEAVEKGHKFEFPVSWGMDLASEHERYLVEQHFKKPVILTDYPKEIKAFYMKQNDDGKTVRAMDVLFPQIGEIIGGSEREDSYEKLMARVEELDIPMKDMWWYLDTRRFGTCPHSGFGLGFERLILFVTGMQNIRDVIPFPRTPKTAEF
>NZ_CP033459.1|WP_111898785.1|2755658_2756162_+|DMP19-family-protein
MRIVIKDSELQKAAQEGMDAFLSVFVKAIEREIDGKLTEEKMADMPSEYITLWAFHLLHEEVMDGGFVQLIVNRNGPFIFFNPFAKVMRLWGLKDLSKLLYRGRELFEKYRDQLEGDFTDEEFMALYETMPEFDDLDDEFVLEEESYVERIAIYIDEHIEDFADIEK
>NZ_CP033459.1|WP_111898784.1|2756185_2756662_+|SsrA-binding-protein-SmpB
MAKKKALKSKTINIKNKRAEFDYQIIDQYTAGIVLYGTEIKSIREGKASLVDTYCYINGGEIFVKNMYIAEYAFGSFRNHATRRERKLLLNKKEIRSLENDTKSPGLTIVPLLLYIDDNGRAKMDIALCRGKKQYDKRAAMKEKDAKRELSRTFHKEY
>NZ_CP033459.1|WP_111898783.1|2756685_2759418_+|methionine-synthase
MQTLEQIIKNRILILDGAMGTMIQKFSLSEEDFRGERFADLPGQQKGNNDLLVLTRPDVISEIHRRYLRAGADIIETNSFNSQRVSMSDYHCEHLCRELNLAAAKLAKQCAEDFSTEEKPRFVAGSVGPTNRMLSMSPDVEDPALRSITFDEMEAAFEEQIQALIDGGVDAVLIETIFDTLNTKAALYAAEEVMKRTRRVPVMLSVTIADKAGRTLSGQNIQAFLASVARPEIFSVGLNCSFGARDMKPFLMELANDAPYYVSCYPNAGLPNSLGQYDQKPEDMAEQVSEFVEEQLVNIIGGCCGTTDAFIAQYPKLVEGKAPRVPKSRPVNMQLAGLDRYELRPNSNFANVGERCNVAGSRKFLRLINEKKYDEAVQIAMKQVEDGAQVIDINMDDGLLDAEKEMTHFLNLLAAEPTVARIPFMIDSSKWNVIRAALKCVQGKCIVNSISLKEGEEKFVEKASEILRYGAATVVMAFDEQGQATTYERRIEICSRAYKILTEKLHFPPQDIIFDPNVLSVCSGIPEHDRYALDFINATKWIRNNLPHVHISGGVSNLSFSFRGNNYIREAMHAVFLYHAINAGMDMGIVNPATSVLYSDIPAERLKIIEDALLCRTSDAAEKLLNLAQETLSEKLQSKADDKADNYAAMTPQQRLADDLRKGVETHLEENINILLGEYPHAINIIEGPLMDGMNKVGELFGAGKMFLPQVIKTARTMKKAVEILKPHIEAEKEEGASSNGKVLIATVKGDVHDIGKNIVSVVLGCNNYEIIDLGVMTPAETIVEAVLNNHVDLIGLSGLITPSLDEMVNTVRALKEANISIPVAVGGATTSEMHTALKIATEYDGPVLWVKDASQMAIVAAKLMQEQSRDKLVSEICQRYETLRREYETSQTETTSLEQARRGKLNLFE
>NZ_CP033459.1|WP_111898782.1|2759446_2760367_+|hypothetical-protein
MKRFIYIIFFFLFAIVSTSQTLGIADGAMTTDGEAVKRSGMTFSKEILAQTADTIVMGLDTLEKYNQRLVRIKIDDNMPLSELDTLVSLLNKRQFTVIMALQDTIDALVQLKQFADRVNGLSGVDYKDAGCVAMWQIPLKAPSAAETVNQVKHFRNEPLVALVVDVKGMEKLEWEVMKINPDAVVLDIDPLKEGWITFENERKALPSVFLKLTAMIDNASRVAADNGIPVLINIEGFPRDNGFRKPDSDYNSRLGLWNYIKSKLDEVPQLWGVTIGQWMGKGNFTEATTSNAIYASDCSLLEQMAQ
>NZ_CP033459.1|WP_111898863.1|2760618_2763018_+|capsule-biosynthesis-protein
MTDTQVMEFIVSENQRGASRSEIVTKLMERGVSIETIRRVRNKYEKQQSKALPGAKNITTQNNSRLRKPNGEKKEEPKKQPPYKTRNTQYRDAEEERDDYYSELERFVPDTIDYYMQDDEQEEKKGEKKIFGRNIFNRKNLSFEPNMNIATPADYRLGPGDAVYVDIYGASQKTFESTVSPDGYINLEGYGPISVNGLTVSQATARLKNTLGRRYQSSQLRVSVGQTKTISVNVFGEVKSPGTYTLSAFATVFHALYLAGGTTEIGSLRSIKVYRHNNLISTVDVYDYILNGKLTGNVKLQSGDVITVQTYDCLVQIAGKVKRPMWYEMKSGESVATLLKYAGGFSGEAYEDNVSVIRKKGGMYSVYSVDKYSRSAFRVADGDSVYVDSTLNRYSNMVEIKGEVNRPGYYQMDGSIATVSQLIEKAGGLTDYALKQRGLMHRRKADRSLEAKSFDVEALMNHEVEDIILKNEDVIFIPSLKDMQEERTVRIEGEVVYPGVYDYIENTSLEDFVLQAGGLKDAASTVKIDVSRRIRNHSAKKADNQIAQWFSFELKDGFVVDGTAGFILQPFDEVYVRRSPGYIEQEHVSVDGEIAFAGVYTLTKKTQRLSDLIEVAGGLTSEGYAHGARLERVMTYSERLNYQNLMNLIITDSLDLARLQLGDTRPVGISLDKALENPGSEYDLVLRNGDRLIIPQYSNTVSINGQVLYPNTVNYKSGATLSYYINQAGGFNNYAKKSKVFAVNMNGTVTRIRSSRDIEPGTQIFVPSKANKKGLSVSEFIGLGTMGASVAAIIASILK
>NZ_CP033459.1|WP_111898781.1|2763028_2764201_+|chain-length-determining-protein
MEQNEIKTDQQNSSVQDVEAGKEQMSKPTENATGKEKKSVLTGKINLGLIFSTIWRNRYKYIIPFVVVGVLSCLLVVTMPKVYKVTVMLAPEYNSSESSSLGGLGSLASMAGINLSSLNSQDAITPSFYPDLMNSMEFVSGLFDVKVTTQDGSFTGALSKYFTTKQKASWIDQQLGKLKRDDNISDVRNKVRTSNGSDKINPFALSKKEYELAQAIMGSITCTVDKKTDVITITTQTQDPLVTALLADTIKERLQVFITQYRTSKARNDLKNAQNLCERAHQDYIKKQKEYATFVDANQDLVLESFKAKEENLENEMQIAYTTYSGLKQQVQLHKAKVEARTPAFTTLQNASVPTKSAGPKRSIIIVVAELITFLITTIFVLIFDKNVKL
>NZ_CP033459.1|WP_151908912.1|2764215_2765178_-|hypothetical-protein
MDNMQPNYNITESNLDALWRNVKEYRQSINFKAVMDACIRFRHLAPYNAMLVETQRPGAKYVLSEKEWRRKYDRGIKPNARPVIVLVPFGPVDFLFEINDTYPLKSTLFWKTDEDILEELAAPYKTKHDVSGQQLLHLMDQLCFHGIAIESFVAGASFAAKIELLQTNSHVIRIPYGRDCCIEWQAEYLLSVNSKAKRGETFGSICHELGHLYCQHLLYPRGWKPWKVRILPHAAKEFEAESISWLICELLGIGNPSEQYLCNYLNKNNEIPTDVSIEHILSATKDIWNMCMLNNRINYRDGLLFKHNEQFKEAIKQAKD
>NZ_CP033459.1|WP_111898779.1|2765332_2766700_-|Fic-family-protein
MTKIEALYNEWKSLQPIREEDANRLHQKFMLEFNYNSNHLEGNTLTYGQTELLLLFGKVVDAANMKDLEDMKASNVGLKMMEKQASSEYPLTETFIRQLHKTILREDYKVYKNLPGGQSFSYTVHAGVYKTRPNSVITQTGERFEYASPEETPSLMTDLINWYREAEESGKYTLAEMCALFHYRYIRIHPFEDGNGRIARLLVNYILAKHDYPMIVVKSSDKENYLNALSTCDGFVGTAPSEGAQATIEQIRPFVSYIEMCMERSLNTCIRAAKGQSIEEDEDFIKELKILERQKKQDFATEQSQTRFSEEEVWNVLEFVYFPLVEKFEKAIKAVNEVFHFTQSIRSNYLSKTQDYKEGLQVNNVQRKTTDPQLLEYVKNSKSMWYVCEIINPMHPKHNQLNFKKKFYVTFFEDHYFVDGILNKNFAYGAYPTTEERKAIVRQFKDDLLDTLKKL
>NZ_CP033459.1|WP_111898778.1|2766787_2767714_-|tRNA-(adenosine(37)-N6)-dimethylallyltransferase-MiaA
MASQYDFTTILGPTASGKTTLACRLAHKTGAEIISGDSRQVYRGMDIGTGKDLSDYVVDGKAIPYHLIDIVNPGYKYSVYEYQRDFLSAYNDIKSRNKPVLLCGGSGLYLESVIRSYRLSPVPPNPTLREELADKSIEELTEILKRYKTLHNTTDIDSPQRAIRAIEIEEHYLREPLDLRSFPQLNSLNIGIDVDRDVRRERISRRLKQRLEEGMLDEIRRLLDSGIAAEDLIYYGLEYKYLTLHVIGQLSHDEMFRQLEIAIHQFAKRQMTWFRGMERRGVKIHWIKESLSTEEKIEQIMALAISQE

You can click texts colored in the table to view more detailed information

Click the colored protein region to show detailed information

Self-targeting detection

CRISPR_ID	Spacer_Info	Spacer_region	Spacer_length	Hit_ID	Protospacer_location	Mismatch	Identity
NZ_CP033459_7	7.2\|2153434\|30\|NZ_CP033459\|CRISPRCasFinder,CRT	2153434-2153463	30	NZ_CP033459.1	14016-14045	0	1.0
NZ_CP033459_7	7.2\|2153434\|30\|NZ_CP033459\|CRISPRCasFinder,CRT	2153434-2153463	30	NZ_CP033459.1	2132993-2133022	1	0.967

1. spacer 7.2|2153434|30|NZ_CP033459|CRISPRCasFinder,CRT matches to position: 14016-14045, mismatch: 0, identity: 1.0

ccgactgctgggtgacattcaggcggagct	CRISPR spacer
ccgactgctgggtgacattcaggcggagct	Protospacer
******************************

2. spacer 7.2|2153434|30|NZ_CP033459|CRISPRCasFinder,CRT matches to position: 2132993-2133022, mismatch: 1, identity: 0.967

ccgactgctgggtgacattcaggcggagct	CRISPR spacer
ccgactgctgggtgacatccaggcggagct	Protospacer
******************.***********

MGE targeting detection<

CRISPR_ID	Spacer_Info	Spacer_region	Spacer_length	Hit_phage_ID	Hit_phage_def	Protospacer_location	Mismatch	Identity
NZ_CP033459_3	3.1\|1209648\|25\|NZ_CP033459\|CRISPRCasFinder	1209648-1209672	25	NC_028974	Streptomyces phage YDN12, complete genome	53408-53432	3	0.88
NZ_CP033459_3	3.1\|1209648\|25\|NZ_CP033459\|CRISPRCasFinder	1209648-1209672	25	NZ_LN831789	Streptomyces leeuwenhoekii strain type strain (C34 = DSM 42122 = NRRL B-24963) plasmid pSLE2	92080-92104	3	0.88
NZ_CP033459_3	3.1\|1209648\|25\|NZ_CP033459\|CRISPRCasFinder	1209648-1209672	25	KY365739	Streptomyces phage BabyGotBac, complete genome	53615-53639	4	0.84
NZ_CP033459_3	3.1\|1209648\|25\|NZ_CP033459\|CRISPRCasFinder	1209648-1209672	25	MH178382	Streptomyces phage Salete, complete genome	53693-53717	4	0.84
NZ_CP033459_3	3.1\|1209648\|25\|NZ_CP033459\|CRISPRCasFinder	1209648-1209672	25	MF975638	Streptomyces phage Abt2graduatex2, complete genome	53798-53822	4	0.84
NZ_CP033459_3	3.1\|1209648\|25\|NZ_CP033459\|CRISPRCasFinder	1209648-1209672	25	KU189325	Streptomyces phage Maih, complete genome	53706-53730	4	0.84
NZ_CP033459_3	3.1\|1209648\|25\|NZ_CP033459\|CRISPRCasFinder	1209648-1209672	25	MH178381	Streptomyces phage BayC, complete genome	53693-53717	4	0.84
NZ_CP033459_3	3.1\|1209648\|25\|NZ_CP033459\|CRISPRCasFinder	1209648-1209672	25	KP876466	Streptomyces phage TP1604, complete genome	53618-53642	4	0.84
NZ_CP033459_3	3.1\|1209648\|25\|NZ_CP033459\|CRISPRCasFinder	1209648-1209672	25	NZ_CP032322	Azospirillum brasilense strain MTCC4035 plasmid p1, complete sequence	849902-849926	5	0.8
NZ_CP033459_3	3.1\|1209648\|25\|NZ_CP033459\|CRISPRCasFinder	1209648-1209672	25	NZ_CP007794	Azospirillum brasilense strain Az39 plasmid AbAZ39_p1, complete sequence	1666043-1666067	6	0.76
NZ_CP033459_7	7.2\|2153434\|30\|NZ_CP033459\|CRISPRCasFinder,CRT	2153434-2153463	30	NZ_CP019641	Planococcus sp. Y42 plasmid unnamed1, complete sequence	198572-198601	6	0.8
NZ_CP033459_7	7.10\|2153958\|29\|NZ_CP033459\|CRISPRCasFinder,CRT,PILER-CR	2153958-2153986	29	NZ_CP043499	Rhizobium grahamii strain BG7 plasmid unnamed, complete sequence	1306535-1306563	7	0.759
NZ_CP033459_7	7.10\|2153958\|29\|NZ_CP033459\|CRISPRCasFinder,CRT,PILER-CR	2153958-2153986	29	MN694402	Marine virus AFVG_250M552, complete genome	5005-5033	7	0.759
NZ_CP033459_7	7.10\|2153958\|29\|NZ_CP033459\|CRISPRCasFinder,CRT,PILER-CR	2153958-2153986	29	KR093630	Moraxella phage Mcat6, complete genome	12666-12694	7	0.759
NZ_CP033459_9	9.1\|2753156\|33\|NZ_CP033459\|CRISPRCasFinder	2753156-2753188	33	NZ_CP014849	Bacillus thuringiensis strain HD12 plasmid pHD120038, complete sequence	34288-34320	7	0.788
NZ_CP033459_9	9.1\|2753156\|33\|NZ_CP033459\|CRISPRCasFinder	2753156-2753188	33	MN065183	Bacillus phage vB_BthS-HD29phi, complete genome	15596-15628	7	0.788
NZ_CP033459_7	7.4\|2153565\|30\|NZ_CP033459\|CRISPRCasFinder,CRT,PILER-CR	2153565-2153594	30	NZ_CP015881	Ensifer adhaerens strain Casida A plasmid pCasidaAA, complete sequence	365578-365607	8	0.733
NZ_CP033459_7	7.4\|2153565\|30\|NZ_CP033459\|CRISPRCasFinder,CRT,PILER-CR	2153565-2153594	30	NZ_CP030263	Ensifer adhaerens strain Corn53 plasmid AA, complete sequence	61849-61878	8	0.733
NZ_CP033459_7	7.6\|2153696\|30\|NZ_CP033459\|CRISPRCasFinder,CRT,PILER-CR	2153696-2153725	30	NC_006823	Aromatoleum aromaticum EbN1 plasmid 1, complete sequence	96257-96286	8	0.733
NZ_CP033459_7	7.6\|2153696\|30\|NZ_CP033459\|CRISPRCasFinder,CRT,PILER-CR	2153696-2153725	30	MN693674	Marine virus AFVG_250M120, complete genome	21756-21785	8	0.733
NZ_CP033459_7	7.7\|2153762\|29\|NZ_CP033459\|CRISPRCasFinder,CRT,PILER-CR	2153762-2153790	29	NZ_CP017280	Enterobacter ludwigii strain EN-119 plasmid pEN-119, complete sequence	60613-60641	9	0.69
NZ_CP033459_7	7.8\|2153827\|30\|NZ_CP033459\|CRISPRCasFinder,CRT,PILER-CR	2153827-2153856	30	NZ_CP032928	Agrobacterium tumefaciens strain 1D1460 plasmid pAt1D1460, complete sequence	163242-163271	9	0.7
NZ_CP033459_7	7.10\|2153958\|29\|NZ_CP033459\|CRISPRCasFinder,CRT,PILER-CR	2153958-2153986	29	NZ_LR594660	Variovorax sp. PBL-H6 plasmid 2	634194-634222	9	0.69
NZ_CP033459_7	7.10\|2153958\|29\|NZ_CP033459\|CRISPRCasFinder,CRT,PILER-CR	2153958-2153986	29	NZ_LR594667	Variovorax sp. SRS16 plasmid 2	203967-203995	9	0.69
NZ_CP033459_7	7.10\|2153958\|29\|NZ_CP033459\|CRISPRCasFinder,CRT,PILER-CR	2153958-2153986	29	NZ_LR594690	Variovorax sp. WDL1 plasmid 2	203535-203563	9	0.69
NZ_CP033459_7	7.10\|2153958\|29\|NZ_CP033459\|CRISPRCasFinder,CRT,PILER-CR	2153958-2153986	29	NZ_LR594672	Variovorax sp. PBL-E5 plasmid 2	203967-203995	9	0.69
NZ_CP033459_9	9.1\|2753156\|33\|NZ_CP033459\|CRISPRCasFinder	2753156-2753188	33	NC_013200	Lactobacillus rhamnosus Lc 705 plasmid pLC1, complete sequence	11735-11767	9	0.727
NZ_CP033459_9	9.1\|2753156\|33\|NZ_CP033459\|CRISPRCasFinder	2753156-2753188	33	NZ_CP016356	Lactobacillus paracasei subsp. paracasei strain TMW 1.1434 plasmid pL11434-1, complete sequence	84850-84882	9	0.727
NZ_CP033459_4	4.1\|1339150\|32\|NZ_CP033459\|CRISPRCasFinder	1339150-1339181	32	MK376342	Pseudomonas sp. strain ANT_J7 plasmid pA7J1, complete sequence	7077-7108	10	0.688
NZ_CP033459_4	4.1\|1339150\|32\|NZ_CP033459\|CRISPRCasFinder	1339150-1339181	32	KY498026	Pseudomonas sp. strain ANT_J3 plasmid pA3J1, complete sequence	1414-1445	10	0.688

1. spacer 3.1|1209648|25|NZ_CP033459|CRISPRCasFinder matches to NC_028974 (Streptomyces phage YDN12, complete genome) position: , mismatch: 3, identity: 0.88

ctgcggtcaccaccatggccatgac	CRISPR spacer
tggcggtcacccccatggccatgac	Protospacer
. ********* *************

2. spacer 3.1|1209648|25|NZ_CP033459|CRISPRCasFinder matches to NZ_LN831789 (Streptomyces leeuwenhoekii strain type strain (C34 = DSM 42122 = NRRL B-24963) plasmid pSLE2) position: , mismatch: 3, identity: 0.88

ctgcggtcaccaccatggccatgac	CRISPR spacer
ctgcggtcaccgccatggccatggg	Protospacer
***********.***********.

3. spacer 3.1|1209648|25|NZ_CP033459|CRISPRCasFinder matches to KY365739 (Streptomyces phage BabyGotBac, complete genome) position: , mismatch: 4, identity: 0.84

ctgcggtcaccaccatggccatgac	CRISPR spacer
tggcggtcaccccgatggccatgac	Protospacer
. ********* * ***********

4. spacer 3.1|1209648|25|NZ_CP033459|CRISPRCasFinder matches to MH178382 (Streptomyces phage Salete, complete genome) position: , mismatch: 4, identity: 0.84

ctgcggtcaccaccatggccatgac	CRISPR spacer
tggcggtcaccccgatggccatgac	Protospacer
. ********* * ***********

5. spacer 3.1|1209648|25|NZ_CP033459|CRISPRCasFinder matches to MF975638 (Streptomyces phage Abt2graduatex2, complete genome) position: , mismatch: 4, identity: 0.84

ctgcggtcaccaccatggccatgac	CRISPR spacer
tggcggtcaccccgatggccatgac	Protospacer
. ********* * ***********

6. spacer 3.1|1209648|25|NZ_CP033459|CRISPRCasFinder matches to KU189325 (Streptomyces phage Maih, complete genome) position: , mismatch: 4, identity: 0.84

ctgcggtcaccaccatggccatgac	CRISPR spacer
tggcggtcaccccgatggccatgac	Protospacer
. ********* * ***********

7. spacer 3.1|1209648|25|NZ_CP033459|CRISPRCasFinder matches to MH178381 (Streptomyces phage BayC, complete genome) position: , mismatch: 4, identity: 0.84

ctgcggtcaccaccatggccatgac	CRISPR spacer
tggcggtcaccccgatggccatgac	Protospacer
. ********* * ***********

8. spacer 3.1|1209648|25|NZ_CP033459|CRISPRCasFinder matches to KP876466 (Streptomyces phage TP1604, complete genome) position: , mismatch: 4, identity: 0.84

ctgcggtcaccaccatggccatgac	CRISPR spacer
tggcggtcaccccgatggccatgac	Protospacer
. ********* * ***********

9. spacer 3.1|1209648|25|NZ_CP033459|CRISPRCasFinder matches to NZ_CP032322 (Azospirillum brasilense strain MTCC4035 plasmid p1, complete sequence) position: , mismatch: 5, identity: 0.8

ctgcggtcaccaccatggccatgac	CRISPR spacer
ccatcatcaccaccatggccatgac	Protospacer
*... .*******************

10. spacer 3.1|1209648|25|NZ_CP033459|CRISPRCasFinder matches to NZ_CP007794 (Azospirillum brasilense strain Az39 plasmid AbAZ39_p1, complete sequence) position: , mismatch: 6, identity: 0.76

ctgcggtcaccaccatggccatgac	CRISPR spacer
tcatcatcaccaccatggccatgac	Protospacer
.... .*******************

11. spacer 7.2|2153434|30|NZ_CP033459|CRISPRCasFinder,CRT matches to NZ_CP019641 (Planococcus sp. Y42 plasmid unnamed1, complete sequence) position: , mismatch: 6, identity: 0.8

ccgactgctgggtgacattcaggcggagct	CRISPR spacer
catcctgctggttgccattcaggcggagcc	Protospacer
*   ******* ** **************.

12. spacer 7.10|2153958|29|NZ_CP033459|CRISPRCasFinder,CRT,PILER-CR matches to NZ_CP043499 (Rhizobium grahamii strain BG7 plasmid unnamed, complete sequence) position: , mismatch: 7, identity: 0.759

agtaatcgtgccacccttgcctgcaatag	CRISPR spacer
tatgatcgtgccacccttgcgcgcaatga	Protospacer
 .*.**************** .*****..

13. spacer 7.10|2153958|29|NZ_CP033459|CRISPRCasFinder,CRT,PILER-CR matches to MN694402 (Marine virus AFVG_250M552, complete genome) position: , mismatch: 7, identity: 0.759

agtaatcgtgccacccttgcctgcaatag	CRISPR spacer
ctctaccgtgccacctttgccagcaatag	Protospacer
  . *.*********.***** *******

14. spacer 7.10|2153958|29|NZ_CP033459|CRISPRCasFinder,CRT,PILER-CR matches to KR093630 (Moraxella phage Mcat6, complete genome) position: , mismatch: 7, identity: 0.759

agtaatcgtgccacccttgcctgcaatag	CRISPR spacer
cttaatggtgccacctttgcctgcagcat	Protospacer
  **** ********.*********..*

15. spacer 9.1|2753156|33|NZ_CP033459|CRISPRCasFinder matches to NZ_CP014849 (Bacillus thuringiensis strain HD12 plasmid pHD120038, complete sequence) position: , mismatch: 7, identity: 0.788

ccctaatgg---acaaagaaacaacgatggttatgg	CRISPR spacer
---tagttgctcacaaagaaacgatgatggttatgg	Protospacer
   **.* *   **********.*.***********

16. spacer 9.1|2753156|33|NZ_CP033459|CRISPRCasFinder matches to MN065183 (Bacillus phage vB_BthS-HD29phi, complete genome) position: , mismatch: 7, identity: 0.788

ccctaatgg---acaaagaaacaacgatggttatgg	CRISPR spacer
---tagttgctcacaaagaaacgatgatggttatgg	Protospacer
   **.* *   **********.*.***********

17. spacer 7.4|2153565|30|NZ_CP033459|CRISPRCasFinder,CRT,PILER-CR matches to NZ_CP015881 (Ensifer adhaerens strain Casida A plasmid pCasidaAA, complete sequence) position: , mismatch: 8, identity: 0.733

tgacctgcgtcgtcccgtcgcagccgagac	CRISPR spacer
ccgccgttgtcatcccgtcgcagccgagag	Protospacer
. .**  .***.*****************

18. spacer 7.4|2153565|30|NZ_CP033459|CRISPRCasFinder,CRT,PILER-CR matches to NZ_CP030263 (Ensifer adhaerens strain Corn53 plasmid AA, complete sequence) position: , mismatch: 8, identity: 0.733

tgacctgcgtcgtcccgtcgcagccgagac	CRISPR spacer
ccgccgttgtcatcccgtcgcagccgagag	Protospacer
. .**  .***.*****************

19. spacer 7.6|2153696|30|NZ_CP033459|CRISPRCasFinder,CRT,PILER-CR matches to NC_006823 (Aromatoleum aromaticum EbN1 plasmid 1, complete sequence) position: , mismatch: 8, identity: 0.733

ctttcgaccagcagtaaggacagcggacat	CRISPR spacer
tctcttgccagcagcaaggagagcggacat	Protospacer
..*.. .*******.***** *********

20. spacer 7.6|2153696|30|NZ_CP033459|CRISPRCasFinder,CRT,PILER-CR matches to MN693674 (Marine virus AFVG_250M120, complete genome) position: , mismatch: 8, identity: 0.733

ctttcgaccagcagtaaggacagcggacat	CRISPR spacer
atttgtaccagcagtaaggacagcagtatc	Protospacer
 ***  ******************.*   .

21. spacer 7.7|2153762|29|NZ_CP033459|CRISPRCasFinder,CRT,PILER-CR matches to NZ_CP017280 (Enterobacter ludwigii strain EN-119 plasmid pEN-119, complete sequence) position: , mismatch: 9, identity: 0.69

gtaacgcgcggctgtgtcttccaccactt	CRISPR spacer
caggcgcgcggccgtgtcttccaccttcg	Protospacer
  ..********.************ ..

22. spacer 7.8|2153827|30|NZ_CP033459|CRISPRCasFinder,CRT,PILER-CR matches to NZ_CP032928 (Agrobacterium tumefaciens strain 1D1460 plasmid pAt1D1460, complete sequence) position: , mismatch: 9, identity: 0.7

gattttgagtatttagacgatgccgattta	CRISPR spacer
cattttgaggatttcgacgatgccatagcc	Protospacer
 ******** **** *********.   .

23. spacer 7.10|2153958|29|NZ_CP033459|CRISPRCasFinder,CRT,PILER-CR matches to NZ_LR594660 (Variovorax sp. PBL-H6 plasmid 2) position: , mismatch: 9, identity: 0.69

agtaatcgtgccacccttgcctgcaatag	CRISPR spacer
ccacgtcgtgccagccttgcctgcaacgc	Protospacer
    .******** ************..

24. spacer 7.10|2153958|29|NZ_CP033459|CRISPRCasFinder,CRT,PILER-CR matches to NZ_LR594667 (Variovorax sp. SRS16 plasmid 2) position: , mismatch: 9, identity: 0.69

agtaatcgtgccacccttgcctgcaatag	CRISPR spacer
ccacgtcgtgccagccttgcctgcaacgc	Protospacer
    .******** ************..

25. spacer 7.10|2153958|29|NZ_CP033459|CRISPRCasFinder,CRT,PILER-CR matches to NZ_LR594690 (Variovorax sp. WDL1 plasmid 2) position: , mismatch: 9, identity: 0.69

agtaatcgtgccacccttgcctgcaatag	CRISPR spacer
ccacgtcgtgccagccttgcctgcaacgc	Protospacer
    .******** ************..

26. spacer 7.10|2153958|29|NZ_CP033459|CRISPRCasFinder,CRT,PILER-CR matches to NZ_LR594672 (Variovorax sp. PBL-E5 plasmid 2) position: , mismatch: 9, identity: 0.69

agtaatcgtgccacccttgcctgcaatag	CRISPR spacer
ccacgtcgtgccagccttgcctgcaacgc	Protospacer
    .******** ************..

27. spacer 9.1|2753156|33|NZ_CP033459|CRISPRCasFinder matches to NC_013200 (Lactobacillus rhamnosus Lc 705 plasmid pLC1, complete sequence) position: , mismatch: 9, identity: 0.727

ccctaatggacaaagaaacaacgatggttatgg	CRISPR spacer
gccaaatggacaaagaaaccacgataaattgag	Protospacer
 ** *************** *****.. *  .*

28. spacer 9.1|2753156|33|NZ_CP033459|CRISPRCasFinder matches to NZ_CP016356 (Lactobacillus paracasei subsp. paracasei strain TMW 1.1434 plasmid pL11434-1, complete sequence) position: , mismatch: 9, identity: 0.727

ccctaatggacaaagaaacaacgatggttatgg	CRISPR spacer
gcctaatggacaaagaacccacgataaattgag	Protospacer
 **************** * *****.. *  .*

29. spacer 4.1|1339150|32|NZ_CP033459|CRISPRCasFinder matches to MK376342 (Pseudomonas sp. strain ANT_J7 plasmid pA7J1, complete sequence) position: , mismatch: 10, identity: 0.688

ctcgacacactccactacagcatcagtaagcc	CRISPR spacer
cagtggacactccactaatgcatcagtaatga	Protospacer
*   . ***********  **********

30. spacer 4.1|1339150|32|NZ_CP033459|CRISPRCasFinder matches to KY498026 (Pseudomonas sp. strain ANT_J3 plasmid pA3J1, complete sequence) position: , mismatch: 10, identity: 0.688

ctcgacacactccactacagcatcagtaagcc	CRISPR spacer
cagtggacactccactaatgcatcagtaatga	Protospacer
*   . ***********  **********

Prophage detection

Region	Region Position	Protein_number	Hit_taxonomy	Key_proteins	Att_site	Prophage annotation

Anti-CRISPR protein detection

Acr ID	Acr position	Acr size	Homology with known anti	Neighbor HTH/AcRanker	Neighbor Aca	In prophage	Protospacer in prophage

Overview of predicted results

Overview of the results

Cas Category Instructions

Results visualization

1. NZ_CP033459

Click the left colored region to show detailed information

CRISPR-Cas detection and classification

Click the colored protein region to show detailed information

Click the colored protein region to show detailed information

Click the colored protein region to show detailed information

Click the colored protein region to show detailed information

Click the colored protein region to show detailed information

Click the colored protein region to show detailed information

Click the colored protein region to show detailed information

Click the colored protein region to show detailed information

Click the colored protein region to show detailed information

Self-targeting detection

MGE targeting detection<

Prophage detection

Anti-CRISPR protein detection